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Résumé français  
 
À l’intérieur de la cellule sillonnent d’innombrables molécules, certaines par diffusion et 
d’autres sur des routes moléculaires éphémères, empruntées selon les directives spécifiques 
de protéines responsables du trafic intracellulaire.  Parmi celles-ci, on compte les sorting 
nexins, qui déterminent le sort de plusieurs types de protéine, comme les récepteurs, en les 
guidant soit vers des voies de dégradation ou de recyclage.  À ce jour, il existe 33 membres 
des sorting nexins (Snx1-33), tous munies du domaine PX (PHOX-homology).  Le domaine PX 
confère aux sorting nexins la capacité de détecter la présence de phosphatidylinositol 
phosphates (PIP), sur la surface des membranes lipidiques (ex : membrane cytoplasmique ou 
vésiculaire).  Ces PIPs, produits de façon spécifique et transitoire, recrutent des protéines 
nécessaires à la progression de processus cellulaires.  Par exemple, lorsqu’un récepteur est 
internalisé par endocytose, la région avoisinante de la membrane cytoplasmique devient 
occupée par PI(4,5)P2.  Ceci engendre le recrutement de SNX9, qui permet la progression de 
l’endocytose en faisant un lien entre le cytoskelette et le complexe d’endocytose. 
Les recherches exposées dans cette thèse sont une description fonctionnelle de deux 
sorting nexins peux connues, Snx11 et Snx30.  Le rôle de chacun de ces gènes a été étudié 
durant l’embryogenèse de la grenouille (Xenopus laevis).  Suite aux résultats in vivo, une 
approche biomoléculaire et de culture cellulaire a été employée pour approfondir nos 
connaissances. 
Cet ouvrage démontre que Snx11 est impliqué dans le développement des somites et dans 
la polymérisation de l’actine. De plus, Snx11 semble influencer le recyclage de récepteurs 
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membranaires indépendamment de l’actine.  Ainsi, Snx11 pourrait jouer deux rôles 
intracellulaires : une régulation actine-dépendante du milieu extracellulaire et le triage de 
récepteurs actine-indépendant.  De son côté, Snx30 est impliqué dans la différentiation 
cardiaque précoce par l’inhibition de la voie Wnt/β-catenin, une étape nécessaire à 
l’engagement d’une population de cellules du mésoderme à la ligné cardiaque.  L’expression 
de Snx30 chez le Xénope coïncide avec cette période critique de spécification du mésoderme 
et le knockdown suscite des malformations cardiaques ainsi qu’à d’autres tissus dérivés du 
mésoderme et de l’endoderme.   
Cet ouvrage fournit une base pour des études futures sur Snx11 et Snx30.  Ces protéines 
ont un impact subtil sur des voies de signalisation spécifiques.  Ces caractéristiques pourraient 
être exploitées à des fins thérapeutiques puisque l’effet d’une interférence avec leurs fonctions 
pourrait être suffisant pour rétablir un déséquilibre cellulaire pathologique tout en minimisant 
les effets secondaires. 
Mots clés : Sorting nexin, trafic intracellulaire, embryogenèse, cardiogénèse, somitogenèse, 
Wnt/β-catenin, actin 
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English Summary 
 
The intracellular milieu is housed by countless numbers of intracellular molecules travelling 
by diffusion or along transient paths, which are regulated by specific trafficking proteins.  Among 
these traffic regulators are the sorting nexins that determine the fate of internalized proteins by 
directing toward a defined path, which can lead to either degradation or recycling.  To date, 33 
sorting nexins (Snx1-33) have been identified, which all share a common characteristic, the 
presence of a PX (PHOX-homology) domain.  The PX domain is a phosphatidylinositol 
phosphate (PIP)-binding domain, which helps bring sorting nexins to PIP-enriched areas of 
lipid membranes.  For example, during receptor endocytosis, the surrounding membrane 
becomes transiently occupied by PI(4,5)P2.  PI(4,5)P2 is then recognized by Snx9, which 
contributes to the progression of endocytosis by linking the receptor complex to the actin 
cytoskeleton. 
The research presented in this thesis is the first to investigate the functions for two sorting 
nexins, Snx11 and Snx30, during embryogenesis and endosomal protein trafficking.  Results 
obtained from knockdown experiments in the frog (Xenopus laevis) were combined with data 
from cell culture and biomolecular experiments to propose a function for these two proteins.  
The data presented here suggest that Snx11 is involved in somitogenesis, and regulates actin-
dependent and -independent processes.  Snx11 could serve as a scaffolding protein, linking 
the extra-cellular matrix to the actin cytoskeleton and could also function in actin-independent 
receptor recycling.  On the other hand, Snx30 is implicated in early cardiogenesis and promotes 
the commitment of a population of mesoderm cells to the cardiac lineage.  It does so through 
the inhibition of Wnt/β-catenin signaling but the underlying mechanism is still unclear.  
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Expression of Snx30 in Xenopus coincides with this critical period of cardiac specification and 
knockdown of Snx30 results in cardiac malformations as well as other defects in mesoderm- 
and endoderm-derived tissue.  In addition, data from both Xenopus and HEK293T cell culture 
show that knockdown of Snx30 increases Wnt/β-catenin signaling. 
This work provides the basis for future studies on Snx11 and Snx30.  Interestingly, Snx11 
and Snx30 seem to act as fine-tuners of signaling pathways.  These proteins could potentially 
become interesting therapeutic targets due to their specificity and relatively subtle impact when 
knocked-down.  As such, interference with their function could be useful to re-balance a cellular 
disequilibrium while minimizing side effects. 
Key words: Sorting nexin, protein trafficking, embryogenesis, cardiogenesis, somitogenesis, 
Wnt/β-catenin, actin 
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Chapter 1: The cellular biology of protein trafficking 
 
Living cells are in constant flux.  As part of a living organism, cells must process signals 
coming from the extracellular milieu, and carry out an appropriate cellular response.  During 
both of these essential steps (signal processing and cellular response) intracellular trafficking 
is fundamental.  The necessity of intracellular trafficking is explained by the fact that molecules 
cannot travel far by free diffusion and signaling effectors must be properly localized to interact 
with their targets.  Intracellular trafficking is thus involved in virtually all aspects of cellular 
biology since proteins must be located at their site of action to properly perform their task.  
Endosomal protein sorting is a form of intracellular trafficking that regulates the transportation 
of membrane-associated proteins across different intracellular compartments.  This form of 
traffic occurs in the following sequence of processes: formation and fission of a transport vesicle 
from a donor membrane, transportation of this vesicle between compartments, and finally 
docking and fission of the vesicle with the acceptor membrane.  However, prior to these 
processes, a decision is made as to which cargo will be selected and what will be its destination.  
This aspect of protein trafficking is termed endosomal protein sorting. 
The main components that contribute to intracellular trafficking (endocytosis, the 
endosomal system and the processes of intracellular trafficking) will be discussed in the next 
sections with examples to illustrate how they function.  Throughout these sections, it is 
important to consider that the results that stem from isolated cellular processes are in fact part 
of a holistic, interconnected system that is the living organism.  As such, I will attempt to 
integrate data from molecular and cellular biology into developmental biology. 
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1.1 – Endocytosis 
 
The entry of material into a eukaryotic cell occurs mostly through a process called 
endocytosis, an essential stage in many signaling pathways as it removes receptors from the 
cell surface.  This limits the magnitude of signaling from extracellular sources and allows 
signaling to proceed from inside the cell.  Endocytosis can also control ligand availability, as is 
the case for the membrane-bound DSL (Delta, Serrate and LAG-2) family of ligands, which 
activate the Notch family of receptors of adjacent cells [1].  Once internalized, material can 
travel throughout boundary-forming lipid membranes collectively known as the endosomal 
network, which includes compartments such as the early and late endosomes, the lysosome 
and the trans-Golgi network.  Transportation of cargo throughout this dynamic network is a 
highly regulated process that requires the coordinated action of specialized trafficking proteins. 
Many mechanisms of endocytosis exist and they have been divided into two major 
categories: clathrin-mediated endocytosis (CME) and clathrin-independent endocytosis (CIE) 
(Figure 1) [2].  Both these types of endocytosis are utilized to displace signaling receptors from 
the plasma membrane to an intracellular compartment.  Endocytosis is also exploited by toxins, 
viruses and bacteria for penetration into the cell but this thesis will focus on the endocytosis 
and trafficking of receptors [3]. 
Endocytosis of a particular receptor can result in different outcomes depending on the 
endocytic route used.  For example, internalization of the epidermal growth factor receptor 
(EGFR) with CME induces its recycling back to the plasma membrane [4, 5].   In contrast, if 
EGFR is internalized via CIE, the receptor is sent to the lysosome for degradation [4, 5].  In 
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addition, CME and CIE do not always produce the same effect.  In Wnt/β-catenin signaling 
through the Frizzled receptor and LRP5/6 co-receptor, CME leads degradation of LRP5/6 while 
CIE leads to its recycling [6].  Therefore, the type of endocytosis alone does not determine the 
fate of internalized material mechanisms but rather contributes to signaling outcome, along with 
other factors such as the cellular context, the identity of internalized material and the trafficking 
machinery implicated in the process.  The fate of internalized material and thus the 
sustainment, amplification or attenuation of signaling is intimately linked to endocytosis and 
subsequent sorting mechanisms.  The next paragraphs provide a brief review of CME and CIE. 
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Figure 1.  The different modes of endocytosis.  Cells can internalize plasma membrane 
and receptors through a number of different routes.  Clathrin-mediated and caveolin-
mediated routes both require dynamin.  The first destination in all routes is the early 
endosome, where protein sorting occurs, which directs cargo either back to the plasma 
membrane via the recycling endosome or into other compartments (multivesicular 
bodies (MVBs) or lysosomes) for degradation. [7] 
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1.2 – Clathrin-mediated endocytosis 
 
The most studied and understood mechanism for the uptake of macromolecules is clathrin-
mediated endocytosis.  Clathrin is a protein that oligomerizes on the cytoplasmic side of the 
plasma membrane and assembles with other proteins to deform the plasma membrane, which 
becomes gradually invaginated, forming a clathrin-coated pit (CCP) (Figure 2).  This CCP 
eventually buds off as a clathrin-coated vesicle, which is quickly uncoated before proceeding 
to their next intracellular destination.  The whole process of clathrin-mediated endocytosis has 
been divided into five stages: nucleation, cargo selection, clathrin coat assembly, vesicle 
scission and uncoating [7]. 
 
1.2.1 – Nucleation 
 
The first stage in CME is membrane invagination, triggered by the formation of a nucleation 
module, which is comprised of FCH domain only (FCHO) proteins, EGFR pathway substrate 
15 (EPS15) and intersectins [8-10].  This nucleation module assembles at a specific site on the 
plasma membrane, transiently enriched with PI(4,5)P2 [11].  During nucleation, the detection 
and induction of membrane deformations play important roles in the progression of 
endocytosis.  For instance, the F-BAR domain of FCHO proteins and Snx9 bind to very low 
curvatures, generating further membrane bending [9, 10, 12]. 
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Figure 2. Clathrin.  A) First identification of clathrin by Barbara Pearse in 1976 [13].  
Shown here is an electron micrograph of bovine adrenal medulla fraction containing 
large clathrin coated vesicles (CCV) (X67,500).  B) Quick-freeze deep-etch micrography 
of the inner plasma membrane surface of A431 cells showing the typical clathrin lattice 
of growing pits [14].  Caveolae are also seen surrounded by F-actin filaments.  C) An 
illustration of the clathrin triskelia (CHC: clathrin heavy chain; CLC: clathrin light chain).  
D) A model of a clathrin-coated vesicle is depicted showing assembled clathrin triskelia 
[15]. 
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1.2.2 – Cargo selection 
 
Once the nucleation module is assembled at the plasma membrane, the AP2 adaptor 
complex joins the module and together, they mediate cargo selection [9].  AP2 acts as a major 
hub of interactions as it can directly and simultaneously bind to PI(4,5)P2 and to motifs in the 
cytoplasmic tails of transmembrane receptors [16, 17].  Indirectly, AP2 can also bind to cargo 
via accessory adaptor proteins.  For example, during Wnt/β-catenin signaling, internalization of 
the Frizzled receptor depends upon the recruitment of and binding to Dishevelled, which 
interacts with AP2 [18].  Other proteins of the endocytosis machinery also contribute to cargo 
selection, such as proteins with the AP180 amino-terminal homology (ANTH) and Epsin N-
terminal homology (ENTH) domains, which are membrane-binding and membrane-bending 
domains, respectively [19, 20]. 
 
 
1.2.3 – Clathrin coat assembly 
 
Once the cargo is selected, clathrin triskelia (Figure 2C) are recruited to the site of the 
nucleation module and adaptor proteins.  Clathrin triskelia consist of three clathrin heavy chains 
and three clathrin light chains that form a polyhedral lattice around the forming vesicle.  As 
invagination of the clathrin-coated pit progresses, adaptor proteins and curvature effectors 
move to the edge of the forming vesicle, where they continue to promote the formation of the 
growing pit [21, 22]. 
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1.2.4 – Vesicle scission 
 
Near the end of CCP formation, a small portion remains attached to the plasma membrane, 
which must be clipped off.  This is largely dependent on the large GTPase called dynamin.  By 
assembling into a spiral around the neck of the clathrin-coated pit, dynamin mediates 
membrane fission and the release of clathrin-coated vesicles (Figure 3) [23].  Recent studies 
have also shown that BAR domain-containing proteins like sorting nexin-9 (Snx9) and actin 
polymerization also contribute to vesicle fission [24-26].  
 
1.2.5 – Uncoating 
 
Once the vesicle has detached from the plasma membrane, ATPase heat shock cognate 
70 (HSC70) and auxilin disassemble the clathrin coat from its lattice arrangement back to 
triskelia [27, 28].  This allows the detached and uncoated vesicle to travel through the cytoplasm 
and fuse with the acceptor membrane of its destination, the early endosome. 
Clathrin coated vesicles are also sometimes formed during vesicle formation from 
intracellular compartments.  The stages of vesicle formation in these cases are very similar, 
except that some modules are interchangeable; for example, AP1 or AP3 may be substituted 
for AP2 during vesicle formation from endosomes and the trans-Golgi network (TGN) [29]. 
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1.3 – Clathrin-independent endocytosis 
 
Several forms of clathrin-independent endocytosis exist and these mediate primarily the 
intake of fluid and membrane.  Clathrin-independent endocytosis accounts for about 70% of 
fluid uptake [30] and 60-85% of membrane uptake [31, 32].  In addition, clathrin-independent 
endocytosis is implicated in plasma membrane repair, cellular spreading, cellular polarization, 
and modulation of intercellular signaling.  
 
1.3.1 – Caveolae 
 
Caveolae are submicroscopic plasma membrane pits (Figure 1B) that sense and respond 
to plasma membrane stresses, remodel the extracellular environment, and contribute to 
signaling pathways as a mode of endocytosis [33].  Caveolae are irregularly distributed across 
tissues and individual cells, and unlike clathrin-coated pits, they have no obvious coat.  For 
example, they are practically undetectable in kidney cells while they can represent up to 50% 
of plasma membrane surface on endothelial cells and adipocytes [34, 35].  The main membrane 
components of caveolae are the oligomeric caveolins, which drive caveolae formation with the 
help of cavins [33, 36].  Cholesterol and phosphatidylserine also seems to be important 
membrane components for caveolae formation since they are abundant in areas that are rich 
in caveolae and their depletion disrupts caveolae formation [37, 38].  Due to the presence of 
these lipids, caveolae are sometimes called lipid-rafts.  Although whether and how caveolae 
undergo endocytosis has been a subject of controversy for many years, a  
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Figure 3.  Membrane scission of a clathrin-coated vesicle.  Contributing factors in the 
scission of endocytic carriers include the pinching action of dynamin as well as the force 
brought about by actin polymerization.  Tubule coat proteins like Snx9 also contribute 
to membrane deformation and activation of dynamin. [39] 
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consensus has emerged that caveolae bud from the plasma membrane in a dynamin-
dependent manner.  In general, internalization of caveolae leads to their fusion with the early 
endosome, from where their components can recycle back to the surface [40]. 
As one of their biological functions, caveolae can flatten in response to stretching of the 
plasma membrane, thereby preventing damage or cell lysis.  This has been shown in several 
cell types, including cardiomyocytes [41].  It is thus possible that caveolae and their 
components play important roles in mechanosensitive responses as both caveolins and cavins 
are released into the plasma membrane and cytoplasm, respectively, during flattening of 
caeolae [42].  Caveolae and caveolins have also been implicated in many signaling pathways, 
such as eNOS, Wnt/β-catenin and PAR-1 signaling, as well as in the regulation of lipids [33, 
43, 44]. 
 
1.3.2 – RhoA, Cdc42, Arf6 
 
In general, small GTPases like Cdc42, Arf6 and RhoA are used to differentiate between the 
endocytic routes employed by glycosylphosphatidylinositol-(GPI) anchored proteins, the major 
histocompatibility class 1 (MHCI) molecules and the interleukin 2 receptor (IL2R), respectively 
[45-47].  Other markers like flotillins are also involved in carrier formation and can be used to 
identify specific clathrin-independent routes [36].  These endocytic routes also make use of 
actin and actin-associated proteins [48, 49], as well as Snx9 [50, 51].  Importantly, clathrin-
independent endocytosis is under differential regulation by signaling pathways and cell type 
[52].  While RhoA-dependent endocytosis requires dynamin and endocytosis via Cdc42 is 
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dynamin-independent, both routes are reported to be dependent on lipid rafts for vesicle 
formation [36, 45, 53].  Also protein toxins such as Clostridium botulinum C2 toxin make use of 
RhoA-mediated endocytosis [54, 55], but this is not exclusive since clathrin-dependent 
endocytosis can also take up a fraction of the C2 toxin [54].   
The largest fraction of fluid uptake is mediated by Cdc42-dependent endocytosis [30, 53] 
but this pathway is also involved in the uptake of GPI-anchored proteins, and has therefore 
been called the GPI-enriched early endosomal compartment (GEEC) pathway [53].  The raft-
associated proteins flotillin 1 and flotillin 2 play a role in both dynamin-dependent [56, 57] and 
-independent endocytosis [58].  Basolateral uptake of GPI-anchored proteins was found to be 
dependent on flotillin 2 and dynamin [56], whereas the flotillin 1-dependent uptake of GPI-linked 
proteins and cholera toxin B was reported to be dynamin-independent [58]. 
As previously mentioned, the endocytic route employed by a particular signaling molecule 
can have varying effects.  An example of this is the endocytosis of LRP6, which is internalized 
in caveolar vesicles that move to early endosomes in a Rab5-dependent process, in response 
to Wnt3A [59].  The same study also showed that LRP6 is recycled back to the plasma 
membrane 4 hr after stimulation in a Rab11-dependent manner but could not exclude the 
possibility that a small portion of internalized LRP6 was transported to the lysosome or 
proteasome for degradation [59].  Interestingly, the same group later found that stimulation of 
LRP6 with the Wnt antagonist, Dkk1, resulted in clathrin-mediated LRP6 endocytosis, and the 
subsequent downregulation of this pathway [60]. 
This example demonstrates the intimate relationship that exists between specific signaling 
pathways and their underlying trafficking mechanisms.  They also help appreciate the diversity 
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of responses a cell can have to an extra-cellular signal as any given endocytic pathway cannot 
be the sole determinant of signaling pathway outcome.  Many factors need to be taken into 
account, including the cell-type, the extracellular signal, the receptor(s) involved, the endocytic 
route employed and the overall cellular context at that moment in time.  The contributing factors 
ultimately act together to engender a cellular outcome. 
 
 
1.4 – The endosomal system 
 
Eukaryotic cells evolved a way to perform specialized reactions within isolated and tailored 
micro-environments, called endosomes.  Endosomes are intracellular compartments that can 
receive and produce fleets of transport vesicles shuttling proteins and lipids (Figure 4).  
Although this membranous network is very dynamic, some compartments stand out as 
specialized stations, occupied by specific resident proteins and lipids, where specialized 
functions are performed.  Accordingly, the various compartments that make up the endosomal 
network have been labeled as early endosomes, recycling endosomes, multivesicular bodies 
(MVB), lysosomes, and the TGN.  This simplified model is made up of a recycling pathway for 
plasma membrane components and their ligands, a degradative pathway for breakdown of 
macromolecules, and an intermediary pathway where intracellular signaling can occur and 
where selected components from the recycling pathway can be transported to the degradative 
system and vice versa.  Early endosomes (EEs) are the main  
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Figure 4.  The major intracellular compartments that make up the endosomal network.  
Internalized cargo (by CME and CIE) first arrives in the early endosome (EE) and makes 
its way sequentially through the endosomal network.  Trafficking proteins sort incoming 
cargo towards their next destination, following one of two main paths, degradation or 
recycling.  Cargo destined for degradation is sorted to the multivesicular body/late 
endosome (LE) which travel along microtubules (MT), eventually fusing with the 
lysosome where catalytic enzymes breakdown proteins into elemental components to 
be reused by the cell.  The endolysosome that is formed matures into a classical dense 
lysosome.  Cargo can also be recycled back to the plasma membrane from any of these 
endosomal compartments directly to the plasma membrane or via the TGN or recycling 
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endosome.  Throughout the endosomal network, retrograde and anterograde transport 
shuttles proteins and lipids to and from the trans-Golgi network (TGN), respectively. [61] 
 
sorting stations where cargo and fluid internalized from different endocytic pathways converge 
[62].  As cargo progresses past early endosomes, it makes its way to multivesicular bodies.  
MVBs are also a transient stopover for lysosomal components travelling from the trans-Golgi 
network (TGN) to the lysosomes.  Lysosomes house hydrolases that break down proteins found 
in this compartment.  The TGN is a major sorting station for newly synthesized proteins and 
lipids that have undergone serial post-translational modifications by first passing through the 
Golgi apparatus.  Throughout the endosomal network, cargo can be shuttled to recycling 
endosomes and transported to the plasma membrane.  Finally, the cytoplasm must also be 
included as it is a source for essential elements of the trafficking machinery. 
How EEs arise is not completely understood, however a significant amount of membrane 
and volume originates from endocytic vesicles (via CME and CIE) [61].  The fate of proteins 
and lipids that end up in EEs is determined through sorting mechanisms.  Receptors, like 
EGFR, are often internalized and continue to signal even when located in EEs [63].  The 
peripherally located EEs contain regions with tubular extensions as well as a few intralumenal 
vesicles (Figure 4) [64].  These morphological differences are a showcase of the dichotomy of 
EEs: tubular extensions of EEs are usually involved in recycling while proteins targeted for 
degradation cluster within multi-vesicular domains [65]. 
A key resident of EEs is the Rab GTPase Rab5.  Rab GTPases constitute the largest family 
of small GTP-binding proteins and are implicated in many trafficking processes.  Much of the 
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biochemical attributes of EEs are acquired through the action of Rab5 and its effectors, which 
include phosphatidylinositol 3-kinase (PI(3)K) (VPS34/p150), early endosomal antigen-1 
(EEA1), and Rabenosyn-5 [66].  PI(3)K generates PI(3)P which is typically enriched in the 
membranes of EEs [66, 67] and required for trafficking from this compartment as it recruits 
PI(3)P-binding proteins [68].  When present on the surface of endosomal membranes, PI(3)P 
acts as a molecular tag recognized by proteins such as EEA1 [69, 70], Rabenosyn-5 [71] and 
PX domain-containing proteins like sorting nexins [72].  Accordingly, EEA1 is one of the most 
commonly used molecular markers for EEs due to its precise localization to this compartment 
through its binding to both PI(3)P and Rab5.  EEA1 enables membrane fusions of incoming 
vesicles in coordination with members of the SNARE family [73, 74].  The FYVE domain present 
in EEA1 is responsible for binding PI(3)P and is also present in Rabenosyn-5 [71].  Although 
the role of Rabenosyn-5 is still unclear, it may mediate the recycling of cargo back to the plasma 
membrane by its interactions with EHD1 and Rab5 [75].  In addition, sorting nexins localized to 
EEs play essential roles in sorting cargo to different endosomal destinations and will be 
discussed later [72, 76, 77].   
Multivesicular bodies, also known as multivesicular endosomes or late endosomes as 
defined by the time it takes for internalized tracers to reach these compartments, are 
distinguished from other organelles by their large number of intralumenal vesicles (ILV) [78].  
This characteristic offers many options to the cell by providing a means to store material in 
vesicles that can be delivered to lysosomes, released by exocytosis, or stored for future use.  
Although many proteins passing through this endosome are en route to the lysosome, some 
proteins do exit the degradation pathway through “back-fusion” of intralumenal vesicles with 
the MVB limiting membrane [79].  Unfortunately, markers of MVBs are few, which is perhaps 
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due to the fact that these endosomes serve as trafficking hubs for proteins en route to other 
destinations and because the machinery involved in MVBs formation is only transiently 
associated to the MVB membrane.  The lysosomal membrane proteins LAMP1 and LAMP2 
can be found on MVB membranes but only in the presence of the cation-independent mannose-
6-phosphate receptor (CI-M6PR), since this latter protein is absent from lysosomal membranes 
[65].  In addition, Rab5, Rab7, Rab9, Rab27 and Rab35 are sometimes associated with MVBs 
[80, 81].  Intralumenal vesicles are occupied by tetraspanins and lysobisphosphatidic acid 
(LBPA), which can be used as additional markers [82, 83]. 
Lysosomes are defined by their acidic pH, mediated by v-ATPase, and the presence of 
hydrolases.  These hydrolytic enzymes originate from the trans-Golgi Network and are first 
transported to MVBs before being ferried to lysosomes.  TGN-to-MVB transport of hydrolase 
receptors is the primary function of the CI-M6PR [84].  On the surface of lysosomes are 
structural proteins, such as LAMP1/2, ion channels, as well as trafficking and fusion machinery 
proteins, like Rabs and SNAREs [85].   
The Golgi apparatus is a central hub for sorting and transporting proteins and lipids that 
travel within the secretory and degradative pathways [86].  It also houses the machinery 
required for the post-translational modification of proteins, which are then sorted in the trans-
Golgi network.  The Golgi system is easily distinguishable by the shape of its structure, typically 
organized as stacks of flattened cisternae with dilated rims (Figure 4) [87].  This dynamic 
network receives cargo from the plasma membrane and endosomes, and directs transport of 
material coming from the endoplasmic reticulum (ER) en route to the secretory pathways [86].   
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1.5 – Receptor degradation and recycling  
 
As cells synthesize new proteins according to their needs, proteins that are damaged, 
misfolded or simply no longer needed are degraded and their amino acids are reused.  As such, 
a fine balance exists between protein synthesis, degradation and recycling.  A deficiency in 
degradation mechanisms would be significant and could lead to catastrophic proteotoxicity 
within the restricted intracellular space [88, 89].  On the other hand, since degradation is 
irreversible, tight regulation is required to avoid reckless destruction.  When possible, proteins 
that are still required and functional can be recycled for reuse.  Rudolf Schoenheimer conducted 
early experiments on protein turnover in the late 1930s.  In a single mass spectrometry 
experiment, he analyzed the fate of stable isotope-labeled amino acids that had been fed to 
mice, which allowed determination of the turnover rate of thousands of individual proteins [90].  
For a long time, the lysosomal compartment was considered the main site of protein 
degradation, through the action of resident proteases.  However, this view was challenged 
when most cellular proteins remained insensitive to alkalinization of the lysosomes.  In later 
years, the ubiquitin-proteasome degradation system was discovered and replaced lysosomes 
as the major catalyst of protein degradation [91, 92].  
Central to this model is the small molecule ubiquitin, which is covalently attached to lysine 
residues of proteins targeted for degradation, through interaction with an E3 ligase protein that 
recruits an E2-enzyme charged with ubiquitin [93].  Typically, proteins targeted to the 
proteasome are tagged with a chain of multiple ubiquitin molecules (polyubiquitination) while 
those destined for lysosomes are tagged with a single ubiquitin molecule (monoubiquitination).  
Proteasomal degradation is performed by ATP-dependent proteases, the most well-known 
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member being the 26S proteasome.  ATP-dependent proteases are multi-subunit protein-
wrecking machines that share the common architecture of a barrel-shaped compartmental 
peptidase capped by a hexameric AAA + unfoldase (ATPases associated with various cellular 
activities) [94].  A monoubiquitination modification induces the sorting of proteins into the 
internal vesicles of EEs [95].  A MVB then detaches from early endosomes and travels along 
microtubules to eventually fuse with lysosomes [95].  Although less common, multiple 
monoubiquitinations and in some cases K63-linked polyubiquitin chains have also been shown 
to provide a signal for MVB targeting [96, 97].  Monoubiquitination is recognized by a series of 
complexes called the endosomal sorting complexes required for transport (ESCRT), which then 
mediate the trafficking of these proteins to the lysosome [98]. 
In mammals, the ESCRT machinery consists of more than 20 proteins, grouped into three 
complexes (ESCRT-I, -II, and –III) and other associated proteins such as the ATPase vacuolar 
protein sorting 4 (Vps4) [99].  ESCRT is mostly known for its role in MVB formation but it is also 
involved in other membrane fission processes, such as the terminal stages of cytokinesis and 
separation of enveloped viruses from the plasma membrane [99].  In yeast, four ESCRT 
complexes have been identified and are numbered according to the order in which they act in 
the ESCRT pathway (ESCRT-0, -I, -II and -III).  Studies from mammalian cells also support this 
model of sequential assembly and disassembly for ESCRT protein dynamics [99].  Near the 
end of MVB biogenesis (and other membrane fission processes), two membranes that remain 
connected by a thin neck are severed, a process attributed to ESCRT [99].  In mammals, 
ESCRT-I is recruited to sites of MVB formation by the adaptor protein Hrs [100].  This and other 
interactions bring about the sequential recruitment of ESCRT-II and –III, and the progression 
of MVB biogenesis [99]. 
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Besides their roles in protein degradation, proteins found in mature MVBs can also be re-
routed back to the plasma membrane or temporarily isolated from the cytoplasm.  This is 
dependent on ESCRT-0, which promotes recycling of certain proteins, such as the β2-
adrenergic receptor and the epithelial Na+ channel [101, 102].  Another interesting example of 
MVBs function, is the sequestration of cytosolic glycogen synthase kinase 3 (GSK3) into ILVs 
during Wnt/β-catenin signaling, which will be discussed further [103]. 
Sorting of receptors for recycling to the plasma membrane is achieved through extensive 
tubulation of the EE membranes [104].  Tubulation is an elongation of endosomal membranes 
where cargo accumulates and eventually buds off inside a vesicle carrier en route to an 
endoplasmic recycling compartment (ERC) or directly back to the plasma membrane.  
Accordingly, recycling directly to the plasma membrane is termed “fast recycling” while 
recycling via the ERC is called “slow recycling”.  For example, slow recycling of the transferrin 
receptor takes between 30-60 minutes, while its fast recycling takes about 10 minutes [105].  
Mediating these pathways are sorting proteins like Rab4, which targets receptors directly back 
to the plasma membrane (fast recycling), and Rab11, which regulates slow recycling [106, 107].  
However, the use of these Rabs as endosomal markers should be done with caution since 
Rab4 has also been detected on membranes of the ERC [108]. 
In addition to the ESCRT machinery, other protein families, such as the sorting nexins and 
the small Rab GTPases, are required for sorting internalized proteins towards various 
endosomal destinations.  These large families of proteins also contribute to protein trafficking 
and are thus intimately linked to protein degradation, recycling and sequestration. 
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1.6 – Sorting nexins 
 
The first description of a mammalian sorting nexin (Snx) was published in 1996, with 
the identification of SNX1 in a yeast two-hybrid screen using the core tyrosine kinase domain 
of EGFR [109].  Mammalian Snx1 was found to contain a region homologous to a previously 
identified yeast protein, Mvp1p, a multicopy suppressor of Vps1p mutants deficient in 
carboxypeptidase Y receptor trafficking [110].  Co-localization of Mvp1p with Vps1p to Golgi 
membranes pointed to a potential role in membrane trafficking [110].  The relevance of the 
interaction between EGFR and Snx1 was uncovered by demonstrating that Snx1 could bind to 
the lysosomal targeting code on EGFR and contribute to its transportation to lysosomes as 
overexpression of Snx1 increased the rate of both constitutive and ligand-induced EGFR 
degradation [109].  This function was later confirmed by others and was also shown to involve 
the hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) [111] and enterophilin-
1 (Ent-1) [112].  Hrs is an ubiquitin-binding protein that sorts ubiquitylated proteins like the 
transferrin receptor into clathrin-coated microdomains of early endosomes, thereby targeting 
them to the late endosome and lysosome, and preventing recycling to the cell surface [100].  
Ent-1 is an intestinal protein involved in enterocyte differentiation and the overexpression of 
Ent-1 reduces cell surface expression of EGFR, an effect increased by co-expression of Snx1.  
Shortly after the discovery of Snx1, Haft et al. (1998) introduced three new sorting nexins (Snx2, 
Snx3 and Snx4), which along with Snx1 as well as others proteins previously identified in 
Caenorhabditis elegans and Saccharomyces cerevisiae all shared a common conserved 
domain, the SNX-PX domain [113].  Today, mammalian sorting nexins count 33 members, all 
characterized by the presence of the sorting nexin PX (SNX-PX) domain (Figure 5) [72, 76, 77].  
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The roles of many sorting nexins have been investigated and members of this protein family 
are now recognized as important factors for endosomal protein sorting.   
 
 
Figure 5.  The domain structure of mammalian sorting nexins.  All sorting nexins (33 
members) contain a SNX-PX domain.  The presence (or absence) of other conserved 
domains is used to divide the sorting nexins into three subfamilies: the SNXBAR contain 
a C-terminal BAR domain (left), the SNXPX contain simply an isolated SNX-PX domain 
(middle), and the SNXother contain another recognized domain, in addition to the SNX-PX 
domain (right) [114] 
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1.7 – The PX domain 
 
The PHOX-homology domain (PX domain), as its name implies, is homologous to the 
PHOX domain, named according to the protein complex where it was initially identified: the 
phagocyte NADPH oxidase (PHOX).  The PHOX motif (110 aa) is present in subunits p40phox 
and p47phox of the NADPH oxidase complex of neutrophils [115].  p40phox and p47phox reside in 
quiescent neutrophils, in association with a third subunit, p67phox.  This tertiary complex 
regulates the oxidative activity of flavocytochrome b558, composed of the catalytic heterodimer 
gp91phox-p22phox, which is kept inactive in quiescent cells.  In these dormant cells, p47phox has 
an auto-inhibitory conformation that hides its SH3 and PHOX domains due to intramolecular 
interactions [116, 117].  When immune mediators activate the neutrophil, p47phox becomes 
phosphorylated and exposes its SH3 domain to interact with p22phox.  In addition, the PHOX 
domain is also released, which allows the protein to interact with PIPs.  The role of p47phox is 
thus essential for the recruitment the membrane of the p47phox-p67phox-p40phox complex and for 
its interaction with flavocytochrome b558.  This way, the assembly of the phagocyte oxidase 
complex at the membrane allows the production of reactive oxygen species that destroy 
invading microorganisms.  Other homologs of p47phox et p67phox have since been identified, such 
as the NOX organizing 1 protein (NOXO1), which contains a PHOX domain that is required for 
the recruitment of proteins at the plasma membrane [118-120]. 
In yeast, PX domain-containing proteins are implicated in processes of vesicular transport, 
cellular signaling, budding control and polarization [77, 121].  The evolutionary conservation of 
the PX domain is strongest in proteins involved in vesicular transport such as Mvp1p, 
Vps5p/Grd2p, Grd19p/Snx3, and Vam7p.  Mvp1p, Vps5p and Grd19p are required for the 
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retrograde transport from the pre-vacuolar endosome/late endosome to the “late” Golgi (similar 
to the trans-Golgi in mammals) [122-125].  Snx4, Snx41 and Snx42 are other SNX-PX domain-
containing proteins, which are implicated in recycling receptors from the sorting endosome 
(post-Golgi endosome) to the “late” Golgi [126]. 
In mammals, many proteins contain the PX domain, including PI3 kinases, CISK and FISH, 
but the majority of these proteins fall under the class of sorting nexins.  Studies in yeast have 
shown that the PX domain is capable of interacting with PIPs, primarily PI(3)P, but also with 
other phosphorylated derivatives, such as PI(3,4)P2, PI(3,5)P2 and PI(4,5)P2, interactions that 
should not be disregarded [77, 127-132].  A total of 27 crystal structures of the mammalian PX 
domain are accessible on the protein database (PDB), stemming from 14 different proteins but 
only two structures have been resolved in complex with PI(3)P : p40phox (PDB : 1H6H) and 
SNX9 (PDB: 2RAK).  The interaction of the PX domain with PI(3)P is an electrostatic bond 
between the 3-phosphate of PI(3)P and a specific and conserved arginine of the PX domain.  
The consensus sequence of the interaction of the PX domain with PI(3)P is R[Y/F]X23-30KX13-
23R (Figure 6) [77]. 
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Figure 6.  The interaction between the PX domain and phosphatidylinositol-3-phosphate. 
Ribbon and surface structures of a representative PX domain from p40phox are shown in 
complex with PI(3)P.  Surface structure color codes indicate hydrophobicity, from blue 
(most hydrophilic) to red (most hydrophobic).  Key PX-PI(3)P interactions: the arginine 
side chain electrostatic association with the 3-phosphate (ArgP3), stacking of the inositol 
ring with the tyrosine (or phenylalanine) side chain immediately downstream from the 
conserved arginine residue (Tyrinositol), contact of a lysine side chain with the 1-
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phosphate (LysP1), and hydrogen bonds of the 4- and 5-hydroxy groups to a second 
arginine side chain (Arg4,5-hydroxyl). [77] 
 
The affinity of different PX domains to phospholipids is determined by two approaches: by 
analyzing the binding to liposomes and by “dot blots” or “PIP-strips”.  The approach by PIP-
strips is technically less challenging than artificially-producing liposomes, which requires 
delicate manipulations due to the instability of PIPs.  In PIP-strips, pure phosphorylated 
derivatives of phosphatidylinositol are applied on nitrocellulose membranes after which proteins 
are incubated and then their affinities are detected by chemiluminescence.  The liposome 
method involves the generation of liposomes composed with up to 50% of the tested 
phospholipid in an environment of varying proportions of phosphatidylserine, 
phosphatidylethanolamine or phosphatidylcholine, required for stability.  Even if the PIP-strip 
method is easier to perform, the liposome method is considered closer to physiological 
conditions since it introduces a structural aspect of the protein-PIP interaction that cannot be 
replicated in 2-dimensional tests like PIP-strips.  In fact, comparisons between both methods 
can produce different results for the same protein [76, 133].  Using PIP-strips, the PX domain 
of Snx1 had specific affinity with PI(3,4,5)P3 and weaker affinity to PI(3,5)P2 [76, 134].  
However, when using the liposome method, Snx1 had comparable affinities with both PI(3)P 
et PI(3,5)P2 [76].  The interaction of Snx1 with PI(3)P instead of PI(3,4,5)P3 seems more 
physiologically plausible since the increase of PI(3,4,5)P3 by a constitutively active PI3K did not 
increase the association of Snx1 to the membrane where PI(3,4,5)P3 was enriched [76].  These 
observations demonstrate the importance to use multiple methods of analysis to determine the 
lipid affinities of unknown proteins. 
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1.8 – Phosphatidylinositol phosphates 
 
Phosphatidylinositol is used as a scaffold that can be phosphorylated at the 3-, 4- and/or 5-
positions to generate phosphatidylinositol phosphates (Figure 5A).  Despite their low 
abundance (less than 10% of total cellular phospholipids), PIPs serve as both structural and 
regulatory molecules in response to stimulation of certain cell surface receptors and control 
endosomal biology by regulating the correct timing and location of vesicular trafficking events 
[135, 136].  Through organelle-specific phosphatidylinositol kinases and PIP phosphatases, 
PIPs can undergo rapid phosphorylation/dephosphorylation cycles that lead to distinct and 
transient subcellular distributions of individual PI species.  These species are recognized by 
PIP-binding modules (PIBMs), which include the FYVE, pleckstrin homology (PH), ENTH, 
ANTH and PX domains.  The expression of proteins with these PIBMs tagged with green 
fluorescent protein (GFP) has permitted the construction of a map of intracellular PIP 
distribution (Figure 3B). 
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Figure 7.  Phosphatidylinositol phosphates and their intracellular distribution.  A) 
Phosphatidylinositol is an amphiphile lipid that can be phosphorylated on positions 3, 
4 and 5 of the polar inositol headgroup.  Depicted here is phosphatidylinositol-3-
phosphate (PI(3)P), phosphorylated on position 3 of inositol.  Other species could be 
generated through the action of kinases and/or phosphatases at positions 3, 4, and 5.  
B) Subcellular distribution of PIs and their metabolizing enzymes in exo- and endocytic 
membrane traffic.  SV: secretory vesicle; CCP: clathrin-coated pit, MVB: multivesicular 
body [137]. 
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Phosphatidylinositol and PI(4)P are considered as the main precursors of PIPs.  However, 
PI(4)P has been shown to interact with cytoskeletal proteins, namely talin, suggesting a 
functional role [138].  PI(4)P is also enriched on the membranes of the Golgi complex, while 
concentrations of PI(4,5)P2 are kept low, which is likely due to the presence of PI(4)K and 
PI(4,5)P2 phosphatase [136].  PI(4,5)P2 is mainly found on the inner side of the plasma 
membrane [139, 140].  It is required for the invagination of clathrin-coated pits after which levels 
of PI(4,5)P2 drop due to 5-phosphatase activity [141].  PI(4,5)P2 is also required during the first 
steps of phagocytosis but is quickly converted to PI(3,4,5)P3 by type I PI(3)K [136]. 
PI(3)P is mainly found on membranes of early endosomes, on intralumenal vesicles of 
MVBs and at the plasma membrane when it is generated during signaling processes [142].  
PI(3)P is also required in Golgi-to-vacuole transport in yeast [143].  During phagocytosis, PI(3)P 
is generated by type III PI(3)K (Vps34) and is required for phagosomal maturation [144].  
Conversion of PI(3)P to PI(3,5)P2 occurs at MVBs and is required for protein sorting at these 
endosomes [136].  During the exocytic cycle, PI(4)P is generated in secretory granules [145].  
PI(4)P and PI(4,5)P2 are also found in the Golgi complex, where PI(4)P promotes transport 
from the Golgi and PI(4,5)P2 is important for maintaining the architecture of Golgi membranes 
[146]. 
Generation of PIPs is also required during transportation processes along cytoskeletal 
routes. For example, enrichment of PI(4,5)P2 in nascent vesicles is required for actin comet tail 
assembly that mediates propulsion and movement [147].  Microtubule-based motility may also 
be regulated by regional PIPs as the motor protein kinesin was shown to interact with PI(4,5)P2 
[148].  Most phosphatidylinositol kinases and phosphatases are cytosolic and their targeting to 
specific regions of lipid membranes is not fully understood.  It may involve small GTPases that 
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either recruit or activate phosphatidylinositol-modifying enzymes, such as Rab5, which 
activates PI(3)K at the early endosome [66, 136]. 
The interaction between the PX domain and PI(3)P (and other PIPs) is in general a weak 
interaction and the recruitment of sorting nexins to membranes is achieved by the contribution 
of other domains and molecular interactions, a concept termed “coincidence detection” [149].  
For sorting nexins of the SNXBAR subfamily, this additional contribution is brought about by the 
BAR domain. 
 
 
1.9 – SNX-BARs 
 
In addition to the PX domain, some sorting nexins also contain a BAR domain, referred to 
as SNX-BARs.  The BAR (Bin/amphyphysin/Rvs) domain is an amphipathic motif exposing 
both a hydrophobic and hydrophilic surface.  In an aqueous solution, this protein domain forms 
monodimers and heterodimers that form a six-helix bundle curved in a banana-shape, which 
bonds with the curved surface of lipid membranes [150-153].  Fifteen structures of the BAR 
domain have been produced, prompting the division of this domain into two sub-groups: the F-
BAR (Fes/CIP4 homology-BAR) and the I-BAR (Inverse-BAR) [151, 154].  The association 
between the F-BAR dimer at the N-terminus of Toca (Transducer of Cdc42-dependent actin 
assembly) and lipid membranes demonstrated how this motif could associate with membranes 
and shape them into cylindrical tubules [155].  By integrating the atomic models of F-BAR 
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dimers [153] with cryo-EM reconstructions of membrane tubules, Frost et al. (2008) were able 
to show how cationic residues on the concave surface of the F-BAR motif engage the lipid 
bilayer and allow the rigid dimer to impose its shape onto the underlying membrane [155].  
Proteins that contain the BAR domain play essential roles in the formation of tubules, which 
preludes vesicle budding.  Tubules are localized and elongated deformations found in many 
endosomes. 
Most of our understanding into the role of sorting nexins comes from retromer studies.  The 
retromer is an evolutionarily conserved pentaheteromeric protein complex that is essential for 
the late endosome-to-TGN retrograde transport of the CI-M6PR receptor in mammals and 
vacuolar protein-sorting receptor-10 (Vps10p) in yeast [156].  The mammalian CI-MPR is a 
type I transmembrane receptor that recognizes the mannose-6-phosphate tag present on 
hydrolytic enzymes at the TGN and delivers these digestive enzymes to late endosomes before 
making its way back to the TGN [70].  The efficient retrieval of these receptors from the late 
endosome to the TGN is accomplished by retromer and is crucial to maintain efficient sorting 
and forward transport of hydrolytic enzymes to the lysosome in mammals [68, 157] or vacuole 
in yeast [73, 122].  Furthermore, the fundamental mechanisms for this retrograde pathway are 
evolutionarily conserved from lower to higher eukaryotes. 
The retromer complex functions as a cytoplasmic vesicle coat that can be divided into two 
distinct sub complexes: a cargo recognition complex and a sorting nexin dimer.  In yeast, the 
cargo recognition complex of retromer is composed of Vps35p, Vps26p and Vps29p, while the 
sorting nexin dimer is composed of Vps5p, Vps17p [158].  Vps35p associates with membranes 
through its interaction with Vps26p, while Vps29p stabilizes Vps35p and interacts with the 
second sub complex (Vps5p and Vps17p) [67, 73, 74, 159].  Vps5p and Vps17p are SNX-BARs 
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that associate with highly curved membranes and PI-enriched regions of lipid membranes [122, 
160].  The yeast retromer therefore localizes to specific regions of vacuolar membranes to 
retrieve Vps10p and mediate tubule/vesicle formation.  In mammals, the cargo recognition 
complex is composed of Vps26-Vps29-Vps35 [158].  However, the exact components of the 
sorting nexin dimer are less clear but is likely made up of a combination of Snx1 or Snx2 (Vps5 
orthologs) and Snx5 or Snx6 (Vps17 orthologs) [158]. 
In addition to SNX1, other sorting nexins also have CI-M6PR-independent functions.  For 
example, SNX5 has been shown to mediate both internalization and recycling of a G-protein-
coupled receptor, the D1 dopamine receptor (D1R) [161].  SNX5 coexists at the plasma 
membrane with D1R and GRK4 (G-protein-coupled receptor kinase 4), where SNX5 interacts 
with the C-terminal of the D1R and forms a functionally cohesive complex for selective receptor 
stimulation and efficient signal propagation, amplification and termination.  In this role, SNX5 
likely functions as a scaffold that is not only essential for endocytosis but also for receptor 
recycling.  Accordingly, in the absence of SNX5, phosphorylation by GRK4 remains unhindered 
and impairs D1R endocytosis and delays recycling, leading to failure of cAMP production on 
agonist stimulation [161].  This findings supports the idea that SNXs are promiscuous proteins 
that can associate with various other trafficking components to direct endosomal sorting of a 
wide variety of receptors.  
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1.10 – PX-only Sorting Nexins 
 
In some sorting nexins, the only conserved protein domain identified to date is a N-terminal 
PX domain.  Many of these SNXs have C-terminal regions that likely play important functional 
roles.  Such is the case for SNX11, where a novel extended PX (PXe) domain was recently 
discovered by crystal structure analysis [162].  Evolutionarily, Snx11 is most closely related to 
Snx10, which was first shown to be important for endosome homeostasis since overexpression 
of Snx10 resulted in the formation of abnormally large vacuole [163].  Later studies showed 
that Snx10 plays a role during osteoclast formation as it is strongly up-regulated during RANKL-
induced osteoclast differentiation in vitro and strongly expressed in osteoclasts in vivo [164].  
In accordance, a mutation in an evolutionarily conserved residue of the PX domain of Snx10 
(R51Q) was found to induce malignant osteopetrosis of infancy [165].  Osteoclasts with this 
mutation abnormally displayed large endosomal vacuoles and impaired resorptive function, a 
major factor in osteopetrosis.   
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Figure 8.  BAR dimers. A) Ribbon and space-fill models of the SNX9 BAR-PX dimer are 
shown.  The two SNX9 proteins are depicted in red/orange/yellow and green/cyan/blue 
(PX domain: red/blue; BAR domain: yellow/green; yolk domain, which links the PX 
domain to the BAR domain: orange/cyan).  Space-fill models showing the electrostatic 
distribution, red (acidic, negative residues), blue (positive, basic residues). [50] 
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Finally, SNX10 was shown to regulate the intracellular trafficking of V-ATPase, a multi-subunit 
complex required for ciliogenesis, acidification of osteoclasts and bone resorption [166].  
Interestingly, Snx11 was found to antagonize Snx10-dependent vacuolation in vitro possibly 
through competitive binding with a common partner but its function remains poorly described 
[162].   
 
 
1.11 – SNX-other 
 
Sorting nexins can also mediate receptor recycling.  For example, fast recycling of the 
β2 adrenergic receptor (β2AR), a seven-transmembrane signaling receptor, is a process that 
requires SNX27 [167, 168].  Here, VPS29 concentrates at β2AR-positive membrane 
tubulations.  Previous to this finding, β2AR recycling was known to occur by the concentration 
of the receptor into endosomal tubulations, and this was dependent on a C-terminal PDZ ligand, 
[169]. However, initial ligand-induced endocytosis did not require retromer components.  
Instead, depletion of VPS35 or VPS29 significantly reduced β2AR recycling and resulted in 
endosomes devoid of β2AR tubules.  This effect was similar to disrupting the receptor’s C-
terminal PDZ ligand.  Further investigation identified Rab4A as another essential component 
of β2AR recycling, as well as PDZ domain-containing SNX27, which acts as a cargo adaptor 
to retromer.  In fact, SNX27 was shown to bind directly to the WASH complex, which in turn 
enabled its association with retromer components [168].  This indicates that retromer 
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components can mediate receptor trafficking at different endosomal compartments, by 
associating with various adaptor proteins. 
 
 
 
1.12 – RABs 
 
As previously mentioned, other important players in regulating membrane identity and 
vesicle traffic are the small Rab GTPases.  Rab GTPases cycle between the GTP-bound state 
(active), catalyzed by guanine exchange factors (GEFs), and the GDP-bound state (inactive), 
driven by the combined action of the intrinsic GTPase activity of the Rab protein and catalyzed 
by GTPase-activating proteins (GAPs) [159].  In humans, over 60 members of the Rab family 
have been identified, which localize to distinct endosomal membranes [157].  Their association 
with membranes occurs through the post-translational addition of hydrophobic geranylgeranyl 
groups, which facilitates the attachment to target membranes and indirectly brings about 
interactions with coat components, motors and SNAREs.  In turn, binding of Rabs to relevant 
membranes and to their respective effector proteins contributes to endosomal trafficking 
processes such as vesicle budding, vesicle uncoating, vesicle motility and vesicle fusion [157]. 
During vesicle budding, sorting of cargo into specific transport vesicles requires its 
association with cytosolic coat complexes.  For example, Rab9 localizes at the multivesicular 
body and, like retromer, is required for retrograde transport of the CI-M6PR from this 
compartment to the trans-Golgi network [170, 171].  Once cargo is included into a transport 
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vesicle, coat complexes must be shed to allow membrane fusion with the acceptor membrane.  
For instance, Rab5, which is present on clathrin-coated vesicles, helps AP2 uncoating by 
promoting dephosphorylation and increasing PI(4,5)P2 turnover [172].  In addition to actin 
microfilaments and microtubules, vesicle motility along these molecular cables is dependent 
on the kinetic force provided by various motor proteins like myosins, kinesins and dyneins.  As 
such, certain Rab GTPases assist in proofreading the interactions between motor proteins and 
transport vesicles.  Such is the case of Rab27a, which connects myosin Va to vesicle-like 
melanosomes shuttling towards the cell periphery [173].  Another example is a resident of 
endocytic recycling vesicles, Rab11a.  Through its interaction with the Rab11 family interacting 
protein 2 (RAB11FIP2), Rab11a links recycling vesicles to myosin Vb [174].  As transport 
vesicles reach their destination, they must dock and fuse with the acceptor membrane.  Here 
again, Rab GTPases are involved in this final step of endosomal trafficking.  Evidence for this 
first came from studying a mutation of the yeast Rab GTPase Sec4, which causes accumulation 
of TGN-derived vesicles [175].  Later studies revealed that Rab GTPases contribute to vesicle 
fusion by recruiting elongated tethering complexes that form long distance connections 
between the vesicle and the acceptor membrane [157]. 
Another essential component of protein trafficking is the cytoskeleton, which provides the 
framework that guides vesicular transport and mechanical force required for reshaping the cell. 
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1.13 – The cytoskeleton 
 
The cytoskeleton is a dynamic intracellular scaffolding system that contributes to 
morphology and plasticity, migration, signal transduction and intracellular trafficking.  During 
these processes, cytoskeletal elements generate the force required for membrane 
deformations, create structural scaffolds and act as tracks for motor proteins.  Microtubules, 
intermediate filaments and actin microfilaments are the three filamentous structures that make 
up the cytoskeleton, regulated through the fine balance between assembly and disassembly.  
Although a brief overview of each component will be given, the main focus will be on actin 
dynamics. 
Microtubules are hollow tubes formed from the association of multiple alpha/beta tubulin 
heterodimers, which radiate from the microtubule-organizing center (MTOC) located at the 
centrosome in the cytoplasm [176].  Structures like the mitotic spindle of dividing cells and the 
core of cilia and flagella are dependent on microtubules.  Microtubules are also important for 
structuring cell shape, maintaining organelle localization and serving as tracks for the 
movement of vesicles and other cytoplasmic particles [177].  As such, both anterograde 
(away from cell body) and retrograde (toward cell body) movements are mediated by 
microtubules [177].  To generate the force needed for transportation of particles, cells rely on 
motor proteins that travel along cytoskeletal tracks, using ATP for chemical energy [178].  
Molecular motors travelling on microtubules are kinesins and dyneins. 
Intermediate filaments (IFs) are named like this because their diameter (10nm) falls 
between that of microtubules (24nm) and actin microfilaments (8nm).  IFs comprise a 
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heterogeneous group of structures encoded by many genes (at least 50 IF genes in humans), 
such as keratins, plectins, lamins, and desmins [179]. 
Actin microfilaments are the main driving force in cellular shape changes, which are 
required for processes such as cellular migration, signaling and cytokinesis [180].  Actin is an 
evolutionarily conserved protein found in all eukaryotic cells and it is also closely related to 
prokaryotic actin-like proteins, suggesting ancient evolutionary origins.  Actin is an ATP-binding 
protein that can be found in monomeric soluble form, globular-actin (G-actin), or assembled 
into filamentous actin (F-actin) (Figure 6).  When bound to ATP, actin monomers can be 
incorporated into microfilaments and shortly after, undergo ATP hydrolysis due to their ATPase 
activity.  As the microfilament grows, actin-ATP subunits cap the growing end to prevent 
disassembly and promote growth.  Actin microfilaments grow from their barbed (plus) end while 
the opposing end, where actin-ADP subunits tend to leave, is referred to as the pointed (minus) 
end.  Since self-assembly is kinetically unfavourable, factors called actin nucleators facilitate 
actin polymerization. 
The ARP2/3 complex is the most characterized actin nucleator, which is comprised of seven 
polypeptides including ARP2 and ARP3 plus five additional subunits, ARPC1-ARPC5 [180].  
The ARP2/3 complex can nucleate filaments de novo and organize them into branched 
networks.  Nascent filaments elongate at their barbed end and are capped by ARP2/3 at their 
pointed end.  Assembly can be initiated by nucleating new filaments from monomers or by 
generating free barbed ends that act as templates for polymerization by uncapping or severing 
existing filaments.  However, the activity of actin nucleation by the ARP2/3 complex alone is 
inefficient and requires filament binding, phosphorylation as well as the involvement of 
nucleation-promoting factors (NPFs).  Most NPFs contain a WCA domain,  
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Figure 9.  Actin.  G-actin is a 42 kDa monomeric ATP-binding protein than can undergo 
cycles of self-assembly into filamentous actin (F-actin).  ATP hydrolysis creates the 
ADP-bound form and subsequent depolymerization of the actin filament.  Growth of the 
actin filament occurs primarily at the barbed end with the addition of ATP-actin and is 
capped by factors such as the ARP2/3 complex at its pointed end (ADP-actin) [181].   
 
 
which is the minimal sequence element required for activation of ARP2/3-mediated actin 
nucleation, found in proteins such as the Wiskott-Aldrich syndrome protein (WASP) superfamily 
and the formins. 
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1.14 – Vesicular transport of proteins 
 
Intracellular traffic of proteins (cargo) between two compartments is conducted by coated 
transport vesicles (carriers) that bud from one membrane and fuse with another.  Selectively 
packaged in these carriers are the cargo as well as machinery proteins required for proper 
targeting.  The three types of vesicular carriers that have been most extensively studied are 
clathrin-coated vesicles (endocytosis and late secretory pathway), COPII-coated vesicles 
(export proteins from the endoplasmic reticulum), and COPI-coated vesicles (within the Golgi 
apparatus and Golgi-ER traffic) [182].  Despite the different structural components and 
compartment specificities of endosomal coat complexes, some of the mechanisms of vesicle 
coat formation are similar and often initiated by the GEF-dependent activation of a small 
GTPases.  During coat formation of clathrin- and COPII-coated vesicles, adaptor complexes 
are first recruited to the membrane followed by the coat complexes, which begin to polymerize 
[182].  These adaptors include the small GTPases of the Arf1/Sar1 family that regulate their 
assembly [183].  In the case of COPI, the adaptor and coat complexes exist as a single 
heptameric complex that is recruited to the membrane as a whole [184].  Transient binding of 
coat complexes to short peptide sequences present on cargo also contributes to cargo 
selection [185].   
Retromer, which assembles at sites of protein sorting, interacts with cargo via the cargo 
recognition complex protein VPS35 and a conserved sorting motif [FW]L[MV] present on the 
cargo protein [186].  However, studies of retromer in C. elegans and yeast have shown that 
alternative sorting motifs or mechanisms of cargo recruitment also exist.  Such is the case in 
C. elegans, where retromer mediates the retrograde trafficking of CED-1, a protein that lacks 
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the previously stated sorting motif [187].  Alternative mechanisms of cargo recognition were 
shown in a study on the yeast protein Grd19/Snx3 (PX-only), which acts as a cargo adaptor for 
retromer.  Grd19 mediates the retrograde transport of the iron transporter Fet3p-Ftr1p by 
binding to retromer and to a sorting motif in the cytoplasmic tail of Ftr1p [188].  Finally, Snx1 
(SNX-BAR) can associate directly with certain cargo proteins (GPCRs) and mediate their 
trafficking independently of retromer [189].  Such evidence highlights the diversification of 
retromer function in higher organisms. 
The role of SNX-BARs in the progression of budding is to induce membrane tubulation, 
which is an elongation of the donor membrane.  As previously mentioned, SNX-BARs 
homodimers and heterodimers can sense and/or induce membrane curvature.  How this is 
accomplished is still unknown, but the mechanism is believed to be similar to that of the N-
BARs [152, 190, 191].  For a protein to induce membrane curvature, the difference in the energy 
of binding to curved versus flat membranes must be greater than the energy required for 
membrane deformation.  If the difference in binding energies is insufficient for deformation, a 
protein may still favour binding to preexisting curved membranes and this is referred to as 
curvature sensing.  The proteins endophilin and amphyphysin have often been used for 
studying the curvature sensing/inducing properties of the BAR domain.  These proteins contain 
an amphipathic helix N-terminal to the BAR domain, which, when inserted into the cytosolic 
leaflet of the bilayer, creates a difference in tension.  This difference drives curvature, which is 
then stabilized by the BAR dimer [152, 190, 191].  It is believed that SNX-BARs function in a 
similar way.  The progression of membrane curvature eventually leads to the formation of an 
elongated tubule, which is explained by the tip-to-tip and lateral contacts made between BAR 
domains that result in the formation of higher ordered helical arrays.  This stabilizes the 
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formation of high curvature membrane tubules and turns local membrane deformation into 
global deformation [192]. 
As the protein coat continues to assemble, other cellular machineries, such as the actin 
cytoskeleton (discussed later), assist in membrane re-sculpturing required for bud formation 
[182].  Scission at the neck of the bud then ensues through the actions of the coat proteins and 
GTPase activity [193, 194].  Interestingly, clathrin-coated vesicles also play a role in retrograde 
trafficking, including retromer biology [192].  Isolated CCVs were shown to contain VPS35 as 
well as Snx1, Snx2, Snx5 and Snx6 [195].  This association may be due to direct binding of 
retromer to clathrin as many SNX-BARs contain an inverted clathrin-binding box within the PX 
domain [196]. 
Lastly, to allow fusion with the target compartment, the coat depolymerizes under the effect 
of GTP hydrolysis mediated by GAPs or by GAP activity within the coat complex [7, 197].  
During retromer-mediated transport, clathrin depolymerization seems to involve RME-8, a 
DNA-J domain protein [198, 199].  DNA-J domain proteins also include auxilin, which are known 
to promote uncoating of CCVs at both the plasma membrane and TGN [28].  RME-8 colocalizes 
and directly associates with Snx1 on early endosomes [198].  In addition, interference with 
RME-8 disrupts trafficking of known retromer cargos, such as CI-M6PR.  As such, through its 
interaction with RME-8, retromer recruits regulators of clathrin dynamics at sites of retrograde 
trafficking.  Transportation of vesicles to their final destination occurs either by diffusion or by 
motor-mediated transport along a microtubule or actin cytoskeletal tracks [200].  All three types 
of molecular motors (kinesins, dyneins and myosins) have been implicated in this process [201-
203].  As the transport vesicle reaches its destination compartment, proteins and protein 
complexes tether the vesicle to its target membrane.  Members of the Rab and Ras GTPase 
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families both play critical roles in determining the specificity of vesicle targeting [204, 205].  
Fusion of the vesicle with its target membrane is dependent on a family of proteins called 
SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptor).  Present on 
both the transport vesicle and target membrane, the two proteins associate to form a complex 
and drive the fusion of two lipid bilayers [206, 207]. 
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Figure 10. The process of retromer-mediated vesicular transport.  For the retromer, 
membrane tubulation is driven by specific combinations of SNX1/SNX2 and SNX5/SNX6, 
which is coupled with cargo sorting through the association of the cargo recognition 
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complex (VPS26-VPS29-VPS35) with cytosolic tails of cargo (e.g. CI-MPR).  Vesicle 
scission proceeds by an unknown mechanism but likely requires dynamin-like proteins 
of the EHD family and force generated by microtubule motors and/or actin 
polymerization.  Uncoating of the vesicle carrier occurs possibly through the action of 
myotubularins, prior to SNARE-mediated fusion.  However, the precise role of clathrin 
in nucleation is still unclear. [192] 
 
 
 
1.15 – Actin and membrane dynamics 
 
Mounting data now strongly suggests an implication for actin polymerization in membrane 
trafficking.  In yeast, the formation of actin microfilaments is a definitive prerequisite for clathrin-
mediated endocytosis [180].  This was shown by observing co-localization between endocytic 
and actin assembly proteins, and from a series of screens for endocytic mutants, which 
identified mutations in actin-binding protein genes [180].  These results were later confirmed 
with live imaging, which demonstrated coordinated assembly and disassembly of endocytic and 
actin-associated proteins at actin patches [208].  In yeast, the initial curvature of the membrane 
is generated by clathrin and endocytic proteins, such as the BAR domain-containing SYP1 
[180].  At this point, SYP1 prevents actin assembly possibly by inhibiting WASP/ARP2/3-
mediated actin polymerization [209].  As invagination progresses, the induced membrane 
curvature is sensed by other BAR domain-containing proteins like BZZ1, which is recruited 
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along with other endocytic proteins and actin polymerization-promoting proteins like ARP2/3 
[210].  Actin assembly then proceeds to force further invagination of the nascent pit and 
eventually the actin network drives the inward flow of the newly formed vesicle. 
In mammalian cells, actin polymerization is required for processes such as phagocytosis, 
macropinocytosis, caveolin-mediated endocytosis, and CME [180].  As in yeast, many 
endocytic adaptors used during CME can interact with actin assembly proteins.  These include 
HIP1R, which inhibits actin assembly at endocytic sites and binds to clathrin, F-actin and 
cortactin [211].  During the formation of clathrin-coated pits, actin polymerization has been 
reported to occur at cortical sites in a temporally regulated manner [212].  There are also BAR 
domain containing proteins such as Snx9/Snx18, which can associate with dynamin and WASP 
proteins while positively regulating WASP/ARP2/3-mediated actin assembly [51].  Snx9 has a 
C-terminal PX-BAR domain and an additional N-terminal SH3 domain.  Snx9 forms BAR 
homodimers, uniting the PX-BAR domains to form a single “superdomain” for membrane 
sculpting [213].  The SH3 domain of Snx9 binds to class I polyproline sequences, which are 
found in dynamin and the actin regulators WASP and N-WASP [214, 215].  In accordance, both 
dynamin 1 and dynamin 2 bind effectively to Snx9 in vitro and in vivo [12, 216].  Binding of Snx9 
to the actin regulators WASP and AP-2 have also been described [217, 218].  Additionally, 
Snx9’s function during this process is greatly enhanced by the presence of PI(4,5)P2, which 
induces Snx9 oligomerization and increases its effect on the GTPase activity of dynamin [213, 
216].  Taken together, these studies support a mechanism whereby Snx9 is recruited to 
clathrin-coated pits, through interactions with AP-2, clathrin and highly curved membrane 
surface enriched in PI(4,5)P2 [213].  Dynamin and Snx9 likely act together to narrow down the 
neck of a clathrin-coated pit to a point at which a sudden pushing force may be required to 
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separate the vesicle from the membrane.  Such a force might be mediated by local actin 
polymerization and would be associated with a shift in Snx9 function, from recruitment an 
assembly of dynamin to binding and activation of N-WASP [213].  Additional data supporting 
this hypothesis comes from studies showing the synergistic effect of Snx9 and phospholipids 
(PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, PI(3,4,5)P3) in activating N-WASP [51, 219].  Also, when Snx9 
lacking the SH3 domain is overexpressed in cells, it leads to the production of long membrane 
tubules, likely due to inefficient recruitment and activation of the scission machinery [215, 220, 
221]. 
Now that I have highlighted the importance of intracellular trafficking on cell signaling, the 
challenge remains to integrate in vitro biomolecular data into an in vivo context.  Cell culture 
studies do not take into account the plethora of factors and physical constraints that influence 
individual cells within a living organism.  Nevertheless, this is the ultimate goal, to better 
understand the role of each gene in vivo.  The next section will delve into embryogenesis and 
the many stages and signaling pathways involved during development.  The focus of this thesis 
will be mainly on cardiogenesis and somitogenesis. 
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1.16 – Embryogenesis 
 
“It is not birth, marriage, or death, but gastrulation, which is truly the most important time in your 
life.”  Lewis Wolpert (1986) 
 
The period between fertilization and birth is called embryogenesis, a time when we build 
ourselves from a single cell.  This process of progressive change is exquisitely regulated by 
maternally transmitted signals, as well as transcriptional, translational and post-translational 
regulation from the embryo, which coordinate cell divisions, fate specification and movements.  
The development of the embryo produces an explosion of cellular diversity, which solicits 
increasingly complex and specific cellular signaling.  Therefore, the intracellular trafficking 
mechanisms associated with these signaling pathways must be in place to prevent any 
erroneous signaling, which the delicate embryo cannot afford.  Hence, by better understanding 
embryogenesis and the processes of cellular differentiation, the cause of many congenital 
defects may be identified and new avenues for regenerative medicine, diagnosis and therapies 
may be discovered. 
Embryogenesis leads to the elaboration of sophisticated body architecture, including the 
formation of the three major axes, namely the anteroposterior (AP), dorsoventral (DV) and left-
right (LR) embryonic axes, with an internal collection of organs of varied morphology and 
function.  Embryogenesis also encompasses the specification of the germ layers, the patterning 
and diversification of cell fates along the embryonic axes.  For simplification, Xenopus 
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embryogenesis will be the main focus although certain aspects of embryogenesis in other 
model organisms will also be discussed when needed. 
Gastrulation is the first major morphogenetic change to occur in vertebrates.  This process 
transforms a mass of morphologically similar cells (blastula) into three distinct germ layers.  The 
ectoderm, the outermost layer of the embryo, gives rise to the peripheral and central nervous 
system, tooth enamel and the epidermis.  The mesoderm is the middle layer and develops into 
cardiac, smooth and skeletal muscle, as well as red blood cells and the tubule cells of the 
kidney.  Finally, the endoderm forms the inner layer of the gastrula and develops into the 
epithelial lining of multiple systems, including the intestine, the lungs, the pancreas, and the 
endocrine glands and organs (Figure 11). 
Gastrulation follows a set of evolutionarily conserved movements: emboly/internalization, 
epiboly, convergence and extension.  Emboly, or internalization, is the defining gastrulation 
movement, which transports the prospective mesodermal and endodermal cells move inward 
through an opening called the blastopore, also known as the primitive streak in the mouse and 
chick, and beneath the future ectoderm.  This generates the three germ layers of the embryo 
and establishes the AP, DV and LR body axes. 
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Figure 11.  Germ layers and their descendants.  Gastrulation leads to the formation of 
the three germ layers: endoderm, mesoderm and ectoderm.  These cell populations give 
rise to distinct organs and systems (shown below each germ line).  Germ cells are also 
produced during gastrulation. 
 
Cells migrating inward along the archenteron generate a tube that will eventually form the 
digestive tract and the cells that line this tract form the endoderm.  During emboly, cells 
migrating inward undergo an epithelial to mesenchymal transition (EMT), which allows them to 
move more freely within the developing embryo [222].  This entails the disassembly of epithelial 
junctions, downregulation of cell adhesion molecules, and remodeling of the cytoskeleton [223].  
Asymmetrical delivery and removal of these cytoskeletal and adhesion components is 
accomplished by polarized membrane transport and endocytosis, which drive these changes 
[224].  Once inside the gastrula, involuted tissue breaks away from and migrates under the 
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internal side of the blastocoel roof [225].  This tissue continues to migrate deep into the embryo, 
as individual but synchronized cells.  As the nascent germ layers begin to thin and spread, the 
embryo starts epiboly.  Cells become narrow and flat by radial intercalation, which results in 
the expansion of a thin sheet of cells and the elongation of the embryo.  Near the end of 
gastrulation, the embryo undergoes the last step of gastrulation, convergent extension (CE), 
which elongates the embryo from head to tail, narrowing dorso-ventrally.  CE is achieved by 
planar intercalation of cells between their anterior and posterior neighbours.  As such, cells 
along the lateral mesoderm converge to the embryonic midline and simultaneously extend 
[226].  
The formation of the three germ layers is molecularly orchestrated and begins with maternal 
signals originating from the vegetal half of the embryo.  The pre-gastrula embryo can be divided 
into three prospective germ layers with the vegetal half forming the prospective endoderm, the 
equatorial region forming the prospective mesoderm and the animal region forming the 
prospective ectoderm.  Maternal VegT is a T-box transcription factor that is expressed vegetally 
and which activates TGF-β and nodal signaling, to induce the mesoderm and endoderm [227].  
The dorsal side of the embryo is regulated differently from the ventral region with the Wnt 
pathway being the primary determinant.  Through the dorsal activation of Wnt signaling, high 
levels of Xnr1 and Xnr2 (Xenopus nodal-related genes) help to establish the posterior and 
anterior domains of mesoderm [227].  As such, the prospective mesoderm can also be divided 
into domains with unique molecular signatures.  For example, while posterior paraxial 
mesoderm gives rise to somites, head mesoderm develops into the branchial arches. 
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Figure 12.  Fate maps and gastrulation movements in Xenopus laevis.  Left: early 
gastrula cross section with animal/anterior up and dorsal to the right.  Prospective 
endoderm is the most vegetal (yellow), while mesodermal precursors (red) form a broad 
band between endodermal and animally located ectodermal precursors.  Dorsal 
enrichment of β-catenin establishes the Spemann organizer, which then coordinates 
gastrulation movements (arrows).  Right: late gastrula cross section depicting the three 
germ layers: ectoderm (blue), mesoderm (red) and endoderm (yellow). 
 
Regulating a vast majority of the changes observed during gastrulation is the Spemann 
organizer (SO), which is located around the initial site of cellular ingression (Figure 12).  Signals 
originating from the SO, namely the two factors, fibroblast growth factor (FGF) and Snail, drive 
EMT.  However these two factors are mutually repressive and maintain the balance of 
ectodermal progenitors in the epiblast and mesendoderm progenitors that ingress during 
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gastrulation [228].  As gastrulation progresses, a small population of mesoderm cells become 
fated to the cardiac lineage. 
 
 
1.17 – Cardiogenesis 
 
In vertebrates, the heart is one of the first organs to fully develop, providing the growing 
embryo with a constant distribution of oxygen and nutrients.  For more detailed information on 
cardiogenesis and the recent advances in the subject, please refer to these excellent reviews 
[229-231].  Vertebrate cardiogenesis is evolutionarily conserved and many similarities exist 
between mammalian and amphibian heart development.  However, compared to a mammalian 
heart, the heart of an amphibian bears significant anatomic differences, the most striking being 
its three chambers versus four in mammals (Figure 13).  The heart of amphibians is made up 
of two partially septated atria and a single, non-septated but highly trabeculated ventricle.  The 
spiral outflow tract in the amphibian heart is equipped with two valves in series, which direct 
blood flow to the pulmocutaneous or systemic arteries based on the relative resistance in these 
vascular beds [232, 233].  Despite these differences, mammalian and amphibian cardiogenesis 
is practically identical during the early phases and only begin to diverge after the heart tube 
stage and the early stages of looping.  By studying cardiogenesis in Xenopus laevis, we may 
further our knowledge of human heart development. 
At the onset of vertebrate gastrulation, prospective heart cells originate as two bilateral 
patches of specified mesoderm on the dorsal side of the embryo (Figure 14A) [234].  During 
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gastrulation movements, these cardiac progenitors migrate dorso-anteriorly as two populations 
of cells and then ventrally to fuse at the ventral midline during neurulation (Figure 14A) [234]. 
 
Figure 13.  Inside the mammalian and amphibian hearts.  Here are simplified illustrations 
of mammalian and amphibian hearts.  Morphological differences and similarities are 
shown, most noticeable is the fact that unlike a human heart, which has four chambers 
(2 atria, 2 ventricles), the amphibian heart has only three (2 atria, 1 ventricle).  As only 
one ventricle pumps blood through the body, a mixture of blood, both Oxygen-rich (red) 
and –poor (blue), leaves the heart.  Interestingly, studies have shown that some form of 
sorting does occurs between O2-rich and –poor erythrocytes [232, 233].   
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Figure 14. Cardiogenesis in Xenopus laevis. A) Prospective heart cells (red) are found 
on the prospective dorsal side (D) of the early gastrula mesoderm, adjacent to the axial 
somitic mesoderm (blue).  By the end of gastrulation, these cardiac progenitors have 
migrated to the dorsoanterior end of the embryo. The bilateral patches eventually fuse 
at the ventral midline during the end of neurulation (Stage 21) [235].  B) Ventral view of 
Xenopus laevis embryos immunostained with anti-fibrillin.  These images show the 
morphological changes that occur during cardiogenesis: primitive heart tube (stage 27), 
formation of the linear heart tube (stage 31), completion of the linear heart tube (stage 
33), spiral looping of the heart tube (stage 35), the onset of chamber formation (stage 
41), completion of the three-chambered heart (stage 46) [232].  
 
Once the two populations of cardiac progenitor cells merge at the ventral midline they begin 
to form the cardiac muscle.  This group cells form the majority of the myocardium and are 
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divided into two distinct cell populations called the first (FHF) and second heart (SHF) fields 
(Figure 15) [230, 236].  The two distinct heart fields can first be detected at the cardiac crescent 
stage.  FHF cells are the first to differentiate while cells of the SHF migrate later to join the 
differentiated FHF cells [230].  The FHF occupies an anterior lateral position and may provide 
a scaffold upon which the SHF forms.  In general, cells from the FHF contribute to the left 
ventricle while SHF cells contribute to the outflow tract and the right ventricle, as well as to both 
atria [237].  These cells eventually form a primitive myocardium that begins its lifelong 
contractions as it continues to develop into a multichambered organ (Figure 14B) [230].  Both 
the FHF and SHF differ with respect to the onset of terminal differentiation but retrospective 
clonal analyzes indicates these two cell populations derive from one common cardiac 
progenitor cell population (CPC) [238, 239]. 
In the final stages of heart development, the cardiac tube undergoes a leftward bend, 
creating the outflow tract, which is followed by the formation of the atrioventricular valve that 
separates the atria from the ventricle (Figure 14B) [230].  Finally, the atrium divides into two 
asymmetrical chambers, the right atrium being the larger of the two, and trabeculae form within 
the wall of the ventricular myocardium [230]. 
On a molecular basis, one of the earliest markers of cardiac progenitors is the transcription 
factors Mesp1 (mesoderm posterior 1), which lies on top of the cardiovascular lineage, 
upstream of other important markers for cardiac progenitors, such as Isl1 [240].  Expression of 
Mesp1 is required for the migration of cells towards the anterior region of the embryo [241].  
This gene is transiently expressed in nascent mesoderm and descendants of these cells 
colonize the whole myocardium, including both heart fields [229].  Myocardial transcription 
factors, such as Nkx2-5 (NK2 transcription factor related, locus 5) and Gata4 (GATA-binding 
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protein 4), are first detected in the cardiac crescent, where myocardial differentiation begins 
[229].  Nkx2-5 and Gata4 depend on positive signaling from BMPs (bone morphogenetic 
proteins) and FGFs (fibroblast growth factors), while an inhibitory effect on differentiation is 
exerted by Wnt signaling [242].  While SHF cells are easily identified by many molecular 
markers, including genes like Fgf8, Fgf10, Isl1, and Tbx1, there is a lack of molecular markers 
for the FHF [229].  Nevertheless, a small set of genes have been proposed, namely Nkx2-5, 
Hand1 and Tbx5, and may be associated with FHF cells due to their mutant phenotypes, which 
display mainly left ventricular defects [229]. 
 
Figure 15.  First and second heart fields during mouse cardiogenesis. Here are shown 
the relative positions and movements of the first and second heart fields, relative to each 
other.  The body axes are indicated.  Ca, caudal; Cr, cranial; L, left; R, right. [243] 
 
During heart development, cardiac progenitor cells undergo multiple phases of specification 
and proliferation.  Early cardiogenesis is marked by signaling from both the bone 
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morphogenetic protein and Wnt signaling pathways, which play pivotal roles [244].  While BMP 
signaling promotes cardiac specification, Wnt/β-catenin signaling can have either a positive or 
negative effect on the progression of cardiogenesis [244, 245].  Early work in Drosophila 
suggested that Wnt/β-catenin signaling plays a general positive role on cardiogenesis [246].  
However, later studies reported conflicting results on the role of Wnt/β-catenin signaling during 
cardiogenesis.  On the one hand, inhibition of Wnt/β-catenin signaling in chick and Xenopus 
embryos promoted heart development while its activation in anterior mesoderm suppressed 
cardiac differentiation [247, 248].  Also, data obtained from mouse studies showed that 
endoderm specific knockout of β-catenin results in the formation of multiple, ectopic hearts 
[249].  On the other hand, cell culture-based experiments showed that inhibition of Wnt/β-
catenin signaling in P19 teratocarcinoma stem cells decreased expression of cardiac specific 
genes [250]. 
These apparently contradictory results have now been resolved into a new model that 
suggests a biphasic effect (agonistic or antagonistic) of Wnt signaling on cardiogenesis 
depending on the developmental timing (Figure 16).  This was elegantly shown in heat shock 
inducible transgenic zebrafish embryos where application of Wnt8, a Wnt agonist, before 
gastrulation produces more cardiomyocytes, whereas application of Wnt8 after gastrulation 
results in less cardiomyocytes [251].  Correspondingly, a reverse effect could be achieved by 
the timed delivery of the Wnt inhibitor Dkk1.  In mouse embryonic stem cells (ESCs), expression 
of some canonical Wnt ligands starts slightly earlier than the expression of cardiac genes, and 
inhibition of these ligands at early time points inhibits cardiac differentiation and reduces the 
contractile area within embryoid bodies [251, 252].   
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Figure 16.  Wnt/β-catenin regulation and cardiac specification.  A) Wnt is a determining 
factor during cardiogenesis.  Wnt/β-catenin signaling promotes specification of cells to 
mesoderm and the concomitant expression of Brachyury (left panel, pre-gastrula).  
Following mesoderm formation, inhibition of Wnt/β-catenin is required for commitment 
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to the cardiac lineage and expression of early cardiac markers Gata6 and Nkx2-5 (right 
panel, gastrula).  The general area corresponding to pre-cardiac mesoderm is circled 
(left panel).  Once specified, cardiac progenitors migrate anteriorly as two lateral 
populations.  The dotted lines (right panel) shows this lateral location.  Mesoderm: red; 
endoderm: yellow; ectoderm: light blue; epidermis: dark blue. B) The multiple phases of 
Wnt signaling during early cardiac development. The actions of canonical and non-
canonical Wnt signaling are shown for the progression of each stage: (1) Mesoderm 
formation, (2) Specification, (3) Proliferation, (4) Terminal differentiation. 
 
As a prerequisite for the formation of cardiac progenitor cells, the mesoderm germ layer 
must be induced in the early embryo and this process is dependent upon Wnt/β-catenin 
signaling (Figure 16A – left panel) [253-257].  In accordance, the canonical Wnt ligands Wnt3 
and Wnt8a are expressed in the early gastrula-stage embryo and are also required during 
differentiation of mouse ESCs into multipotent mesoderm cells [254, 258].  A known marker for 
newly formed mesoderm cells is the T-box transcription factor Brachyury (Bry), which is 
required for posterior mesoderm formation and likely a direct target of Wnt/β-catenin signaling 
[256, 257].  In addition to the prerequisite of expressing Bry, mesoderm progenitors that are 
Flk-1+/Mesp1+ will follow the cardiac lineage, while those are Flk1+/Mesp1- are fated for the 
hematopoietic cell lineage [259]. 
As prospective cardiac progenitors mature and acquire a mesoderm signature, Wnt/β-
catenin signaling suddenly becomes a negative factor in their progression through 
cardiogenesis [244].  Evidence supporting this idea first came from studying Notch signaling, 
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which can redirect differentiating mouse embryonic stem cells fated for the hematopoietic 
lineage toward the cardiogenic lineage [260].  Here, Notch activation resulted in an upregulation 
of molecules inhibiting Wnt/β-catenin signaling, namely secreted Frizzled-related protein-1 
(Sfrp1) and Sfrp4, and the addition of Wnt3a (canonical) but not Wnt5a (non-canonical) 
completely abolished the effect of Notch.  In another study, it was found that overexpression of 
a stable variant of β-catenin in Isl1-positive cardiac progenitor cells caused a downregulation 
of several important cardiac genes [261].  Supporting these data were the findings that Wnt/β-
catenin signaling negatively regulates Gata6 (early cardiac transcription factor), and that the 
Wnt inhibitor Dkk1 can improve the differentiation of Mesp1-induced cardiomyogenesis [254, 
262].   
Contrary to Wnt/β-catenin signaling, non-canonical Wnt signaling contributes to 
cardiogenesis in mesoderm cells (Figure 16B).  Supporting evidence comes mostly from 
studies of Wnt11 and Wnt5a, which induce contractile tissue formation and is upregulated in 
Bry+/Flk1+ cardiogenic progenitors, respectively [251, 260, 263-265].  In addition, Notch 
signaling or Mesp1 activation seem to upregulate non-canonical Wnt ligands during 
cardiogenesis [266, 267].    
Even with these results, we still cannot draw a clear picture of heart development.  Although 
the importance of Wnt/β-catenin signaling has been demonstrated, the molecular components 
and mechanisms that regulate the activation and inhibition of this signaling pathway across 
each step of cardiogenesis are still poorly understood.  Initiation of this pathway occurs when 
Wnt is secreted protein, which ends up stabilizing the transcriptional co-activator β-catenin.  
Between these key proteins lie many transducing factors, which determine whether the Wnt 
signal is received and acknowledged by the cell.  Therefore, to fully comprehend the implication 
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of Wnt/β-catenin signaling during cardiogenesis, we must better understand the mechanisms 
that regulate this major signaling pathway. 
 
 
1.18 – Wnt signaling 
 
The Wnt family of secreted glycoproteins is a large family of evolutionarily conserved 
morphogens; essential for a wide array of developmental and physiological processes, they 
are involved in embryonic axis formation, segmentation, organogenesis, as well as stem cell 
proliferation [268-275].  Furthermore, Wnt pathways are closely linked to disease, such as 
tumorigenesis [276, 277], bone disease [278] and neurodegenerative diseases [279].   
As Wnt signaling is activated, a Wnt molecule, originating from a close or distant cell, binds 
to a cell-surface receptor, which initiates a cascade of events leading to transcriptional 
changes.  In the classical (canonical) model, Wnt signaling requires binding of Wnt to both a 
receptor (Frizzled (Fz), Fz1-10 in humans) and a co-receptor (low-density lipoprotein receptor-
related protein (LRP), LRP5/6) [280, 281].  Frizzled receptors are seven-transmembrane 
proteins that bind with high affinity to Wnt ligands while LRP5/6 are single-pass transmembrane 
proteins that bind poorly to Wnt but help stabilize the Fz-Wnt-Lrp complex and contribute to 
downstream signaling [282].  Other less described co-receptors implicated in Wnt signaling 
include the Tyrosine kinase-like orphan receptor (ROR) [283], protein Tyrosine kinase 7 (PTK7) 
[284], receptor Tyrosine kinase (RYK) [285], muscle skeletal receptor Tyrosine kinase (MUSK) 
[286] and proteoglycan families [287].  Secreted receptor-binding agonists of Wnt signaling 
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include 19 known Wnts, the R-spondin (RSPO) family and Norrin [288].  Known antagonists of 
Wnt signaling are either secreted as soluble molecules or expressed at the cell surface as 
transmembrane inhibitors. Inhibition can be achieved by competitive binding of antagonists to 
receptors and co-receptors, by binding of secreted inhibitors to secreted Wnts, by preventing 
the maturation of receptors or by interfering with receptor interactions and internalization [288].  
Secreted inhibitors include Cerberus, the Dickopf-related proteins (Dkk), secreted Frizzled-
related protein, SOST, Wnt inhibitory factor (WIF), and Wise/SOST [288].  Transmembrane 
inhibitors identified to date include Shisa, Wnt-activated inhibitory factor 1 (Waif1/5T4), 
adenomatosis polyposis coli down-regulated 1 (APCDD1), and Tiki1 [288]. 
Activation of Wnt signaling can produce different results; it can stabilize the cytoplasmic 
protein β-catenin (canonical Wnt signaling) or produce a β-catenin-independent response (non-
canonical Wnt signaling).  Using this classification, Wnt1, Wnt3a, Wnt8 and Wnt8b are 
recognized as canonical Wnt signaling agonists whereas Wnt4 and Wnt5a take part in the non-
canonical pathway [289].  However, this classification is a highly subjective oversimplification 
since several Wnts can activate both the canonical or non-canonical pathways, depending on 
the cellular context and the receptors present at the cell-surface.  In addition, new research has 
revealed that considerable crosstalk occurs between β-catenin-dependent and –independent 
signaling pathways [289].  There are at least 15 different Wnt receptors and co-receptors, and 
their specific combination with a specific Wnt determines the downstream pathway.  For 
example, Wnt5a, which was initially classified as a non-canonical Wnt activator, has been 
shown to activate the Ca2+ signaling pathway when specific Frizzled receptors are present, 
namely Fz2, Fz3, Fz4, Fz5, and Fz6 [290-292].  Yet, Wnt5a can also activate the canonical 
Wnt pathway if it encounters both Fz4 and LRP5 [293].  Despite this simplified classification 
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and due to the scope of this work, canonical and non-canonical Wnt nomenclature will still be 
used to refer to instances of β-catenin-dependent and –independent signaling, respectively. 
Canonical Wnt signaling (Wnt/β-catenin) revolves around a cytoplasmic protein, β-catenin 
(Figure 17).  Newly synthesized β-catenin is found at adherens junctions, immobilized by E-
cadherin.  There it can indirectly modulate the actin cytoskeleton through its interaction with α-
catenin.  During inactive Wnt/β-catenin signaling, levels of cytoplasmic β-catenin (from excess 
synthesis or released from adherens junctions) are kept low due to phosphorylation of β-catenin 
by the “destruction complex” [289].  This complex includes glycogen synthase kinase 3, 
adenomatosis polyposis coli (APC), Axin, the E3-ubiquitin ligase β-TrCP and casein kinase Iα 
[294].  Phosphorylation of β-catenin depends on kinases in the destruction complex and serves 
as a signal that targets β-catenin for proteasomal degradation [289].  The interaction of Wnt 
with Frizzled and LRP5/6 activates Wnt/β-catenin signaling by causing the disassembly of the 
β-catenin destruction complex.  In turn, β-catenin accumulates in the cytoplasm and eventually 
translocates to the nucleus where it acts as a transcriptional co-activator, associating with the 
transcription factors TCF (T cell factor) and LEF (lymphoid enhancer-binding factor) [295-297].  
The disassembly of the β-catenin destruction complex is not completely understood but 
involves the recruitment of two scaffolding proteins, Dishevelled and Axin, to the intracellular 
domains of Frizzled and LRP5/6, which inhibits the phosphorylation of β-catenin [294].  Other 
mechanisms that promote the stabilization/accumulation of β-catenin have recently been 
discovered and will be discussed in the “Endocytosis and Wnt/β-catenin signaling” section. 
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Figure 17.  The different pathways of Wnt signaling. A) Planar cell polarity (PCP) 
signaling activates of the small GTPases RHOA and RAC1, which in turn activate RHO 
kinase (ROCK) and JUN-N-terminal kinase (JNK), respectively, leading to cytoskeletal 
rearrangements, namely actin polymerization and microtubule stabilization.  Cellular 
activities influenced by this pathway include the regulation of cell polarity, cell motility 
and morphogenetic movements. B) In the absence of a Wnt ligand (from excess 
synthesis or released from adherens junctions), levels of cytoplasmic β-catenin are kept 
low due phosphorylation by the destruction complex (GSK3-APC-Axin-CKIα) and 
subsequent ubiquitination/proteasomal degradation.  When Wnt receptors/co-receptors 
are activated by Wnt, a Fz-LRP-Wnt complex is formed, which inhibits the destruction 
complex.  LRP signalosomes are formed, sequestering certain components of the 
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destruction complex, such as GSK3 to MVBs, allowing β-catenin to accumulate in the 
cytoplasm.  β-catenin then translocates to the nucleus where it associates with the 
LEF/TCF transcription factors to activate transcription of target genes. C) The Wnt-Ca2+ 
pathway activates Ca2+- and calmodulin-dependent kinase II (CAMKII), protein kinase C 
(PKC) and calcineurin.  In turn, Calcineurin activates nuclear factor of activated T cells 
(NFAT), which regulates the transcription of genes involved in cell fate determination 
and cell migration.  Both the PCP and Ca2+ pathways inhibit Wnt/β-catenin signaling at 
various degrees. [289] 
 
Non-canonical (β-catenin-independent) Wnt signaling encompasses pathways that do not 
use β-catenin but instead employ different signaling cascades to elicit a transcriptional 
response.  These include the planar cell polarity (PCP) signaling, the Ca2+ pathway, and the 
Wnt5A-ROR signaling (Figure 17).   
PCP signaling involves a cascade of activated molecules initiated by the activation of 
Frizzled receptors, the small GTPases RAC1 and RHOA, and RHO kinase (ROCK) and Jun-
N-terminal kinase (JNK) [289].  The downstream output of the PCP pathway leads to 
cytoskeletal remodeling and changes in cell polarity via small GTPases and/or transcriptional 
activation of JNK-dependent transcription factors, for example the activating transcription factor 
2 (ATF2) [287, 298].  The PCP pathway is prominently involved in regulating cell polarity in 
morphogenetic processes, such as cell movement during gastrulation, neural tube closure and 
the orientation of stereocilia in the inner ear [287, 298]. 
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Another possible consequence of activating Wnt signaling is the transient increase in 
concentrations of inositol 1,4,5-triphosphate (IP3), 1,2 diacylglycerol (DAG), and Calcium 
(Ca2+) [299].  IP3 diffuses through the cytosol and interacts with calcium channels on the 
membrane of endoplasmic reticulum, releasing Ca2+ ions and resulting in the activation of 
calcium calmodulin dependent protein kinase II (CaMKII) [290].  DAG also travels through the 
cytosol and activates protein kinase C (PKC), and the combined action of CaMKII and PKC 
activates various regulatory proteins (NFκB and CREB), which translocate to the nucleus as 
transcription factors [299, 300]. 
Aside from its association with Frizzled receptors, Wnt5a can also bind another 
transmembrane protein, the receptor tyrosine kinase Ror1/2, and mediate non-canonical signal 
transduction [299].  Wnt5a/Ror signaling also activates the calcium pathway, which has 
important implications in the neural tube formation, axonal pathfinding of the mammalian brain, 
testes development, and heart and bone formation [299, 301]. 
 
 
1.18.1 – Endocytosis and Wnt/β-catenin signalling 
 
Endocytosis is an essential step in Wnt/β-catenin signaling but the mechanism regulating 
this and the following steps are only beginning to be understood.  The first evidence for the role 
of endocytic trafficking in regulating Wnt signalling came from work in Drosophila.  During the 
early stages of embryogenesis, signals like Wnt, act as short (distance three cell diameters) 
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and long range (distance over twenty cell diameters) signaling molecules, secreted in the form 
of soluble morphogens.  In the Drosophila embryonic epidermis and the wing imaginal disc, Wg 
(Drosophila homolog of Wnt) can be detected in cytoplasmic puncta within Wg-responsive cells 
and interference with endocytosis abolishes this intracellular localization of Wg [302, 303].  In 
these endocytosis-defective cells, Wg accumulates on the extracellular surface, suggesting 
that Wg is normally internalized through the endocytic pathway.  In addition, by providing a 
degradation route, endocytosis seems to regulate the distribution of Wg in the extracellular 
medium and restricts the range Wg signaling [304].  When endocytosis and subsequent 
lysosomal degradation are compromised in embryonic epidermis, excess Wg levels cause 
increased signalling and misspecification of epidermal cell fate.  In accordance, Wg, arrow 
(Drosophila homolog of LRP) and DFz2 (Drosophila Frizzled 2) are trafficked to the lysosome 
in the wing imaginal disc of wild-type animals [305].  In this context endocytosis seems to play 
a negative role on Wnt signaling.  However, later studies have revealed a positive role of 
endocytosis in activating Wnt/β-catenin signaling, as clathrin, dynamin and Rab5 were each 
shown to be required for activation of this pathway in Drosophila and mouse L cells [306, 307].   
Recent work has begun to shed a light on the mechanism behind endocytosis of the 
Wnt/Fz/LRP complex.  This process follows a series of events including phosphorylation and 
trafficking of the complex to the appropriate endosomal compartment.  After Wnt stimulation, 
CK1 phosphorylates the LRP6 intracellular domain in a Dvl-dependent manner, which then 
recruits the negative regulator Axin [308-311].  Phosphorylation of LRP6 occurs at multiple 
conserved sites, notably at PPSXS motifs, where both Serine (or Threonine) residues are 
phosphorylated [282].  In addition to phosphorylation by the non-proline kinase CK1, 
phosphorylation of LRP6 is also carried out by proline-directed kinases GSK3, Protein kinase 
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A (PKA), Pftk members, and G protein-coupled receptor kinase (Grk5/6) [282].  Recent studies 
have shown that 15 minutes after Wnt stimulation, protein aggregates called LRP6 
signalosomes are formed at and under the plasma membrane [311].  LRP6 signalosomes are 
made up of phospho-LRP6, Frizzled, Dvl, Axin and GSK3, and partially co-localize with 
caveolin, suggesting that caveolae-dependent endocytosis is at play in this context [311].  Once 
GSK3 is recruited to the cytoplasmic side of LRP6 signalosomes, it propagates Wnt signaling 
by phosphorylating LRP6 and other substrates such as Dvl, APC, Axin and β-catenin [312].  
However, GSK3 activity must then be inhibited in order for β-catenin to accumulate in the 
cytoplasm.  Therefore, GSK3 has paradoxical positive and negative effects in early and mid 
Wnt/β-catenin signaling [313].  To prevent phosphorylation of β-catenin by GSK3, GSK3-
containing LRP6 signalosomes are sequestrated into multivesicular bodies, a process which 
leads to β-catenin stabilization (Figure 18) [103].  This isolates GSK3 from all cytoplasmic 
proteins and prevents GSK3-mediated phosphorylation of its substrates, including β-catenin.  
By avoiding phosphorylation by GSK3, β-catenin accumulates in the cytoplasm and 
translocates to the nucleus.  Sequestration of the LRP6 signalosomes into MVBs depends upon 
at least two components of the ESCRT machinery, namely Hrs and Vps4 but other factors are 
also likely involved [103].  However, the inclusion of the ESCRT machinery in this process 
confirms the requirement for MVB formation as these proteins are essential in MVB formation.  
These recent advances have shed light onto the mechanism of Wnt/β-catenin signaling 
activation but many questions remain.  For example, how are LRP6 signalosomes sorted at the 
early endosome and routed towards the MVBs?  Answers to this and other questions will likely 
have important impacts on our understanding of Wnt signaling and Wnt-related illnesses. 
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Figure 18. Model of Wnt-dependent sequestration of LRP6 signalosomes into 
multivesicular bodies during canonical Wnt signaling.  Binding of GSK3 (red) to the Wnt 
receptor complex (including phosphor-LRP6, phosphor β-catenin, Dvl, Axin, and APC) 
sequesters GSK3 inside the intralumenal vesicles of MVBs. [103] 
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To continue on aspects of embryogenesis relevant to this work, we will now cover a post-
gastrulation process called somitogenesis. 
 
 
1.19 – Somitogenesis 
 
The vertebrate body plan is segmented, a feature most clearly seen in the skeleton.  Early 
during development (after gastrulation), the formation of epithelial blocks of mesoderm begins, 
a process called somitogenesis [314, 315].  Each somite gives rise to various mesoderm 
descendants: the ventral part of the somite, the sclerotome, gives rise to cartilage and bone of 
the vertebrae and ribs, whereas the dorsal side of the somite, the dermomyotome, contributes 
to the overlying dermis of the back and to the skeletal muscles of the body and limbs [316].  In 
amniotes like chicken and human, the somitic lineage is part of the paraxial (or presomitic) 
mesoderm (PSM) while in lower vertebrates such as fish and frog, it is part of the dorsal 
mesoderm [314].  During somitogenesis, somites progressively segments into bilaterally 
symmetrical epithelial somites, in an anterior to posterior direction (Figure 19).  As somites 
emerge from the anterior end of the PSM, proliferating cells in the primitive streak replenish the 
posterior PSM [314].  Soon after their formation, somites subdivide into the sclerotome, and 
dermomyotome. 
Somitogenesis is controlled by a molecular periodicity acting in PSM cells, which has been 
termed the “segmentation clock” [314].  Although this segmentation clock and the major 
signaling pathways involved are evolutionarily conserved, some characteristics are species-
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specific, such as the periodicity and final number of somites.  For example, the rhythm of somite 
production in zebrafish is around 30 minutes while in mammals it can take up to several hours 
(4-5 hours in humans) [317].  This periodicity of gene expression in vertebrates was first 
illustrated by the rhythmic expression of the HES1 (hairy and enhancer of split-related 1) mRNA 
in the chick embryo PSM [318].  The transcriptional oscillations of c-hairy occurred with the 
same periodicity as the somitogenesis process and were the basis upon which the clock model 
was built.  Subsequently, studies in fish, frog and mouse identified several other genes (the 
vast majority belonging to the Notch, Wnt and FGF signaling pathways), which exhibit the same 
periodicity and indicate an evolutionarily conserved mechanism in vertebrates [318-323] .   
Notch signaling is required for synchronization of the oscillations among neighbouring cells 
[317].  Among the downstream targets of Notch signaling are HES1 as well as the notch ligand 
Delta.  In zebrafish, mutations in Notch signaling suppress the cyclic gene expression pattern, 
which is rather replaced by a salt-and-pepper expression pattern [324, 325].  In these mutants, 
the first somites segment normally, suggesting that oscillations are set initially.  However, owing 
to the lack of Notch-dependent coupling, segmentation progressively drifts out of synchrony, 
resulting in segmentation failure.  The current models holds that oscillations in expression are 
generated and maintained through negative feedback loops driven by unstable negative 
regulators of this pathway, such as Her1 and Her7 (zebrafish homologues of HES1) [326, 327].  
In other words, activation of Notch results in the expression of both Delta and Her1.  As Delta 
ensures the transmission of Notch signaling to adjacent cells, Her1-Her7 simultaneously 
inhibits additional expression of both itself and Delta.  Therefore, Her1-Her7 ensure that Notch 
signaling only last for a short period of time.  Of note, the Her1-Her7 oscillator also requires the 
Her13.2 partner, which is downstream of FGF signaling [314]. 
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In amniotes like the mouse, a similar mechanism of synchronism exists but involves 
additional genes.  Here, FGF and Notch signaling induce expression of Notch inhibitors (like 
Lfng (lunatic fringe) and the HES genes) and Notch ligand, which ensure the transmission of 
Notch signaling to adjacent cells as well as the activation of a negative feedback loop, similar 
to the Her-based loop in zebrafish [314].  However, Wnt signaling is also involved in 
synchronizing the clock cycle in the mouse.  Interestingly, Wnt signaling oscillates in opposite 
phase to the cyclic genes products of Notch and FGF signaling.  Downstream Wnt targets 
include the several negative feedback inhibitors of the pathway, such as Dkk1 [323].  The 
complex epistatic relationships and multiple crosstalks between the Notch, FGF and Wnt 
signaling pathways makes it challenging to determine their respective contributions to the 
molecular circuitry responsible for generating the oscillations, i.e. “the segmentation clock 
pacemaker”.  Future work will be needed to produce a working model of these relationships 
and will most.  
As much as the signaling pathways involved in somitogenesis and cardiogenesis are 
important for the changes in gene expression and cellular identity, the underlying mechanisms 
that regulate each signaling pathway, such as receptor trafficking, are also essential.  However, 
this aspect of cellular signaling adds an additional layer of complexity to an already complex 
model.  The unification of cell culture and developmental studies will require precise 
characterization of gene function on both levels.  Therefore, simple and well-characterized 
models are essential in helping further our understanding of complex developmental 
processes.  One such model organism is the African clawed frog, Xenopus laevis. 
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1.20 – Model organism: Xenopus laevis 
 
Historically, X. laevis embryos, were used for studying early embryogenesis whereas later 
events of were not examined due to technical limitations.  X. laevis was favoured as a model 
organism for early embryogenesis because of the ease at which microinjections of mRNAs in 
specific cleavage-stage cells could be done for both gain and loss-of-function experiments.  
The steps of X. laevis embryogenesis are well-characterized and share many genetic and 
anatomic similarities with other vertebrates, including humans.  Today, studies using X. laevis 
have yielded many insights into how vertebrate development is controlled from heart and liver 
organogenesis to the development of the skeleton and central nervous system.  In particular, 
cardiac defects can be extensively analyzed in living embryos since early embryogenesis can 
proceed in the absence of a functional circulation system, a process that takes approximately 
3.5 days and is complete at 80 hours post-fertilization (hpf) (Stage 42).  Work by Nieuwkoop 
and Faber (1994) describing each stage of development, from the first cell division to the 
formation of adult morphology has helped immensely in providing a standard by which to stage-
characterize Xenopus embryos.  A single female can be induced to lay thousands of eggs year-
round, which quickly develop externally in an aqueous solution.  Embryos are relatively large 
and exhibit a remarkable ability to recover from microsurgery.  In addition, Xenbase 
(www.xenbase.org) is a useful and community-oriented online resource where information on 
Xenopus developmental biology, genetics and experimental procedures can be obtained. 
The eggs laid by a female are fertilized using sperm extracted from the male testis, which 
must be dissected due to their internal localization.  The zygote develops through multiple cell 
divisions and eventually generates a large mass of cells, called the blastula, at 4 to 5 hours 
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post fertilization (Stage 7-8).  Gastrulation commences quickly after (Stage 10, 9 hpf), and the 
blastopore become discernible.  This circular opening eventually closes shut at around 16 hpf 
(Stage 14), which marks the end of gastrulation, and the beginning of neurulation.  The neural 
plate becomes progressively more prominent on the dorsal side of the embryo.  From stage 14 
to 26 (30 hpf), the embryo undergoes extensive cell rearrangements and starts to show many 
recognizable features of a tadpole (ex: head, body and tail).  The transformation of the embryo 
from a spherical to an elongated shape is the result of convergent extension along the anterior-
posterior body axis.  During this process, mediolateral intercalation of cells in the neural plate 
and underlying mesoderm simultaneously squeezes the blastopore shut and closes the neural 
tube.  Following neural tube closure, organs such as the brain, heart and eyes start to develop.  
At stage 42 (80 hpf), most major organs have developed and are now functional. 
A common tool for studying gene function in X. laevis is by morpholino-induced gene 
knockdown.  Morpholinos oligos (MO) are short chains of about 25 antisense morpholino 
subunits offered commercially by GeneTools, LLC.  Each morpholino subunit is comprised of 
a nucleic acid base, a morpholine ring and a non-ionic phosphorodiamidate intersubunit 
linkage.  By binding with high affinity to mRNA, they block translation initiation through a steric 
blocking mechanism.  Unlike RNA, morpholinos do not degrade and are therefore functional 
inside the embryo until multiple cell divisions lowers their concentration within each cell and 
renders them ineffective.  Through the use of microinjections, specific amounts of MO can be 
injected into a fertilized zygote or into specific cells of which the descendants are known. 
Despite these advantages, certain limitations do exist when studying Xenopus 
development.  For example, micro-injections do not persist in the embryo for more than a few 
days, making it unrealistic to manipulate gene functions in later stages of development.  
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Therefore, exploiting the characteristics of multiple models (both in vivo and in vitro) may be 
most beneficial in understanding the role of any gene.  Through the study of developmental 
process in Xenopus laevis and of their associated signaling pathways in cell culture models, 
we will better understand the underlying mechanisms that regulate the many steps of 
embryogenesis.  In turn, this understanding may lead to improved detection and treatment of 
human diseases. 
 
 
1.21 – Disorders related to endosomes and sorting nexins 
 
Since protein degradation is such an important aspect of cellular biology, it is not surprising 
to find that dysregulation in this process can have deleterious effects.  Inheritable lysosomal 
storage diseases are an example of this and have been classified according to the stored 
substance (ex: sphingolipidoses, mucopolysaccharidoses, mucolipidoses, glycoprotein and 
glycogen synthase storage diseases) [328].  Under pathological conditions, these substances 
are enzyme substrates that accumulate inside the cell, which is manifest most commonly by 
neurodegeneration [329].  Among the lysosomal storage diseases, a few have been approved 
for enzyme replacement therapy (ERT) but obstacles to this therapy remain, including immune 
reactions against the infused enzyme, mistargeting of enzymes to organelles other than 
lysosomes, and intractable tissues.  Mutations in various sorting nexins have also been linked 
to disease.  Snx10 is involved in osteoclast formation and resorption activity and has been 
associated with osteopetrosis [164, 165].  Snx31 has been identified as a new gene possibly 
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linked to melanoma [330].  Finally, in addition to its role in Wnt secretion (which is likely relevant 
in Wnt-associated diseases), Snx3 could be involved in erythropoiesis and disorders of iron 
metabolism due to its regulation on transferrin receptor trafficking [331] 
 
 
1.22 – Wnt/β-catenin signaling and disease 
 
The link between Wnt/β-catenin signaling and cancer has been known since the discovery 
of the gene int-1 as a mammary oncogene in mice [332, 333].  Additional support for this came 
from the finding that ~85% of colorectal cancers have an inactivated APC gene, leading to 
constitutive nuclear localization of β-catenin [334-336].  Often, dysregulation of Wnt/β-catenin 
signaling is observed in tumours and hematologic malignancies without any mutations in the 
coding regions of the respective genes.  For example, epigenetic silencing of Wnt antagonists 
like the SFRPs has been shown in colon, breast, prostate and lung cancers [337-341].  
Increased expression of Wnt ligands and dishevelled have also been described for many 
cancer types [342-345].  Even though elevated Wnt/β-catenin signaling may suggest poor 
prognosis for patients with cancer, this is not always the case.  For example, in melanoma, high 
Wnt/β-catenin signaling is associated with lower proliferative index and correlates with a more 
favorable prognosis for patients [346-349].  This is explained by the fact that elevated β-catenin 
in melanoma promotes expression of MITF, which itself drives differentiation toward a 
melanocyte-like fate and reduces cell movements [350, 351].  Better prognosis is also 
associated with increased Wnt/β-catenin signaling in patients in at least some stages of 
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prostate, ovarian and colorectal cancers [352-354].  In some mouse models, activation of 
Wnt/β-catenin signaling appears to function as a tumour suppressor.  For example, inhibition 
of Wnt in human mesenchymal stem cells leads to high-grade sarcoma formation in nude mice 
[355].  In some cancers, such as in mouse models of pancreatic ductal adenocarcinoma 
(PDAC), overexpression of constitutively active β-catenin can arrest transformation, resulting 
in the formation of a much more benign tumour type [356, 357].  In addition to cancer, Wnt 
signaling is implicated in neurological and autoimmune diseases, and inflammation [358].  Both 
schizophrenia and Alzheimer’s disease have also been associated with aberrant Wnt/β-catenin 
signaling [359-361]. 
Interestingly, a mutation in the N-terminal region of Snx4 (upstream from the PX domain) 
was found in the primary tumour of lobular breast cancer (oestrogen-receptor-positive) [362].  
This mutation, along with five other mutations, was also prevalent 9 years later after analysis 
of metastatic lobular breast cancer tumours.  This is yet another important finding that suggests 
essential roles for SNX-BARs in regulating major signaling pathways involved in cellular 
proliferation and differentiation. 
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Background: Sorting nexins (SNXs) without a BAR (Bin-Amphiphysin-Rvs) domain remain 
largely uncharacterized. 
Results: SNX11 regulates somitogenesis, actin polymerization and PI3-kinase dependent 
receptor recycling. 
Conclusion: SNX11 functions in actin-dependent and –independent processes. 
Significance: A functional description of each sorting nexin will provide a better 
understanding of how endosomal sorting integrates into developmental processes. 
 
ABSTRACT 
Proteins of the sorting nexin family are involved in processes that regulate endosomal protein 
sorting of diverse cargo through their association with membranes and cargo-binding protein 
complexes that move along filamentous paths.  After identification of Snx11 as a positional 
candidate gene for canine tricuspid valve malformation, we set out to functionally characterize 
SNX11 in vitro, in cell culture and Xenopus knockdowns. We found that SNX11 physically and 
functionally interacts with many of cytoskeletal proteins, including actin. SNX11 was widely 
expressed in adult mouse tissues. We show a functional role for SNX11 in actin nucleation, 
somite development and receptor trafficking. We propose SNX11 as a functional candidate for 
competitive interaction with other SNX family members.  
__________________________________________________________________________ 
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The sorting nexin (SNX) family of proteins includes 33 members implicated in a wide variety of 
intracellular sorting and trafficking events (1-3).  Their PHOX-homology (SNX-PX) domain 
associates with phosphatidylinositol-phosphates (PIPs), enriched in specific regions of 
endosomal membranes where sorting events occur (4).  Three sorting nexin subfamilies were 
determine by domain architecture and include SNX that only contain an isolated SNX-PX 
domain (SNXPX), those containing a C-terminal BAR (Bin-Amphyphysin-Rvs) domain 
(SNXBAR), and SNXs that contain another recognized domains in addition to the SNX-PX 
domain (SNXPX-other), and (5). Early work on SNXs focused on their role in the retrograde 
transport of the cation-independent mannose-6-phosphate receptor (CI-M6PR), which 
maintains an active pool of hydrolase receptors in the trans-Golgi network (3,6). The 
mammalian pentaheteromeric retromer is composed of a SNX-BAR dimer and a cargo-
recognition complex (VPS26-VPS29-VPS35).  The BAR domain of SNX-BARs is a banana-
shaped C-terminal domain that dimerizes and induces and/or senses membrane deformation 
such as tubulation (7).  Following the identification of SNX11 as a positional candidate gene for 
canine tricuspid valve malformation, we set out to characterize this SNXPX, of which many 
members remains poorly characterized (8). 
Two phylogenetic relatives of SNX11, namely SNX3 and SNX10, have recently been 
investigated.  In the mouse, loss of SNX3 in leads to anemia due to defective recycling of the 
transferrin receptor (9) while earlier studies described a critical role for SNX3 in the secretion 
of the Wnt ligand (2,10).  Homozygous recessive mutations of human SNX10 cause early-onset 
osteoporosis, corroborating previous findings in which SNX10 is required for osteoclast 
formation and resorption activity (11,12). These studies reveal the functional diversity that 
SNXPX can play across multiple signaling pathways.   
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The goal of this study was to clarify the function of SNX11 by in vivo and in vitro methods.  We 
first investigated SNX11’s expression profiles in mice and then analyzed the functional role 
during embryogenesis.  We provide evidence that this ubiquitously expressed protein is 
involved in somitogenesis and interacts with proteins involved in actin organization.  We also 
show that SNX11 can regulate recycling of the delta opioid receptor (DOR).  The ability of 
SNX11 to simultaneously bind specific phospholipids and proteins suggests that it is an 
organizer of the coupling between membrane and cytoskeletal proteins in the mammalian cell. 
 
EXPERIMENTAL PROCEDURES 
Plasmid construction-RNA was extracted from newborn mouse hearts using Trizol according 
to manufacturer’s instructions (Invitrogen) and cDNA were synthesized with oligodT primers 
and SuperScript Reverse Transcriptase (Invitrogen). The full-length murine SNX11 was 
amplified from cDNA by PCR and cloned into pCR2.1 vector (TA cloning kit; Invitrogen). Two 
clones with different restriction enzyme digest fingerprints were chosen for sequencing and 
further analysis. The isoforms were named SNX11a (long) and SNX11b (short) based on 
length.The sequences were cloned in pBluescript II sk(-)into HindIII and XbaI sites. The human 
pCMV-sport6-SNX11 was from Open Biosystems. 
The full length isoform SNX11 A was amplified by PCR and cloned into pEGFP-N1 (XhoI and 
HindIII). 
Bacterial expression plasmids were generated by insertion of respective full-length or truncated 
SNX11 fragment into pGEX-4-T1 or pET30a (Figure 3A). 
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shRNA-SNX11 was from Open Biosystems (confirm clone ID: RHS127684). 
Cell culture, transfection and establishment of HEK293T_SNX11-GFP cell line-HEK293T cells 
were cultured at 37ºC in the presence of 5% CO2 in Dulbecco’s modified Eagle medium 
(DMEM, Wisent) supplemented with 10% FBS, 100 u/mL penicillin and 100µg/mL streptomycin. 
Cells were seeded a day before in 12 wells plate at 100,000 cells par well.  1-2µg DNA (pEGFP-
SNX11 A) and 16µg of polyethylenimine 1 mg/ml (PEI, Sigma) in basic DMEM without FBS 
and antibiotics were mixed and incubate for 15 minutes before transfected the cells. This mix 
was added to the cells and incubated for 4-5 hours at 37ºC in the presence of 5% CO2 before 
changing with completed DMEM. Establishment of the stable cell line, HEK293T_SNX11-GFP 
was done by selection for the transfected plasmid with 400µg/mL G418 (Wisent). 
Murine cDNA and PCR- Total murine RNA was extracted with TRIzol reagent (Invitrogen) from 
dissected tissues.  cDNA was synthesized with Superscript II reverse transcriptase (Life 
technologies).  Murine Snx11 (F: CGTCAAGGTCTCCAGCATTTCC; R: 
CGCCCTGATCTTGGAAGAAAGC) and GAPDH (F: AAGATGGTGATGGGCTTCCCG; R: 
TGGCAAAGTGGAGATTGTTGCC) were amplified by PCR. 
Antibodies-SNX11 was detected by immunochemistry with a goat anti-SNX11 antibody (Novus 
Biological). For its detection by western blotting and immunofluorescence, a rabbit polyclonal 
SNX11 antibody was produced with the following antigen sequenced 
CGWAQEERQSTSHLAKGDQ by Open Biosystems.  
For EEA1, Mannose-6-phosphate, LAMP1, we used antibodies from Abcam. Golgi tracker, 
mitochondria tracker and ER tracker, AlexaFluor 594 and 488 were purchased from Molecular 
probes. The GST tagged proteins and Flag tagged proteins were respectively detected with a 
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monoclonal mouse anti-glutathione-S-transferase (Sigma) and a monoclonal mouse anti-flag 
M1(Sigma). A polyclonal anti-GFP (Santa-Cruz) was used to amplify the GFP detection in some 
immunofluorescence experiments. 
Anti-ITM2A, -cathepsin L (ctsl) and -tubulin-α (sc-12462) were purchased from Santa Cruz 
Biotechnology, Inc., anti-Na+/K+ ATP1B1 was from Millipore upstate, anti-phalloidin was from 
Sigma (P1951), and LASP-1 was detected with a monoclonal mouse antibody (Chemicon 
International). 
SDS-PAGE and Western blotting-The tissues from rat and mouse organs were homogenized 
in RIPA buffer (Tris-HCl 50 mM, pH 7.4, 1% Igepal CA-630, 0.25% Na-deoxycholate, 150 mM 
NaCl, 1 mM EDTA).  After centrifugation, the supernatant was quantified with bicinchoninic acid 
and 25 µg/µl of proteins were solubilized in Laemmli buffer.  Proteins were separated by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose by standard 
methods.  The blots were probes with an affinity purified anti-SNX11 antibody (dilute 1/400) 
and peroxydase conjugated anti-rabbit antibodies (Biorad) followed by Super signal West 
Femto (Thermo Scientific).  The autoradiography was made with a hope Micromax X-ray film 
processor. 
Immunohistology-Tissue from rat (kidney, heart, vasculature, skin, uterus, liver and lung) and 
human tissues were fixed in paraformaldehyde 4%, embedded in paraffin and cut in sections 
of 5 µm. Antigen retrieval was processed by incubating the slides in 0.01M sodium citrate for 
20 min at 68ºC. Then, the Vectastain ABC kit (Vector laboratories) was used to stain SNX11 
according to the manufacturer instructions. The goat polyclonal anti-SNX11 antibody (Novus 
biological) concentration was 2.5 µg/mL. The slides were counterstained with methyl green. 
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Immunofluorescence of SNX11 in HEK293T_SNX11-GFP cells-HEK293T_SNX11-GFP cells 
were grown on collagen-coated coverslip. Cells were starved at 37ºC/5% CO2, washed with 
PBS and fixed with methanol for 10 minutes at room temperature. Image-iTFX signal enhancer 
(Invitrogen) was added for 30 minutes before blocking in PBS/5%BSA.  Cells were then 
incubated with anti-EEA1 (2.5 µg/mL), anti-LAMP1 (1 µg/mL), anti-Mannose-6-phosphate 
receptor (2 µg/mL), anti-ATP1B1, anti-cathepsin L (CTSL), anti-LASP1 (1 μg/mL), or anti-
ITM2A (1μg/mL) antibodies in PBS/1%BSA for 1h at room temperature. After washing with 
PBS, the slides were incubated 1h at room temperature with AlexaFluor 594 secondary 
antibodies (2 µg/mL). Cells were also incubated with an anti-GFP antibody (1 µg/mL) for 1h at 
room temperature. After washes with PBS, the cells are incubated with an AlexaFluor 488 
secondary antibody. The coverslip were mounted on slides with Prolong antifade reagent 
(Invitrogen). 
For live staining of the Golgi apparatus and mitochondria, HEK293T_SNX11-GFP cells were 
starved during 4h at 37ºC/5% CO2 and incubated with Golgi- (0.25 µM), ER- (0.5 µM) and mito-
trackers (0.5 µM) (Molecular Probes) for 15 min at 37ºC in the presence of 5% CO2 according 
to the manufacturer’s instructions. Cells were then washed with PBS and fixed with 
paraformaldehyde 4% for 15 minutes. 
Optiprep subcellular fractionation-Two 15-cm culture dishes of HEK293T_SNX11-GFP cells 
were starved with DMEM medium containing 100U/mL penicillin and 100mg/mL streptomycin 
(without FBS) for overnight.  In the next day the cells reached to 100% confluent and were 
harvested in a 50-ml tube and centrifuged at 1500 rpm for 10 min. The cells were washed with 
cold PBS and suspended in 0.8ml Homogenization Buffer (0.25M Sucrose, 25mM KCl, 5mM 
MgCl2, 20mM Tris-HCl, pH7.4 and 1 x protease inhibitor cocktail complex). The cells were then 
 87 
 
homogenized by 12 gently strokes to pass through a 25-gauge needle on ice. The post-nuclear 
supernatant (PNS) fraction was obtained by centrifugation of the homogenate at 700 x g at 4oC 
for 10 min. 
An OptiPrep (Sigma) gradient was prepared in a 16 x 96mm Ultra-Clear Centrifuge Tube 
(Beckman), which contains 2ml of 2.5%, 3.5ml of 10%, 3.5ml of 20%, and 3.5ml of 30% 
OptiPrep. The prepared PNS fraction (about 0.9ml) was mixed with 2.1ml 50% OptiPrep to get 
35% OptiPrep concentration and loaded on the bottom of the gradient OptiPrep tube. After 
ultracentrifugation at 130,000 x g at 4oC for 22 hours, the OptiPrep was separated into 12 
fractions (each contains 1.3ml OptiPrep) from heavy to light density order.  
To identify the subcellular fraction, each 20ul of the fractions were separated by an 8% SDS-
PAGE (for EEA1) or 12% SDS-PAGE (for RAB9A) for immunoblot analysis. The early 
endosome fraction was identified with rabbit polyclonal EEA1 antibody (Santa Cruz), and the 
late endosome fraction was proved by mouse monoclonal RAB9A antibody (Santa Cruz), 
SNX11 was dectected with the rabbit antibody purchase from Open Biosystem. 
Yeast two-hybrid screen-A yeast-two hybrid (Y2H) screen was performed according to 
instructions of the manufacturer (MatchMaker GAL4 Two-hybrid System 3, Clontech, Palo Alto, 
CA, USA). The newly cloned isoform of SNX11, SNX11 B, was cloned full-length as bait into 
pGBKT7 downstream of the sequence for the DNA-binding domain of GAL4 and transformed 
into AH109 competent yeast cells.  A lack of protein toxicity or transcriptional activation in 
AH109 cells was assayed in culture and protein expression confirmed by western blot using an 
anti-c-Myc antibody.  Transformed AH109 cells were mated with strain Y187 yeast pre-
transformed with a Matchmaker 17 day mouse embryo library (Clontech).  Diploid yeast were 
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assayed on SD/-Leu, SD/-Trp, and SD/-Leu/-Trp media for mating efficiency and selected for 
bait/prey interactions on SD/-Ade/-His/-Leu/-Trp/X- -Gal media (high-stringency).  Positive, 
blue colonies were scored for growth, confirmed by 2 replica plating on high stringency media, 
and selected for plasmid isolation in library-specific antibiotic broth.  360 activation 
domain/library inserts were amplified by PCR, run on agarose gels to eliminate clones 
containing multiple library plasmids, and fingerprinted by HaeIII digestion to eliminate duplicate 
clones. Selected PCR products were sequenced to determine interacting prey protein identity. 
A comprehensive table of prey clones identified in this screen is appended (Table 1). 
GST pull-down-In order to confirm the interactions of SNX11 B with 10 prey clones of interest 
were re-
confirmed by GST pull-down assay (MagneGST, Promega). 
Bacterial protein expression and purification-BL21-Gold (DE3) Competent Cells (Stratagene) 
were transformed with either GST or his-clones according to the manufacturer instructions. 
Bacteria were grown over-night at 37 ºC with agitation. A dilution 1/50 of this pre-culture was 
grown 2h in LB medium before the induction of target protein with 0.1 or 0.5 mM of Isopropyl 
ß-D-thiogalactopyranoside (IPTG) for 3h. The bacteria were harvest and centrifuge 10 min at 
4000 rpm. The induction was confirmed in gel electrophoresis and staining with Coomassie 
blue for GST-tagged proteins and in western blotting with a his probe (Santa Cruz) for the his-
tagged proteins (data not shown). 
The GST-tagged proteins were purified with MagneGST Protein Purification System according 
to Promega instructions.  
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The His-tagged proteins were purified with the Ni-NTA column (Qiagen) according to the 
manufacturer instructions. 
Lipid overlay assay-PIP strip (Echelon Biosciences Inc.) were blocked with 5% non-fat dry milk 
in TTBS (20 mM Tris-base, 150 mM NaCl, 0.1% tween 20) overnight at 4ºC. The PIP strips 
were incubated with the purified GST-protein for 1h at room temperature. After washes in 
TTBS, they were incubated with GST antibody (4.5 µg/mL).  The PIP-strip were washed and 
incubated with a anti-mouse HRP conjugated antibody (40 ng/mL, Bio-Rad). The detection was 
processed with ECL plus (Perkin Elmer). The autoradiography was made with a hope Micromax 
X-ray film processor. 
Morpholino knockdown of Xenopus SNX11-Female Xenopus laevis were primed with 50 IU of 
pregnant mare serum gonadotropin (PMSG) 2 to 4 days before injection of 500-800 IU human 
chorionic gonadotropin (hCG) on the evening before egg collection. Nine to 12 hours after 
injection, eggs were collected and transferred into a fresh petri dish with Marc’s Modified 
Ringers (MMR, 0.1M NaCl, 2mM KCl, 1mM MgSO4, 2 mM CaCl2, 5 mM HEPES (pH 7.8), 0.1 
mM EDTA). The eggs were fertilized in vitro with male frog testis and de-jellied by soaking them 
for 5-15 min in 2-3% L-Cysteine, pH8. Staging of embryos was performed according to 
Nieuwkoop and Faber (13).  The eggs were injected with different concentration of morpholino. 
Antisense morpholino oligonucleotides were designed by Gene Tools, LLC. The antisense 
morpholino was designed to the translation start. Morpholinos were injected into the dorsal 
animal blastomeres at the 1 and 2-cell stages. The injections were confirmed by monitoring 
fluorescence from labeled oligonucleotides. The morpholinos used were Snx11 utr- 5′- 
CTGAGCCGGGATTATCCTGAGACA-3’-fluorescein. The specificity of the morpholinos was 
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tested in western blot with the SNX11 antibody produced by Open Biosystems. Rescue 
injections were carried out with capped mRNA as previously described (14). 
Actin polymerization-For this assay, we used the actin polymerization biochem kit 
(Cytoskeleton). The pyrene labeled muscle actin was resuspended with general actin buffer (5 
mM Tris pH 8, 0.2 mM CaCl2) supplemented with 0.2 mM ATP and 1 mM DTT and left on ice 
for 1h to depolymerise actin oligomers. The residual nucleating centers were remove by 
centrifugation at 14,000 rpm at 4ºC for 30 min. The Arp2/3 was diluted to 0.3 mg/mL in G-buffer 
and kept on ice. The VCA domain protein was resuspended to 1 mg/mL by adding 500µl of 
milli-Q water. Just before use, the pyrene labeled actin was diluted to 0.1 mg/mL in ice-cold 
general actin buffer supplemented with 0.2 mM ATP and 1 mM DTT. According to the wells, 5 
µl of VCA 1 mg/mL, 2 µl Arp2/3 complex 0.3 mg/mL, 200 µl polymerization buffer (5 mM Tris 
pH 7.5, 50 mM KCl, 2 mM MgCl2, 0.1 mM CaCl2, 1 mM EGTA, 0.5 mM DTT, 0.2mM ATP) and 
1 µM his-tagged proteins (or 0.5 µM for his-SNX11A + 0.5 µM his-lasp1) were added. Actin 
polymerization was followed by the increase in fluorescence emission from 410 nm +/- 20 nm 
over 60 min period at room temperature (ecitation wavelength 355 +/- 20 nm) on an Envision 
microplate reader (Perkin Elmer) 
DOR recycling-Recycling of internalized receptors to the plasma membrane was estimated 
using an ELISA-based method adapted from a previously published protocol (PMID: 
18363847). HEK293T cells stably expressing Flag-DOR were seeded at a density of 200,000 
cells/well and grown on 24-well polylysine-coated plates for 48 h. For SNX11 experiments, 
HEK293T cells were transfected 24 h after plating either with 8µg Flag-DOR or 4µg Flag-DOR 
and 6µg shRNA SNX11, which ensured similar membrane expression of Flag-DORs in both 
conditions. The experiment was carried out 48h post transfection. The day of the experiment, 
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one hour preceding induction with a single dose of DPDPE (1 μM; 30 min), protein synthesis 
was blocked with 10 μM cycloheximide that remained present throughout the duration of the 
assay. At the end of the internalization period, the agonist was removed by washing with DMEM 
at 37°C (3 × 1 min). Cells were then placed within the incubator to recover in an agonist-free 
medium (DMEM/HEPES/cycloheximide containing vehicle, cytochalasin (10µM), nocodazole 
(10μM), wortmannin (10nM) or BEZ235 (10nM)) for increasing periods of time. Experiments 
were stopped by addition of cold PBS, and cells were subsequently fixed for 15 min at 4°C in 
paraformaldehyde (3%) and nonspecific binding was blocked by incubation with PBS/BSA 
1%/CaCl2 1 mM at room temperature (RT) for 30 min. Cells were subsequently incubated with 
anti-FLAG M1 antibody (1:1000; Sigma-Aldrich) for 1 h (RT), washed three times, and 
incubated with peroxidase-conjugated (HRP) anti-mouse antibody (1:8000; GE Healthcare) for 
30 min. After extensive washing, 200 μl of the HRP substrate o-phenylenediamine 
dihydrochloride (SIGMA FAST OPD, Sigma-Aldrich) was added to each well. The reaction was 
allowed to proceed for 8 min and stopped using 50 μl of 3N HCl. Two-hundred microliters of 
the mix were then transferred to a 96-well plate for optical density (OD) evaluation at 492 nm 
in a microplate reader (Victor3; PerkinElmer). OD readings corresponded to the signal 
generated by receptors at the cell surface. The amount of surface receptors internalized 
following exposure to agonists was calculated by subtracting OD obtained in the presence of 
agonist from the one obtained in its absence. Results were expressed as percentage of 
receptors initially present at the membrane according to the following calculation: 100 × 
(ODBasal −ODStimulated)/(ODBasal) where ODBasal and ODStimulated correspond to the 
signal obtained in absence or presence of agonist respectively.The amount of internalized 
receptors that recycled back to the surface was expressed as percentage of receptors 
internalized following exposure to the agonist. 
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Mutation screening of SNX11-Patients with Ehlers-Danlos (ED) syndrome negative for disease-
causing mutations in known ED genes were identified from a database at the Shriner’s Hospital 
in Montreal, QC. Informed consent was obtained from the parents, legal guardians, or patients, 
respectively. The study was approved by the Institutional Review Boards at all participating 
institutions. 
 
RESULTS 
SNX11 homology, and murine and human expression-Sorting nexin 11 (2333 bp, gene 
accession: AF121861) encodes a protein (264aa, predicted molecular weight 30 kDa) with a 
single conserved N-terminal PX domain (aa 8-123) and two low complexity domains (aa 179-
192 and 207-224) at the C-terminal end, as predicted by the Simple Modular Architecture 
Research Tool (SMART) (Figure 1A) (15,16).  Compared to hSNX11, the predicted mouse 
(isoform a) and Xenopus proteins share 85% (PX domain: 99%) and 69% (PX domain: 95%) 
sequence identity, respectively.  Although human and mouse sequence are very similar, 
Xenopus Snx11 is shorter in length (165aa) and lacks the C-terminal low complexity domains.  
Based on protein sequence alignment, the closest phylogenetic relative of human SNX11 is 
SNX10, which shares 83% sequence identity (PX domain: 86%) but also lacks the second low 
complexity domain (Figure 1A). Cloning of the murine full-length open reading frame from 
mouse heart cDNA revealed the presence of a shorter murine Snx11 isoform (isoform b) arising 
from the exonization of an Alu-repeat element. Isoform b is identical to 
ENSMUST00000127375 and predicted to be 197aa in length, identical with the long isoform 
(isoform a) up to aa180 (predicted molecular weight 22 kD) (Figure 1A). 
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SNX11 was widely expressed across adult tissue derived from all three germ layers with 
strongest expression in brain, skeletal muscle, spleen, lung and testis (Figure 1B).   In 
accordance, immunohistochemical staining of SNX11 in adult human tissues revealed 
widespread expression, as shown by staining in the kidneys and cartilage (Figure 2A-E, M).  
Likewise, expression of SNX11 was also prevalent in diverse tissues as shown by staining in 
heart, vessels, skin, uterus, liver, and lungs (Figure 2F-L). In human kidneys, SNX11 was most 
strongly expressed in the podocytes, distal tubules and glomerular cells (Figure 2A-E).  In rat 
heart, SNX11 was found in the fibrous skeleton and valvular tissue of the heart (Figure 2F, G).  
Moreover, the staining was more intense in the mitral tissue as compared to the tricuspid tissue 
(Figure 2G). In human cartilage, SNX11 was highly expressed in the chondrocytes of the 
superficial zone (Figure 2M). 
SNX11 associates with PtdIns(3)P-To assess the lipid-binding properties of SNX11, we 
performed a lipid overlay assay using lipid blots (PIP-strips).  Full length SNX11 (isoforms a 
and b) associated with PtdIns(3)P, but truncated versions of SNX11 were unable to associate 
with any phospholipid (Figure 3B), demonstrating that alone, the PX domain of SNX11 (aa14-
132) is insufficient for PtdIns(3)P binding. Thus, the two C-terminal alpha-helices (coiled-coil 
domains) are required for lipid-binding, consistent with previous results of protein 
crystallography defining an extended PHOX-domain for SNX11 (17). 
SNX11 localizes to the Golgi and late endosomes-To better understand the role of Snx11 and 
its interaction partners, we examined its intracellular localization.  We transfected HEK293T 
cells with a GFP-tagged Snx11 construct (Snx11-GFP) and examined its expression profile by 
confocal microscopy.  Snx11-GFP protein was mainly visible as punctate, vesicular structures 
throughout the cytoplasm (Figure 4A-G).  We stained transfected cells with antibodies against 
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early endosome antigen-1 (EEA1, early endosomes), lysosomal-associated membrane protein 
1 (LAMP1, lysosomes), RAB9 (late endosomes), M6PR (late endosomes), as well as with 
Golgi-, mitochondria- and endoplasmic reticulum-trackers.  We found that Snx11 co-localized 
most strongly with markers of late endosomes (Figure 4A, G), and of the Golgi (Figure 4C) but 
little with EEA1 and other compartments (lysosome, mitochondria, endoplasmic reticulum) 
(Figure 4B, D-F).  The presence of Snx11 in endosomes was evaluated by Western blot using 
subcellular fractions of cell lysates.  After subcellular fractionation by gradient separation, some 
Snx11 was found in the fraction corresponding to early endosomes but it was mostly seen in 
late endosomal fractions (Figure 4H). 
Knockdown of Snx11 in Xenopus laevis causes aberrant somitogenesis-To further characterize 
Snx11 functions, we investigated the effect of morpholino-induced knockdown of this gene 
during Xenopus laevis embryogenesis.  We designed our morpholino to the translation start 
site and confirmed its ability to block translation of Xenopus Snx11 by Western blot (Figure 5H).  
Morphants had short tails with a deformation of the dorsal axis and disorganization of the 
somites.  This disorganization was confirmed by histology and electron microscopy (Figure 5A-
G). In Snx11MO-treated embryos somite boundaries were formed but disorganized, displaying 
incomplete development and a lack of regularity between somites. Also, knockdown embryos 
had large seemingly undifferentiated fibroblastic areas (5E’). The penetrance of this phenotype 
was low, as only 20-30% of SNX11MO-injected embryos were abnormal compared to 10% in 
injected controls and efficiently rescued with cDNA injections (data not shown).  
SNX11 interacts with cytoskeleton proteins-In numerous SNXs, sorting events are 
accomplished through the formation of multimeric protein complexes.  To better understand the 
function of SNX11, we screened for interacting partners using the yeast two-hybrid system.  
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Many of the positive isolates identified belong to the cytoskeleton (i.e, contractile apparatus, 
and extracellular matrix) as well as nuclear/perinuclear proteins (involved in DNA repair, 
transcription and translation), and are associated with many types of human diseases (Table 
1).  In accordance with these interactions, SNX11-GFP was found to co-localize with LASP1, 
CTSL, ITM2a and ATP1B1 in HEK293T cells (Figure 6A-D). 
Snx11 promotes actin polymerization-The identification of several components of the 
cytoskeleton in our yeast two-hybrid screen, we tested the effect of Snx11 on actin 
polymerization over time. The baseline values for this assay were first determined using the 
nucleation-promoting factors, Arp2/3 and VCA, alone and in combination. As expected, we 
observed an increase in steady-state and equilibrium values when adding Arp2/3, VCA or 
Arp2/3-VCA (except for the slightly lower steady-state value of VCA alone).  Interestingly, 
SNX11 alone or in combination with these enhancers increases both the steady-state and 
equilibrium values of this assay (Figure 7), pointing for an actin-nucleation promoting effect. 
SNX11 is involved in trafficking of the delta-opioid receptor-Given the known role of other SNX-
PX in receptor trafficking (PMID: 23416069), we set out to determine whether Snx11 is involved 
in receptor recycling.  We used the delta-Opioid receptor (DOR) as a proxy to investigate the 
role of Snx11 in receptor recycling, since this receptor is known to traffic to late endosomes 
(18). Cells expressing the DOR were transfected with either non-silencing (negative control) or 
Snx11 shRNA and stimulated with DPDPE.  Knockdown of SNX11 in shRNA-Snx11-treated 
cells was confirmed by Western blot.  In unstimulated cells, the DOR remained at the plasma 
membrane. Following removal of the agonist DPDPE, we observed increased recycling of the 
DOR to the plasma membrane in cells treated with Snx11-shRNA (Figure 8C).  Snx11 shRNA 
did not affect internalization of DOR nor the total amount of DOR, demonstrating that Snx11 
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did not affect the amount of receptor available for recycling after internalization (Figure 8A, B).  
In control conditions, 50% of internalized DOR was recycled back to the membrane but 
treatment with Snx11 shRNA cells increased this amount to 90%.  As expected, inhibition of 
PtdIns(3)P kinase by treatment with BEZ235 (100nM) and wortmannin (100nM), produced a 
similar effect as Snx11 knockdown, supporting the necessity for binding of SNX11 to PtdIns(3)P 
during DOR recycling (Figure 8D). Since microtubules and actin filaments have been shown to 
be involved in protein sorting, we wanted to determine whether either of these cytoskeletal 
elements are involved in DOR recycling.  We used nocodazole and cytochalasin, which 
interfere with microtubule and actin polymerization, respectively.  Surprisingly, treatment with 
cytochalasin (100mM) did not produce any difference in DOR recycling but treatment with 
nocodazole (100mM) reduced the amount of DOR recycled from (Figure 8E).  No co-
localization was observed with the late endosome marker, RAB9 (Figure 8B, F) but upon 
stimulation with DPDPE, the DOR to co-localized with RAB9 (Figure 8F), marking a 
compartment also associated with Snx11 (Figure 4A, G).Taken together, these results 
demonstrate that Snx11 inhibits DOR recycling in an actin-independent fashion, that the DOR 
travels along microtubules during this process and that the site of action of Snx11 in DOR 
recycling is the late endosome. 
Mutations of SNX11 are not associated with human Ehlers-Danlos syndrome-Since several 
interaction partners identified in our SNX11 yeast-two-hybrid screen point to a biologically 
plausible role of SNX11 in human Ehlers-Danlos syndrome (Table 1), we screened 14 patients 
for disease-causing mutations in SNX11. No disease-causing mutations were identified. Thus, 
SNX11 does not seem to play a major role in this disease spectrum. 
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DISCUSSION 
In this study, our analysis of Snx11 in mouse, Xenopus and cells revealed a widely expressed 
gene that appears to be involved in at we provide evidence for the broad expression of Snx11 
across many tissues originating from all three germ layers. This suggests Snx11 is a ubiquitous 
protein possibly involved in common cellular processes.  Although expression of Snx11 was 
widespread, the level of Snx11 expression in the mouse was tissue-specific, suggesting that 
Snx11 follows organ-specific transcriptional regulation (Figure 1B). In addition to this, we 
propose two seemingly distinct functions of Snx11: regulation of actin-dependent processes 
that involve the interaction with or secretion of factors into the extra-cellular milieu; and an actin-
independent role in receptor recycling that occurs from late endosomes. 
First, we showed that proper segmentation of the Xenopus embryo requires Snx11. The 
formation of vertebrate segments, somitogenesis, is an evolutionarily conserved embryonic 
process that follows a “segmentation clock” (19).  Regulating this clock are several pathways, 
including the Notch, FGF, Wnt and Retinoic acid (RA) signaling pathways (19).  Factors from 
these pathways are secreted (or cell-bound) into the extra-cellular milieu, creating a gradient 
of morphogens that together regulate somitogenesis. Data from mouse knockouts suggest that 
somite border formation requires proper Notch signaling followed by activation of Mesp2 to 
suppress Notch signaling and delimit the somite boundary (20).  The somite border defects 
seen in Snx11-knockdown embryos allude to an involvement of Snx11 in regulating Notch 
signaling, which requires extensive protein trafficking of ligands and receptors during signaling 
(21). However, this remains to be confirmed and does not exclude the possibility that Snx11 
could also regulate FGF, Wnt and RA signaling.  
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Mechanistically, the secretion of factors and subsequent receptor activation both require 
extensive membrane remodeling that occurs during exo- and endocytosis.  These processes 
are sensitive to actin (22,23) and interestingly, we found that Snx11 can promote actin 
polymerization as well as associate with components of the actin cytoskeleton. The majority of 
the proteins found in our Y2H screen were important for structural components of the cell like 
the cytoskeleton, and contractile, cell adhesion, and matrix proteins, while no other members 
of the sorting nexin family were identified. This was in accordance with our expression analysis 
and supports a function for SNX11 in the cartilaginous and smooth muscle tissues.  SNX11 
interacted with different actins (alpha and gamma) and Lasp1, an actin-binding protein (24).  
The implication of actin in receptor trafficking has been reported in studies of retromer function 
(6). 
The other proteins identified in our screen were metabolic and translational protein such as 
ATP1B1.  This latter gene is part of the β-subunit of Na+/K+ ATPase holoenzyme complex, 
which regulates the translation and transport of the catalytic α-subunit to the plasma membrane 
(25,26).  The strong expression of SNX11 in the distal tubules of the kidney therefore makes it 
an interesting candidate to chaperone the Na+/K+ ATPase complex during its transport to the 
cell surface.  The interactions of SNX11 with CTSL, ITM2a and ATP1B1 support a role for 
SNX11 in coupling the actin cytoskeleton to processes of protein trafficking at the plasma 
membrane. 
The increase in actin polymerization in the presence of SNX11 alone could be the result of 
increased actin nucleation by recruitment of actin.  In physiological conditions, the interaction 
between SNX11 and LASP1 could promote actin nucleation by recruiting actin and nucleation-
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promoting factors. These results point toward a role for SNX11 in linking the actin cytoskeleton 
to membrane dynamics. 
The similarity between protein sequences of SNX11 and SNX10 (83% sequence identity), as 
well as our findings, may point to similar functions.  Snx10 is thought to play a role during 
osteoclast formation as it is strongly up-regulated during RANKL-induced osteoclast 
differentiation in vitro and expressed in osteoclasts in vivo (11).  As such, a mutation in the PX 
domain of SNX10 (Arg51Gln) was recently found to induce malignant osteopetrosis of infancy 
(12).  Given the recent findings that SNX10 and SNX11 act antagonistically in endosome 
vacuolation (17), it is possible that SNX11-binding proteins identified in our study could also be 
implicated in SNX10 function.  Future studies of the uncharacterized protein domains of 
SNX10/11 and exhaustive protein interaction studies in different cellular contexts will be 
required for clarification. The presence of Snx11 in smooth muscle and cartilage is compatible 
with an involvement in the regulation of the extra-cellular matrix (ECM).  Snx11 could thus play 
a role in exocytosis, similar to the role of SNX3 in the secretion of Wnt (2). 
PX domains are known for binding to phospholipids, in particular PtdIns(3)P (27).  This was not 
different for SNX11A and B which preferentially associated with PtdIns(3)P.  The inability to 
bind to associate with lipids for each of the truncated versions of SNX11 is likely due to protein 
misfolding, as the adjacent protein sequence might also be required for proper folding of the 
PX domain. Similar results have been reported for other SNX’s, including SNX9 (28). Although 
the C-terminus of Snx11 has yet to be recognized as functional domain, the region likely plays 
an important functional role.  Such is the case for SNX10, which requires its C-terminal domains 
for function (29). PtdInsPs are critical determinants of membrane domain identity (30) and help 
recruit proteins events such as membrane trafficking, intracellular signaling, cytoskeleton 
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organization and apoptosis (31). PtdIns(3)P is found on the surface of early and late 
endosomes as well as on the membranes of the intralumenal vesicles of multivesicular bodies 
(MVBs) (7,32).  The presence of SNX11 in late endosomes shown by confocal microscopy and 
subcellular fractionation supports of role for SNX11 in trafficking to and/or from late endosomes.  
Although late endosomes and the Golgi network are endosomal compartments used by the 
retromer, the lack of a BAR domain in SNX11 points towards retromer-independent functions.  
Many reports have shown that some retromer-independent sorting, involving membrane 
remodeling and receptor trafficking, still occurs when one of the retromer subcomplexes is 
missing (33,34).  Late endosomes (or MVBs) can host a diverse set of proteins that do not 
always share the same fate and that therefore require tailored trafficking machinery.  In 
contrast, the M6PR travels continuously between late endosomes and the trans-Golgi network 
(35). 
Secondly, we show that Snx11 participates in trafficking of the DOR in an actin-independent 
manner.  This was demonstrated in our recycling assay, where the DOR co-localized with 
SNX11 after stimulation with DPDPE and where knockdown of Snx11 increased DOR 
recycling.  This along with the co-localizations of both RAB9-DOR (with DPDPE) and RAB9-
SNX11, suggest that DOR recycling follows an SNX11-dependent route via late endosomes 
whereby SNX11 reduces DOR recycling.  However, direct binding of SNX11 to DOR is not 
expected due to the fact that sorting nexins often bind indirectly with their cargo via accessory 
adaptor proteins. Proteins travelling to late endosomes are often en-route to lysosomes for 
degradation but it has also been shown that intralumenal vesicles can undergo “back-fusion” 
with the late endosome limiting membrane, suggesting some proteins can exit this 
compartment (36).  The increase in DOR recycling observed in the absence of SNX11 is 
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perhaps due to a defective transport of DOR to late endosomes.  Upon Snx11 knockdown, 
trafficking to late endosomes might fail and the receptor might instead be returned to the cell 
surface via a fast recycling mechanism. As expected, increased DOR recycling was observed 
by inhibition of PtdIns(3)P production, which supports a role for Snx11 in suppressing DOR 
recycling. Surprisingly, inhibition of de novo actin polymerization did not affect DOR recycling, 
while inhibition of microtubules did.  Although the mechanism by which Snx11 inhibits DOR 
recycling is still unclear, these data therefore support a role for Snx11 in trafficking the DOR 
whereby membrane deformations are not dependent upon actin polymerization. 
In conclusion, we propose that Snx11 has dual functions. First it associates with the actin 
cytoskeleton to regulate signaling pathways involved in secreting or responding to factors 
present in the extra-cellular milieu, such as the Wnt, FGF, RA and Notch pathways. Second, 
we describe an actin-independent role for Snx11 in receptor recycling, as demonstrated by the 
positive effect of Snx11 knockdown on recycling of the DOR. Advances in the biology of cellular 
trafficking are revealing a complex yet finely-tuned network of shuttles that regulates the fate 
of intracellular proteins.  With a better understanding of cellular trafficking, we will better 
understand how signaling pathways are regulated. 
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Table 1: List of interacting clones found by yeast two-hybrid, using mouse SNX11b as bait, and ordered by biological function.  The 
major associated human phenotypes are also shown. 
 
DESCRIPTION GENE GROUP / DESCRIPTION BIOLOGICAL FUNCTION HUMAN PHENOTYPE (OMIM#) 
C
y
to
s
k
e
le
to
n
, 
C
e
ll
 a
d
h
e
s
io
n
, 
E
x
tr
a
-c
e
ll
u
la
r 
m
a
tr
ix
 
ACTC1 Cardiac Alpha actin Cardiac actin 
Dilated cardiomyopathy/left ventricular 
non-compaction (102540) 
Hypertrophic cardiomyopathy (115196) 
Atrial septal defect (612794) 
ACTG Gamma actin Cytoskeletal, Cell adhesion 
Autosomal dominant deafness 
(604717) 
Baraitser-Winter syndrome 2(614583) 
MYBPC1 
Myosin binding protein C, 
slow type 
Cell contractility 
Distal arthrogryposis (614335) 
Lethal congenital contracture 
syndrome 4 (614915) 
Col1a2 
Procollagen, type I, alpha 
2 
Extra-cellular matrix 
Ehlers-Danlos syndrome, cardiac 
valvular form (225320) 
Ehlers-Danlos syndrome, type VIIB 
(130060) 
Osteogenesis imperfecta II, III, IV 
(166210, 259420, 166220) 
Col5a2 Procollagen, type V Extra-cellular matrix Ehlers-Danlos type I (130000) 
Col11a1 Procollagen, type XI Extra-cellular matrix 
Fibrochondrogenesis (228520) 
Marshall syndrome (154780) 
Stickler syndrome type II (604841) 
Plod1 
Procollagen-lysine, 2-
oxoglutarate 5-
dioxygenase 1 
Collagen synthesis 
Ehlers-Danlos syndrome type VI 
(225400) 
Itm2a 
Integral membrane protein 
2A 
Myogenic, chondrogenic 
differentiation 
 
Lasp1 LIM and SH3 protein 1 Cytoskeleton, focal adhesions  
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Table 1: List of interacting clones found by yeast two-hybrid, using mouse SNX11b as bait, and ordered by biological function.  The 
major associated human phenotypes are also shown. (continued) 
 
DESCRIPTION GENE GROUP / DESCRIPTION BIOLOGICAL FUNCTION HUMAN PHENOTYPE (OMIM#) 
T
ra
n
s
c
ri
p
ti
o
n
, 
tr
a
n
s
la
ti
o
n
, 
D
N
A
 r
e
p
a
ir
 
Polr2c 
Polymerase (RNA) II (DNA 
directed) polypeptide C 
Transcription, subunit of RNA 
polymerase II complex 
 
Supt4h 
Suppressor of Ty 4 
homolog 
transcription 
initiation/elongation, chromatin 
remodeling 
 
Rnf141 Ring finger protein 141 
Transcription, Posttranslational 
modification, protein turnover, 
chaperones 
 
Eif3s2 
Eukaryotic translation 
initiation factor 3, subunit 2 
(beta) 
Translation initiation  
Eif3s10 
Eukaryotic translation 
initiation factor 3, subunit 
10 (theta) 
Translation initiation  
Eef1a1 
Eukaryotic translation 
elongation factor 1 alpha 1 
Translation elongation  
Eef2 
Eukaryotic translation 
elongation factor 2 
Translation elongation 
Spinocerebellar ataxia 26 
(609306) 
Arbp 
Acidic ribosomal 
phosphoprotein P0 
Translation elongation, 
ribosome assembly 
 
RDM1 
RAD52B, RAD52 homolog 
B 
RNA recognition motif, DNA 
repair 
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Table 1: List of interacting clones found by yeast two-hybrid, using mouse SNX11b as bait, and ordered by biological function.  The 
major associated human phenotypes are also shown. (continued) 
 
DESCRIPTION GENE GROUP / DESCRIPTION BIOLOGICAL FUNCTION HUMAN PHENOTYPE (OMIM#) 
T
ra
ff
ic
k
in
g
 
Gphn Gephyrin 
Synaptic receptor clustering, 
molybdene cofactor synthesis 
Molybdenum cofactor deficiency C 
(615501) 
S
ig
n
a
li
n
g
 
PIP5K1A 
Phosphatidylinositol 
phosphate kinase 
Signaling, Golgi, trafficking  
L
y
s
o
s
o
m
e
 
Ctsl Cathepsin L Proteolytic enzyme, lysosome  
Npc2 Niemann Pick type C2 
late endosomal/lysosomal 
system 
Niemann Pick type C2 (607625) 
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Table 1: List of interacting clones found by yeast two-hybrid, using mouse SNX11b as bait, and ordered by biological function.  The 
major associated human phenotypes are also shown. (continued) 
 
DESCRIPTION GENE GROUP / DESCRIPTION BIOLOGICAL FUNCTION HUMAN PHENOTYPE (OMIM#) 
M
it
o
c
h
o
n
d
ri
a
l 
Mrpl4 
(S100A9) 
Mitochondrial ribosomal 
protein L4 
mitochondrial  
Fech Ferrochelatase Porphyrin metabolism 
Erythropoietic protoporphyria 
(17700) 
Ech1 
Enoyl coenzyme A 
hydratase 
Beta oxidation  
Atp5d 
ATP synthase, H+ 
transporting, 
mitochondrial F1 complex, 
delta subunit 
Ion / proton transport  
Ndufs8 
NADH dehydrogenase 
(ubiquinone) Fe-S protein 
8 
Oxidoreductase Leigh syndrome (256000) 
Cyc1 Cytochrome c1 Mitochondrial electron carrier 
Mitochondrial complex III 
deficiency, nuclear type 6 
C
a
rb
o
h
y
d
ra
te
 m
e
ta
b
o
li
s
m
 
Akr1a4 
Aldo-keto reductase 
family 1, member A4 
(aldehyde reductase) 
Carbohydrate metabolism  
FUCA2 Alpha-L-fucosidase   
ALDOA 
Aldolase A, fructose-
bisphosphate 
Pentose phosphate pathway Aldolase A deficiency 
G6pd 
Glucose-6-phosphate 
dehydrogenase 
Pentose phosphate pathway 
G6PD deficiency (134700, 
300908) 
Eno1 
Enolase 1, alpha non-
neuron, 2-phospho-D-
glycerate hydrolase 
Glycolysis, gluconeogenesis Enolase deficiency 
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Table 1: List of interacting clones found by yeast two-hybrid, using mouse SNX11b as bait, and ordered by biological function.  The 
major associated human phenotypes are also shown. (continued) 
 
DESCRIPTION GENE GROUP / DESCRIPTION BIOLOGICAL FUNCTION HUMAN PHENOTYPE (OMIM#) 
O
th
e
r 
Atp1b1 
ATPase, Na+/K+ 
transporting, beta 1 
polypeptide 
Membrane associated Na K 
pump 
 
Ahsg 
Fetuin-A ;alpha-2-HS-
glycoprotein 
MMP inhibitor  
Wfdc1 
WAP four-disulfide core 
domain 1 
Protease inhibitor  
Tbc1d22b 
TBC1 domain family, 
member 22B 
GTPase-activating protein  
Dgcr6 
DiGeorge syndrome 
critical region gene 6 
Nuclear phosphoprotein  
Lgals9 
Lectin, galactose binding, 
soluble 
Galactose binding, signal 
transduction, chemoattractant 
 
LOC329575 
FOG, Zn finger containing 
protein 
hypothetical  
2210412D01 Catalytic domain hypothetical  
Ntan1 N-terminal Asn amidase 
Ubiquitination, protein 
turnover 
 
H19 H19 fetal liver mRNA gene with no protein product 
Beckwith-Wiedemann (130650) 
Silver-Russell (180860) 
Wilms tumor 2 (194071) 
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Figure 1. The domain structure of SNX11 and expression profile in various mouse tissues.  A) 
Across all species and isoforms, the SNX11-PX domain is located at the N-terminal (as 
predicted by SMART).  Two C-terminal low complexity domains (coiled-coils) are present in 
hSNX11 and mSNX11a but not in other isoforms or species.  SNX10 (closest phylogenetic 
relative) contains an N-terminal PX domain and a single low complexity domain.  Length in 
amino acid (aa) is indicated. B) RT-PCR of mSnx11, determined from tissue-derived cDNA.  
GAPDH was used as positive control. 
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Figure 2. SNX11 is expressed ubiquitously.  Seen here are rat and human histological sections 
stained with goat anti-SNX11 antibody (polyclonal) and counter-stained with methyl 
green.  Tissue sections shown are as follows: A) human kidney tubules (10x) B) human 
kidney (10x) C) human kidney glomerular tissue (40x) D) human kidney (20x) E) human 
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kidney (40x) F) rat heart fibrous tissue (20x) G) rat heart valvular tissue (20x) H) rat vessel 
(40x) I) rat skin (10x) J) rat uterus (10x) K) rat liver (10x) L) rat lung (10x).  M) As seen in this 
human knee cartilage section (upper panel) and bar graph (lower panel), SNX11 staining is 
strongest in the superficial zone.  
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Figure 3. SNX11 bind to PtdIns(3)P.  The production of various mouse isoforms and truncated 
versions of GST-tagged SNX11 (A) was induced (IPTG) in BL21-Gold bacteria (see Figure S1 
for expression in BL21-Gold bacteria).  Purified proteins were subjected to a phospholipid 
overlay assay (PIP-strips) and subsequent Western blotting.  Binding to PtdIns(3)P can be seen 
in blots of SNX11A and SNX11B whereas all other constructs were unable to bind. 
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Figure 4. Distribution of SNX11-GFP in HEK293T cells.  Localization of SNX11-GFP (green) 
and various endosomal markers (red) in HEK293T_SNX11-GFP cells; a yellow signal signifies 
co-localization.  A) Cation-independent mannose-6-phosphate receptor (CI-M6PR) – late 
endosome.  B) Lysosome-associated membrane protein-1 (LAMP1) – lysosomes.  C) Golgi-
tracker – Golgi network.  D) Mito-tracker – mitochondria.  E) ER-tracker – endoplasmic 
reticulum.  F) Early endosome associated protein-1 (EEA1) – early endosomes.  G) Rab9 – 
late endosomes.  H) Distribution of EEA-1, RAB9 and SNX11 in a subcellular fractionation of 
HEK293T_SNX11-GFP cells. 
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Figure 5. Morpholino-induced knockdown of Snx11 in Xenopus laevis.  A-B) Staining with on 
fixed embryos injected with control or Snx11MO (magnification is indicated).  Somites are well-
formed in controls (A-B) but in knockdown embryos somite boundaries are abnormal and 
somite structure is disorganized (A’-B’).  These defects are also seen with fibronectin (C-C’) 
and phalloidin (D-D’) staining.  E-G) Electron microscopy scans of somites at stage 40 (scale 
= 1μm (E), 200nm (F), 50nm (G)).  H) Western blot showing the increased SNX11 knockdown 
with an increasing dose of Snx11MO.  Actin was used as loading control. 
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Figure 6: Co-localization of SNX11-GFP (green) and Y2H isolates (red) in HEK293T cells.  
SNX11-GFP co-localizes (yellow) with A) LASP1, B) CTSL, C) ITM2a and D) ATP1B1. 
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Figure 7: SNX11 promotes actin polymerization.  The effect of various combinations of 
nucleation-promoting factors (Arp2/3 and VCA) on the relative rate of actin polymerization.  The 
addition of SNX11 increases actin polymerization. 
 
 
 
 
 
 
 
 119 
 
 
 120 
 
Figure 8: SNX11 negatively regulates DOR recycling to the membrane. A, C) Protein synthesis 
in HEK293 cells stably expressing Flag-DOR (Control) or Flag-DOR/shRNA Snx11 (shRNA) 
was blocked 1h before the start of internalization and recycling experiments.  A) Internalization 
of Flag-DOR 30 minutes after induction with DPDPE (1μM; 30 min) in control and shRNA cells.  
B) Total amount of Flag-DOR at the plasma membrane after transfections with Flag-DOR or 
Flag-DOR/shRNA Snx11 without DPDPE.  C) Internalization was induced as in A after which 
cells were placed in the incubator in an agonist-free medium (DMEM/HEPES/cycloheximide) 
for increasing periods of time.  Percent of Flag-DOR recycled to the plasma membrane was 
determined by ELISA-based method.  Results are expressed as percentage of maximal 
recovery of internalized receptor in control cells.  The data represent mean ± S.E.M. from five 
independent experiments carried out in triplicate.  Statistical comparison between curves 
(Control versus shRNA) was assessed using two-way ANOVA (p˂0.0001).  D) Recycling 
assays were carried out as in C except that recovery was done in an agonist-free medium 
containing either vehicle (control), wortmannin (10nM) or BEZ235 (10nM).  E) Recycling assays 
were also carried out as in C except that recovery was done in an agonist-free medium 
containing either vehicle (control), cytochalasin (10μM) or nocodazole (μM).  The data 
represents mean ± S.E.M. from three independent experiments carried out in triplicates. 
Statistical comparison between curves (Control vs Cytochalasin vs Nocodazole) was assessed 
by two-way ANOVA (p=). (E) HEK293T cells stably expressing Flag-DOR (red) were fixed 
before (basal) and after (DPDPE) treatment with DPDPE (1μM; 30min).  Co-localization 
(yellow) with Rab9 (green) is seen in treated cells. 
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Figure S1. Expression of full length and truncated SNX11 in BL21-Gold bacteria. Shown here 
is a coomassie stain of total and purified protein (arrows) from BL21-Gold bacteria expressing 
various SNX11 constructs. The eluate was used for PIP-strip overlay assay.
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Synopsis and Graphical Table of Contents: 
 
Snx30 negatively regulates Wnt/β-catenin signaling both in vivo and in vitro. Knockdown of 
Snx30 impaired cardiogenesis in Xenopus laevis increased Wnt/β-catenin signaling in both 
Xenopus and HEK293T cells. Inhibition of Wnt/β-catenin signaling is required for cardiac 
specification and was therefore insufficient upon loss of Snx30, as shown by a smaller cardiac 
population. In HEK293T cells, the Snx30-driven inhibition of Wnt/β-catenin was strongest upon 
expression of specific Frizzled receptors, such as Fz8. Snx30 may thus provide cells a means 
by which to fine-tune this pathway. 
 
Abstract 
During Wnt/β-catenin signalling, Fz/LRP/Wnt signaling complexes are sorted to 
multivesicular bodies where GSK3 is also sequestered to allow the accumulation of 
cytoplasmic β-catenin. However, the mechanisms regulating this trafficking are 
unknown. Sorting nexins are a large protein family that regulates endosomal trafficking 
of proteins such as receptors. Here, we provide the first functional characterization of 
sorting nexin-30 (Snx30). Snx30 was highly expressed during early Xenopus laevis and 
Mesoderm Cardiac specification
Wnt/β-catenin signaling
Snx30
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Gallus gallus development and SNX30-GFP localized mainly to RAB9- and M6PR-
positive endosomes (multivesicular bodies) in HEK293T cells. In Xenopus knockdown 
of Snx30 increased Wnt/β-catenin signaling, reduced Nkx2-5 expression and caused 
heart malformations. In accordance, knockdown of Snx30 in HEK293T co-expressing 
each of the ten Wnt receptors (Fz1-10) and LRP5, significantly increased Wnt/β-catenin 
signaling for all receptors except Fz1/Fz4/Fz9. The specificity of this effect was evaluated 
using cell-surface biotinylation, where knockdown of Snx30 reduced the localization of 
Fz8 at the cell membrane, while leaving Fz4 unaffected. Snx30 could be involved in 
trafficking components of this complex from this compartment. Supporting this 
argument, we found that SNX30 localized to intralumenal vesicles in a Wnt3a-dependent 
manner. We propose that Snx30 negatively regulates Wnt/β-catenin signaling and 
contributes to the inhibition of this pathway required during cardiogenesis. 
 
Introduction 
The Wnt signaling pathway is involved in a vast array of developmental and physiological 
processes, including cardiogenesis (1, 2), and diseases like cancer (3) and bone disease (4). 
Several studies point to a biphasic effect of activation of the Wnt cascade in cardiogenesis and 
while the formation of mesoderm requires Wnt/β-catenin signaling, this pathway must be 
inhibited for the subsequent commitment of these cells to the cardiac lineage (1). During this 
latter stage, many factors such as IGFBP-4, which competitively associates with the Wnt 
receptor Frizzled 8 (Fz8), contribute to this inhibition (5). Recent advances have revealed the 
importance of trafficking during Wnt signal transduction. Upon activation of Wnt/β-catenin 
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signaling, receptor-ligand complexes are internalized and sequestered into multivesicular 
bodies (6, 7). As such, transport vesicles shuttle Wnt receptors to and from the plasma 
membrane, sequentially fusing with dynamic intracellular compartments. However, the 
mechanisms responsible for sorting Wnt receptors within the endosomal network remain 
largely unknown. 
Sorting nexins are a diverse family of membrane-associated proteins that orchestrate 
intracellular receptor trafficking (8). Through their PHOX-homology (PX) domain, sorting nexins 
can detect and bind to phosphatidylinositol phosphate (PtdIns)-enriched elements of 
membranes, where sorting events occur (9). Within the family of sorting nexins, a subgroup of 
12 members contains an additional BAR domain that detects and induces membrane curvature 
(10, 11). Through the dimerization of their BAR domain, they can form higher order oligomeric 
complexes, leading to cargo sorting. Many studies have focused on the role of sorting nexins 
as part of the retromer protein complex, which mediates the retrograde transport of the 
mannose-6-phosphate receptor (M6PR) from the endosome to the trans-Golgi (12). However, 
retromer-independent processes responsible for endocytosis, recycling, secretion and 
degradation, have also been identified (13). Although SNX30 has not been shown to induce 
membrane tubulation in vitro, this SNX-BAR can homo- and heterodimerize with SNX4, 
suggesting roles in sensing membrane curvature (14). Aside from these findings, Snx30 
remains largely uncharacterized. In this study, we demonstrate that SNX30 is required early 
during embryogenesis of Xenopus laevis and plays an important role in cardiogenesis. We also 
provide evidence that SNX30 inhibits Wnt/β-catenin, possibly by disrupting LRP6 signalosomes 
where the β-catenin inhibitor GSK3 is also sequestered during signaling. 
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Results and Discussion 
Snx30 is expressed in early embryogenesis with strong expression in cardiac tissue 
X. laevis (BC097784) and Gallus gallus (BB-GG17906) SNX30 are 79% and 87% identical in 
amino acid sequence, respectively, to human Snx30 (AK127013), and share the same protein 
structure, with an N-terminal PX domain and a C-terminal BAR domain (Figure S1) as predicted 
by the Simple Modular Architecture Research Tool (SMART) (15, 16). To determine the spatio-
temporal expression profile of Snx30, we performed in situ hybridization with DIG-labeled 
antisense RNA probe on chick and Xenopus embryos. In Xenopus Snx30 transcripts were 
detected in the animal pole of the embryo at NF10.5, and later was found in latero-anterior 
mesoderm tissue near the cardiac crescent (NF21), as well as in head and heart tissue (NF35) 
(Figure 1A). In the chick, Snx30 was detected at all stages examined (Figure 1C). At HH stage 
3, Snx30 transcripts were localized to the primitive streak and mesoderm. At late gastrula 
stages (stages 6-7), expression was observed in the primitive streak, notochord and head 
process. Snx30 expression was observed in the heart beginning at the onset of heart tube 
formation. At stage 23, Snx30 was broadly expressed with highest levels in the heart. 
 We analyzed Snx30 expression by RT-PCR on stage-matched Xenopus embryos and human 
heart tissue. In Xenopus, Snx30 was expressed throughout development, from stage NF1 to 
NF42 (Figure 1B) and peaked prior to gastrulation at stages NF7-11. These stages coincide 
with mesoderm specification, which occurs in the equatorial region of the mid- to late blastula 
(NF7-9) from which a subset of mesoderm-derived cells commit to the cardiac lineage during 
gastrulation (1). In human heart tissue, expression of Snx30 was at least two-fold stronger in 
all fetal cardiac tissue (gestational day 20) except for fetal right atrium, where expression of 
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Snx30 was still stronger than in adult tissue (Figure 1D). These results suggest an evolutionarily 
conserved role for Snx30 in heart development. 
 
SNX30 localizes to multivesicular bodies 
We assessed by immunohistochemistry the intracellular distribution of SNX30 in HEK293T 
cells transfected with a SNX30-GFP construct. SNX30-GFP was mobile within these cells 
(Movie M1) and was mainly visible as punctuate, vesicular structures throughout the cytoplasm 
(Figure 2). Although many SNX-BARs are found in early endosomes (17), we found little co-
localization of SNX30-GFP with EEA1 (early endosomes) (Figure 2A), and no co-localization 
with RAB11 (recycling endosomes) (Figure 2B), or LAMP1 (lysosomes) (Figure 2D). SNX30-
GFP co-localized with RAB9 and M6PR, both markers of multivesicular bodies (MVBs) (Figure 
2C,E). These results suggest that Snx30 is mainly involved in trafficking events that occur in 
MVBs. The association of SNX-BARs to specific endosomal compartments is dependent upon 
the association of the PX domain with phosphatidylinositol-phosphates (PtdInsP) (9). To 
assess the lipid-binding properties of SNX30, we performed a lipid-overlay with GST-purified 
human SNX30 (GST-SNX30). GST-SNX30 associated with PtdIns(3)P, PtdIns(4)P and 
PtdIns(5)P (Figure S2). PtdIns(3)P is found in early endosomes and intralumenal vesicles of 
MVBs (18), in accordance with our previous data. 
To identify possible binding partners of Snx30, we performed tandem affinity purification on 
human SNX30. HEK293T cells were transfected either with pCTAP-hSNX30 or pCTAP 
(negative control). Purified proteins were separated by SDS-PAGE and a single band unique 
to pCTAP-hSNX30 analyzed by LC-MS/MS. After peptide analysis with the MASCOT 
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database, SNX4 and SNX30 were identified as the interacting partner to SNX30. To confirm 
the ability of SNX30 to homo- and hetero-dimerize, we immunoprecipitated GFP-tagged SNX30 
and SNX4 from cells co-transfected with V5-SNX30 and –SNX4. Both SNX4 and SNX30 
formed homo- and heterodimers, confirming a previous report (Figure S3 A) (14). We also 
found SNX4 to bind the retromer component VPS35 but not VPS26, whereas no association 
was found with SNX30 (Figure S3 B). Despite these findings, we did not see any co-localization 
between SNX4 and SNX30 in HEK293T cells (Figure S4). 
The existence of SNX30-SNX30 and SNX30-SNX4 dimers demonstrates the complexities of 
protein sorting alluded to by others (19) and would provide a diversity of interactions required 
for fine-tuning signaling pathways. Each Snx30 dimer likely has distinct membrane-binding 
properties that could be responsible for different sorting functions, in multiple signaling 
pathways, similar to the multiple roles of Snx1 (20, 21). However, the identification of cargo 
associated with each dimer may prove challenging due to the fact that these interactions likely 
occur indirectly through associations with a cargo-recognition sub-complex and due to 
difficulties in isolating the instance when interactions occur. 
 
Snx30 regulates gastrulation and is important for cardiogenesis 
To gain insight on Snx30 function during embryogenesis, we produced a knockdown phenotype 
using anti-sense morpholino (MO) oligonucleotides. A 25-mer morpholino was designed to 
complement the 5’-UTR sequence immediately upstream to the start codon (Snx30MO). The 
efficacy of our morpholino in preventing translation of Xenopus Snx30 was confirmed by co-
injecting GFP-tagged Xenopus Snx30 mRNA (100ng) and Snx30MO (20ng), since we were 
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unable to obtain an appropriate antibody (Figure S5A). Embryos responded in a dose-
dependent manner to Snx30MO: while 10ng produced no effect, 20ng decreased survival to 
about 30%, and 40ng was lethal (Figure S6). Co-injection of 100pg of human Snx30 mRNA in 
Snx30MO-treated (20ng) embryos increased survivability by about 20% but we were unable to 
completely rescue the Snx30MO phenotype (Figure S6). For all following morpholino analysis, 
20ng of Snx30MO was used. The first defects appeared during gastrulation (Figure 3B, 3G), 
as blastopore closure defects, leading in some cases to the spilling out of cells (Movie M2). 
This stage was also marked by a sharp decrease in survival (Figure S6). From this point on, 
knockdown embryos were developmentally delayed (Figure 3A-3J, movie M1), shorter in length 
with anterior defects, including generalized malformations of the head and gut as well as ventral 
oedema (Figure 3E, 3J). 
We next examined heart morphology in transverse cross-sections of Snx30MO-injected 
embryos at stage 42 (Figure 3K-3N). Snx30-knockdown embryos had many heart defects 
including a hypoplastic ventricle, poorly developed trabeculations, pericardial oedema, and an 
absent interatrial septum. In accordance, staining for Nkx2-5 transcripts, an early cardiac 
marker, was markedly reduced (Figure 4O, 4P).  
 
Snx30 downregulates Wnt/β-catenin signaling by altering cell-surface expression of 
specific Wnt receptors 
Since the Snx30 phenotype appeared at the onset of gastrulation with a delay in blastopore 
closure and that expression was in proximity to cardiac tissue, we looked at variations in gene 
expression of genes involved in Wnt/β-catenin signaling, known to be important during 
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gastrulation and cardiogenesis (1). In SNX30MO-treated embryos, genes upstream of β-
catenin signaling were unaffected (Wnt3A, Wnt8 and β-catenin), however downstream target 
genes were upregulated (Xnr3, Siamois) (Figure 4A). Xnr3 remained activated up to stage 
NF19, whereas expression in controls was markedly reduced at stage NF15. Expression of 
Xbra, an early mesodermal marker and downstream target of Xnr3 (22), was also stronger in 
Snx30MO-treated embryos. 
To validate the effect of Snx30 knockdown on Wnt/β-catenin signaling observed in Xenopus, 
we used stable HEK293T cells expressing the TOPflash β-catenin-dependent luciferase 
reporter (firefly luciferase and Renilla luciferase (HEK293T+TF) (23). These cells were infected 
with either Snx30 or control shRNAs via lentivirus (Figure S5B) and later co-transfected with 
each mouse Frizzled receptor (mFz1-10) and LRP5, and stimulated with WNT3A-conditionned 
medium. In control conditions (non-silencing shRNA), cells transfected with each of the ten Wnt 
Fz receptors activated β-catenin signaling in response to WNT3A stimulation (Figure 4B). In 
shRNA Snx30 cells, stimulation with WNT3A-conditioned medium significantly increased 
Wnt/β-catenin signaling for a subset of Fz receptors (Figure 4B). The effect of Snx30-
knockdown was strongest in cells were transfected with Fz8 (25 fold increase), while no 
difference was observed in cells transfected with Fz1, Fz4 and Fz9. An important step in Wnt/β-
catenin signaling is the inhibition of GSK3, which normally prevents the accumulation of 
cytoplasmic β-catenin (24). The Snx30 knockdown-dependent increase in Wnt/β-catenin 
signaling was also observed in HEK293T cells without the need for overexpression of Frizzled 
receptors (Figure S9).  This supports the finding that Snx30 effects Wnt/β-catenin signaling 
with endogenous expression of sigaling components.  Treatment of HEK293T+TF cells with 
non-specific (LiCl) (25), or specific (CHIR 99021) GSK3 inhibitors induced a stronger fold 
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activation of Wnt/β-catenin signaling upon Snx30 knockdown compared to controls (Figure 4D). 
This confirmed our previous observations that knockdown of Snx30 in Xenopus embryos 
increases expression of Wnt/β-catenin target genes (Xnr3 and Siamois). 
An essential component of Wnt signaling is the localization of Wnt receptors at the cell surface 
to receive Wnt-mediated extracellular signaling and the subsequent sequestration of a LRP 
signalosome to multivesicular bodies (6). To determine whether Snx30 is involved in Frizzled 
receptor localization to the cell surface, we performed a biotinylation assay on HEK293T+TF 
cells transfected with either Fz4 or Fz8. In accordance with our previous results, knockdown of 
Snx30 did not change the localization of Fz4 (Figure 4C). On the other hand, we did observe 
reduced cell-surface expression of Fz8 (Figure 4C). In both cases, total protein levels of Fz4 
and Fz8 appeared unchanged by knockdown of Snx30 (Figure 4C), suggesting that Snx30 is 
not responsible for degradation of the Fz receptors. Also, we did not find any direct physical 
interaction between either Fz4 or Fz8 and Snx30, using GFP-trap pull-down (Figure S7). 
These results suggest that knockdown of Snx30 in Xenopus embryos caused a delay in the 
inhibition of Wnt/β-catenin usually observed during gastrulation and required for cardiogenesis 
(1). The appearance of gastrulation defects in Snx30MO-treated embryos coincides with the 
upregulation of Wnt/β-catenin target genes, Xnr3 and Siamois, and immediately follows the 
peak in XSnx30 expression observed by RT-PCR. In addition, the upregulation of Xbra and the 
reduced Nkx2-5 staining denotes overactive Wnt/β-catenin signaling, as the activation of this 
pathway is required for mesoderm specification followed by inhibition for cardiac specification 
(1, 2). Although we detected strong expression of Snx30 in later stages of heart development 
such as chamber formation, we did not evaluate expression of downstream target genes due 
to technical difficulties in isolating heart tissue from Xenopus embryos. Nevertheless, the role 
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of Snx30 in regulating Wnt/β-catenin signaling in later stages of cardiogenesis may hold as 
Wnt/β-catenin signaling could still undergo phases of activation/inhibition. 
The increased signaling for certain Fz receptors in Snx30-knockdown cells might be due to the 
specificity of Snx30 towards these receptors and may be a fine-tuning mechanism of Wnt 
signaling. In the case of Fz1, Fz4 and Fz9, for which knockdown of Snx30 had no significant 
effect, Snx30 might not be implicated in sorting these receptors. Alternatively, stimulation of 
these receptors with Wnt3A could induce the use of Snx30-independent routes, while 
stimulation with another ligand might recruit Snx30. The increase in Wnt/β-catenin signaling 
observed upon Snx30 knockdown in cells treated with both GSK3 inhibitors (LiCl and CHIR 
99021) indicates that Snx30 regulates Wnt signaling independently of GSK3 and that 
knockdown of Snx30 acts synergistically with these inhibitors to increase signaling.  
Here, we found that Snx30 can influence the localization of Fz8, as shown by reduced cell-
surface expression of this receptor in Snx30-knockdown cells. This was specific to Fz8 as no 
effect was observed with Fz4, which was neither affected by Snx30 knockdown in our TOPflash 
assay. It is likely that upon Wnt3a stimulation, Fz8 is sequestered to in Xenopus embryos MVBs 
as part of a LRP6/GSK3 signalosomes (6). The fate of Fz and LRP after their passage in MVBs 
is still unknown. A common fate of proteins found in these compartments is degradation. 
However, after Wnt stimulation, levels of GSK3 do not drop suggesting an alternative fate (6). 
Another possibility is that intralumenal vesicles may be recycled back into the cytosol by “back-
fusion” to the late endosome limiting membrane (26). If this is the case for LRP6 signalosomes, 
Snx30 would be a likely candidate for mediating this type of sorting. In agreement, Wnt3a 
stimulation induced a relocalization of SNX30-GFP to intralumenal vesicles of giant endosomes 
(induced by expression of RAB5QL-dsRed) (Figure S8). We speculate that Snx30 may sort 
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specific Fz receptors out of MVBs, thereby disrupting the LRP6 signalosome and releasing 
GSK3 back into the cytoplasm. This would explain a simultaneous decrease of Fz8 at the cell 
surface and increase in Wnt/β-catenin signaling, upon Snx30 knockdown. The synergistic effect 
of Snx30 knockdown in Wnt/β-catenin signaling for cells treated with GSK3 inhibitors could be 
due to the presence of certain Fz receptors in MVBs, which unable to exit due to inefficient 
sorting, although this requires confirmation. 
Taken together, our results show that Snx30 plays a negative role in Wnt/β-catenin signaling 
during gastrulation possibly by regulating the localization of specific Fz receptors within the cell. 
The localization of Snx30 in multivesicular bodies suggests a function in sorting Fz receptors 
from this compartment. We thus propose that Snx30 contributes to the biphasic nature of 
Wnt/β-catenin signaling that occurs during early cardiogenesis (1). As cell-based therapies 
continue to make progress, understanding every step of cardiac differentiation is essential to 
apply these techniques in clinical settings. 
 
Materials and Methods 
Cloning of Gateway Entry and Expression clones 
All expression clones were generated with the Gateway cloning system (Invitrogen). Entry 
clones were produced using a two-step Gateway cloning procedure (27): 1) open reading 
frames (ORF) were amplified from cDNA clones (human Snx4: BC018762; human Snx30: 
BC165765; X. laevis Snx30: IMAGE 6868636 – Open Biosystems) for 11 cycles using gene-
specific primers, and 2) 5μL of step-1 PCR products were used as template for amplification 
(24 cycles) of target sequence with step-2 primers (Table S1). Reverse primers were designed 
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to produce an ORF with or without a stop codon, thus allowing the production of N- or C-terminal 
fusion proteins. Clones were sequenced (Sanger) at the McGill University and Génome 
Québec Innovation Center. PCR products were purified by gel extraction (QIAguick gel 
extraction kit, QIAGEN) and used in recombination reactions according to manufacturer 
protocol. 
Expression plasmids were made by recombinations between entry clones and the following 
destination clones: pDS-X-GFP (C-terminal GFP, ATCC: 1032336345), pDS-GFP-X (N-
terminal GFP, ATCC: 1032336345), pcDNA3.1_nV5-DEST (N-terminal V5 tag, Invitrogen), 
pDEST565 (N-terminal GST tag, Addgene), pDEST_CS-CeGFP (C-terminal eGFP tag). 
pDEST_CS-CeGFP was made by amplifying eGFP from pEGFP-N1 and inserted into pCS-
DEST (a generous gift from Nathan Lawson) with XhoI and XbaI restriction enzymes. 
 
Whole-mount in situ hybridization 
All animals were handled in accordance with the guidelines of the Sainte-Justine Hospital 
bioethics committee. X. laevis embryos were generated by in vitro fertilization, their handling, 
culture, and staging followed standard procedures (28). Whole-mount in situ hybridization was 
performed as described (29) using digoxygenin-UTP-labeled probes (Roche). For antisense 
DIG-labeled RNA probes, pEXP-CS_Xsnx30 was linearized with BglII (T3), and pCS-Xnkx2-5 
was linearized with HindIII (T7) (Fermentas). Probes were detected with the DIG detection kit 
(Roche) according to the manufacturer’s manual. Fertile chicken (Gallus gallus) eggs were 
obtained from Hy-Line International (Spencer, IA) and incubated 37°C in a humid environment 
until the desired Hamburger-Hamilton stage (1951, 1992). Embryos were fixed in 4% 
 135 
 
paraformaldehyde in PBS overnight at 4ºC. In situ hybridizations were performed as described 
(30) with minor modifications (protocol available at http://geisha.arizona.edu). The antisense 
DIG-labeled RNA probe for SNX30 was transcribed from a cDNA template corresponding to nt 
20-830 of the chicken SNX30 mRNA sequence (XM_424910). 
 
RT-PCR (Xenopus) and RT-qPCR (human) 
Total Xenopus RNA was extracted with TRIzol reagent (Invitrogen) from three stage-matched 
embryos at indicated stages. Primer sequences for the following genes can be found in Table 
S1: β-catenin, Brachyury (Xbra), Nkx2-5, Nodal-related 3 (Xnr3), Ornithine decarboxylase 
(ODC), Siamois (Sia), Sorting nexin-30 (Xsnx30), Wnt3A, Wnt8. 
Total human RNA was prepared and treated with RNase-free DNase (Ambion). 500 ng to 1 μg 
of RNA was reverse transcribed into cDNA using random hexamers and Oligo (dT) with 
Superscript III Reverse Transcriptase (Invitrogen). QPCR was performed on a MasterCycler 
EP RealPlex (Eppendorf) using QuantiFast SYBR Green PCR Kit (Qiagen). Expression levels 
were normalized to the housekeeping gene TATA box binding protein (TBP). In addition to TBP 
for normalization across samples, genomic DNA was used as a DNA standard. The y axis of 
RT-qPCR graphs represents copy numbers of the gene of interest divided by copy numbers of 
TBP, and therefore is an arbitrary but absolute unit, that can be compared between 
experiments. Error bars represent standard error of the mean (s.e.m.). 
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Immunohistochemistry 
HEK293T cells were seeded on Poly-L-lysine-coated coverslips in 12-well plates and fixed in 
methanol for 10 minutes at 4˚C, blocked for 1 hour at room temperature in blocking buffer 
(TBS/5% fat-free milk/5% goat serum) and incubated overnight with primary antibodies at 4˚C. 
Cells were washed 3 x 5 minutes in TBS and incubated 1 hour at room temperature with 
secondary antibody (1:1000) in blocking buffer (Alexa 594 anti-rabbit, anti-mouse, Invitrogen). 
Cells were washed 3x 5 minutes and placed on microslides with ProLong Gold antifade reagent 
(Invitrogen). Pictures were taken on a ImageDisc confocal microscope. 
 
Antibodies 
Anti-SNX30 (HPA019346), anti-EEA-1 (HPA03158) and anti-GST (G 1160) antibodies were 
from Sigma. Anti-Vps26 (ab23892), anti-Vps35 (ab57632), anti-, anti-LAMP1 (ab24178), and 
anti-M6PR (ab2733) antibodies were from Abcam. Anti-V5 (MA1-81617) antibodies were from 
ThermoScientific. Anti-Rab9 (sc-53145) and anti-Rab11 (sc-166523) antibodies were from 
Santa Cruz. Anti-1D4 antibody was a generous gift from Jeremy Nathans. 
 
Antisense morpholinos, RNA transcription and microinjection 
Antisense morpholino oligonucleotides were designed and manufactured by Gene Tools LLC. 
The antisense 25-mer morpholino for Xsnx30 was designed against the 5’UTR immediately 
preceding the start codon (5’-GTTTTTGTACCTCCCAGCACTCACA-3’). As a control, a 25-mer 
morpholino with no target and no significant biological activity was used (5’-
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CCTCTTACCTCAGTTACAATTTATA-3’). Morpholinos were injected in stage 1 embryos after 
fertilization. Only the embryos that went on to stage 2 were used and accounted for during all 
experiments. Comparisons between Snx30MO- and CtlMO-treated embryos were done in 
same-fertilization batches to avoid non-specific effects. Capped RNAs were transcribed in vitro 
using the mMessage mMachine kit (Ambion) from the pEXP-CS_Xsnx30-3UTR clone. We 
injected 100pg of Snx30 RNA into stage 1 embryos. 
 
Biotinylation 
Biotinylation was performed as previously described (31). Briefly, cells were washed with ice-
cold PBS/CM (1x PBS, 0.9mM CaCl2, 0.33mM MgCl2) and incubated with PBS/CM + 
0.5mg/mL Sulfo-NSH-SS-biotin (Fisher, PI21331). After quenching with PBS/CM + 50mM 
NH4Cl, cells were lysed in 500μL ice-cold lysis buffer (50mM Tris-Cl, pH 8.0, 1.25% Triton X-
100, 0.25% SDS, 150mM NaCl, 5mM EDTA and 10μg/mL PMSF). Biotinylated proteins were 
immobilized on streptavidin beads (GE Healthcare) and separated on SDS-PAGE. Vectors for 
mouse Frizzled receptors, pRK5_Fz1-10, pRK5_Fz4-1D4 and pRK5_Fz8-1D4, were obtained 
as a generous gift from Jeremy Nathans (32). 
 
GFP-Trap 
HEK293 cells were co-transfected with pEXP_V5-SNX30 or pEXP_V5-SNX4 and SNX30-GFP 
or pEXP_SNX4-GFP, SNX30-GFP and Fz4-1D4 or Fz8-1D4 and harvested 48h later for GFP 
co-immunopurification. GFP-tagged proteins purified from cellular extracts by GFP-trap_M 
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(Chromotek, Martinsried, Germany) following the manufacturer’s manual. Purified samples 
were separated on SDS-PAGE and co-immunopurification of GFP- and V5-tagged constructs, 
Fz4/8-1D4, Vps26 and Vps35 were determined by Western blot. 
 
Lentivirus production 
The lentiviruses encoding shRNAs against human and mouse Snx30, and control vector were 
purchased from OpenBiosystems (pGIPZ-shRNA_hSnx30-338031 and pGIPZ-
shRNA_mSnx30-86452, pGIPZ). Viruses were produced as described previously (33) and 
titers adjusted when necessary to achieve ~90% infectivity. 
 
TOPflash reporter assay 
HEK293T cells stably expressing the β-catenin-dependent luciferase reporter (firefly luciferase) 
and Renilla luciferase (23) (under the control of the constitutive EF1α promoter as a 
normalization probe) were infected with Snx30 lentivirus. Conditioned media were produced as 
previously described (23). Briefly, mouse L cells expressing Wnt3A (CRL-2647) were cultured 
to 100% confluence, after which the medium was harvested and replaced every 2 days for a 
total of 6 days. Medium from different days was assayed by using the TOPflash reporter assay 
and fractions with greatest activation were pooled and subsequently used for stimulation 
experiments. Conditioned medium from parental mouse L cells not producing Wnt3A (CRL-
2648) was produced in parallel and used as control. Cells were transfected with Fz receptors 
(pRK5-Fz1 to -10, a generous gift from Jeremy Nathans) and LRP5 (pRK5-LRP5), and 
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stimulated with conditioned media 48h after. Stimulated cells were assayed 24h after 
stimulation according to the dual luciferase protocol (Promega) using an Envision plate reader 
(Perkin-Elmer). The GSK3β inhibitors LiCl and CHIR 99021 (Selleckchem, S1263) were used 
to activate the TOPflash reporter. Cells were treated with LiCl or CHIR 99021 for 24h prior to 
performing the dual luciferase assay (Promega). 
 
Protein-lipid overlay assay 
The expression clone pEXP565-hSnx30 was transformed into E. coli BL21 and expression of 
the GST-tagged construct was induced with 1mM IPTG. Purification was performed with the 
MagneGST system (Promega). Purified proteins were incubated (1μg/mL) with PIP Strips 
(Echelon-inc) according to manufacturer protocol. Binding to phospholipids was detected by 
Western blot using anti-GST antibody. 
 
Tandem Affinity Purification 
SNX30 was cloned into a mammalian expression vector (pCTAP-A) that has a C-terminal TAP-
tag composed of a streptavidin-binding protein and a calmodulin-binding protein (InterPlay 
Mammalian TAP System, Stratagene). HEK293T cells were transfected with pCTAP_SNX30 
and with the empty vector as a negative control (pCTAP-A). Tagged proteins were purified 
according to manufacturer protocol, separated on SDS-PAGE and silver-stained. A single band 
only present in our Snx30-TAP sample was cut, digested (trypsin) and analyzed by mass 
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spectrometry LC-MS/MS (Institute for Research in Immunology and Cancer). Proteins were 
identified with the MASCOT database. 
 
Statistical analysis 
Data are expressed as mean ± standard deviation. Differences were considered significant if 
p<0.05 threshold. 
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Figure 1. Expression profile of Snx30 in Xenopus laevis and Gallus gallus.  A) In situ 
hybridization in X. laevis shows expression in the animal pole at NF10.5, in latero-anterior 
mesoderm tissue at NF21 and in head and heart (arrow) at NF35. B) RT-PCR of Xenopus 
laevis Snx30 shows expression throughout development with increased expression at stages 
NF7-11 (ODC was used as control) C) In situ hybridization in Gallus gallus embryos at indicated 
stages shows Snx30 expression in the primitive streak, early mesoderm, heart tube, neural 
tube and notochord. At stage 12 and 18, expression was strongest in the heart and notochord. 
D) RT-qPCR analysis for Snx30 in human fetal heart tissue and adult heart. LV, left ventricle; 
RV, right ventricle; AP, Apex; LA, left atria; RA, right atria, AVJ, atrioventricular junction; AH, 
adult heart. Error bars represent s.e.m., n = 6.  
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Figure 2. Intracellular localization of SNX30-GFP in HEK293T cells. HEK293T cells transfected 
with pEXP- SNX30-GFP were stained using markers of specific intracellular compartments 
(red). These markers were A) EEA1 (early endosome), B) RAB11 (recycling endosomes), C) 
RAB9 (multivesicular bodies), D) LAMP1 (lysosomes), and M6PR (multivesicular bodies). The 
panels on the right are merged channels and a yellow signal indicates co-localization (arrows). 
Scale bar = 10μm. 
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Figure 3. Phenotype of Snx30 knockdown in X. laevis. A-J) Single-cell embryos injected with 
Snx30 morpholino were developmentally delayed, starting after gastrulation. Embryos were 
shorter in length with anterior defects (scale = 1mm). K-N) Heart morphology in control embryos 
(K, L) vs Snx30 knockdown embryos (M, N) (scale = 25μm). Knockdown of Snx30 caused 
pericardial oedema, hypoplastic ventricle, absent interatrial septum, poorly formed 
trabeculations (M). Trabeculations were normal in controls (L) but almost inexistent in Snx30 
knockdown embryos (N). O,P) Nkx2-5 staining by in situ hybridization was reduced in 
SNX30MO-treated embryos at stage NF21 compared to controls. 
  
 
 149 
 
 
Figure 4. Effect of Snx30 knockdown on Wnt/β-catenin signaling. A) RT-PCR analysis of genes 
involved in Wnt/β-catenin signaling. The β-catenin targets Siamois and Xnr3 were upregulated 
as well as the mesoderm marker Xbra. Expression of Wnt8, Wnt3A and β-catenin were 
unaffected. B) HEK293T cells stably expressing the β-catenin-dependent luciferase reporter 
(TOPflash) and either non-silencing or hSnx30 shRNA were co-transfected with each of the ten 
Frizzleds (Fz1-10) and LRP5. Fold activation of Wnt/β-catenin signaling after stimulation with 
Wnt3A is shown (n = 9). C) Cell-surface expression of Fzd4 and Fzd8 was assessed by 
biotinylation and subsequent isolation with streptavidin beads. Compared to controls, 
knockdown of Snx30 reduced cell-surface expression of Fz8 (6% band density compared to 
control) while that of Fz4 (123% band density compared to control) remained unchanged. D) 
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Treatment of HEK293T+TF cells with increasing doses of the non-specific (LiCl) and specific 
(CHIR 99021) GSK3 inhibitors caused a stronger fold activation of Wnt/β-catenin signaling in 
Snx30-knockdown cells than in controls (n = 3). *p<0.05, **p<0.01, error bars represent 
standard deviation. 
  
 
 
 
Cameron_Supplemental Movie M1 
Live cell imaging of SNX30-GFP. SNX30-GFP is mobile inside the cell. Each frame represents 
a 5 minute time-lapse.  Scale bar = 6μm. 
 
 
Cameron_Supplemental Movie M2 
Time-lapse of gastrulation and neurulation up to stage Nieuwkoop-Faber 35 in Snx30 
knockdown versus normal controls (Xenopus laevis). 
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Figure S1. SNX30 protein structure. Amino acid positions are indicated at the start and end of 
each predicted protein domain. 
 
 
 
  
Figure S2. Lipid overlay assay. Purified GST-SNX30 from bacterial culture was incubated with 
a PIP-strip (Echelon). SNX30 bound to PtdIns(3)P, PtdIns(4)P and PtdIns(5)P. 
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Figure S3. Co-immunoprecipitation of SNX30 and SNX4. A) GFP-trap was used to 
immunoprecipitate GFP-SNX30 or GFP-SNX4 from cell lysates transfected with V5-tagged or 
GFP-tagged constructs (L: load; U: unbound; W: wash; B: bound). In all conditions, SNX30 and 
SNX4 homo- and hetero-dimerize. GFP was used as a negative control. B) Interactions 
between SNX4/30 with endogenous retromer components VPS35 and VPS26 were evaluated. 
Only SNX4 bound to VPS35. 
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Figure S4. Distribution of SNX30-GFP and SNX4 in HEK293T cells. HEK293T cells were 
transfected with SNX30-GFP and stained with anti-SNX4 antibody. No co-localization was seen 
between SNX30-GFP and SNX4. 
 
 
 
Figure S5. Proof of Snx30 knockdown. A) Proof of knockdown in X. laevis injected with GFP-
SNX30 capped mRNA (100ng). Left panel shows reduced GFP expression in Snx30MO-
treated embryos. Right panel shows reduced expression as shown by Western blot. B) 
HEK293T cells were infected via lentivirus with shRNAs (non-silencing and Snx30). shRNA-
Snx30 was effective at reducing endogenous protein expression. 
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Figure S6. Survival curve of one-cell X. laevis embryos injected with indicated morpholinos. 
 
 
 
Figure S7. GFP-trap of SNX30 and Fz4/Fz8. This pull-down experiment shows the lack of 
physical interaction between SNX30 and the Wnt receptors Fz4 and Fz8. 
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Figure S8. Confocal analysis of SNX30 localization upon Wnt stimulation. Top panel: green, 
SNX30-GFP; red, RAB5QL-dsRed. Bottom panel: DIC photograph providing cell contours. 
SNX30-GFP localizes to intralumenal vesicles after stimulation with Wnt3a. Cells transfected 
with RAB5QL-dsRed and SNX30-GFP were treated with control and Wnt3a conditioned 
medium for 4 hours. Cells were then fixed and observed with a confocal microscope. After 
stimulation with Wnt3a, SNX30-GFP localized to the intralumenal vesicles of giant endosomes 
created by expression of RAB5QL (6). 
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Figure S9. Knockdown of Snx30 (shRNA Snx30) increases Wnt/β-catenin signaling. TOPflash 
HEK293T treated with either shRNA non-silencing or shRNA Snx30 were treated with Wnt3A-
conditioned medium and assayed for activation of the Wnt/β-catenin signaling using a dual 
luciferase assay.  (* p < 0.05) 
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Table 1. Primer sequences (S: sense, AS: antisense; Y corresponds to T or C). 
Gene Primers 
β-catenin 
S: 5’-CACACTGGCCTTTGATAAAG-3’ 
AS: 5’-TTCAACAATCTCCTCCATGC-3’ 
Human Snx4 
S: 5’-GGCTCCACCATGGCGGGCGGGCCCCCC-3’ 
AS: 5’-TGGGTGGATYCACTTGGCCTCTTGTTTCTCC-3’ 
Human Snx30 
S: 5’-GGCTCCACCATGGCGGGCGGGCCCCCC-3’ 
AS: 5’-TGGGTGGATYCACTTGGCCTCTTGTTTCTCC-3’ 
Siamois 
S: 5’-AAGATAACTGGCATTCCTGAGC-3’ 
AS: 5’-GGTAGGGCTGTGTATTTGAAGG-3’ 
Wnt3A 
S: 5’-CTGGGGAAGGCTGGAAGTG-3’ 
AS: 5’-TTGGGGGAGCTCTCATAGTAAATC-3’ 
Wnt8 
S: 5’-AGATGACGGCATTCCAGA-3’ 
AS: 5’-TCTCCCGATATCTCAGGA-3’ 
Xbra 
S: 5’-GCCTGTCTGTCAATGCTCCA-3’ 
AS: 5’-TGTGCTCCATGCTCATACAA-3’ 
Xnr3 
S: 5’-ACCGTCCAAAGCTTCATCGCTA-3’ 
AS: 5’-TCCTTGCCGTCATTGGTATGGT-3’ 
Xenopus snx30 (for 
cloning) 
S: 5’-GGCTCCACCATGTCAGGCTCCAGTTCTCC-3’ 
AS: 5’-TGGGTGGATYCACTTTGGTTCCTGTTTGTCTTGTAGC-3’ 
Xenopus snx30 (for 
RT-PCR) 
S: 5’-TGCGGAATTTGCCACCGTAACA-3’ 
AS: 5’-AGCAGTTTCCAACACAGGCTGA-3’ 
eGFP 
S: 5’-AATTCTCGAGATGGTGAGCAAGGGCGAGGAG-3’ 
AS: 5’-TTATGATCTAGAGTCGCGGCC-3’ 
Step-2 Gateway 
Cloning 
S: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTCCACCATG-3’ 
AS: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTGGATYCA-3’ 
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Chapter 4: Conclusion 
 
The work presented here is the first to explicitly address the roles of two sorting nexins, 
Snx11 and Snx30, during embryogenesis.  These proteins are part of a network of molecules 
that regulate endosomal protein trafficking.  The data presented in this work contributes to our 
understanding of how protein trafficking can affect signaling pathways.  However, since these 
studies are the first to address the function of Snx11 and Snx30, there are still many questions 
to be answered before a clear picture about their function can be made.  Nevertheless, these 
results shed light upon two proteins that may eventually become as therapeutic targets. 
  
Characterization of two new sorting nexins 
 
When studying a new gene, a few classical “fishing” experiments must be performed.  
Expression profile analysis and knockdown (or knockout) experiments are the most important.  
Protein-protein interaction assays can also be very informative but even when using 
independent assays, they run the risk of identifying too many candidates, of which many can 
be false-positives. 
Having analyzed the expression profile, knockdown effects, and potential protein-protein 
interactions, Snx30 seems to behave as a dimerizing protein (with another SNX-BAR) that is 
expressed early on during embryogenesis with the potential to not only affect heart 
development but also the development of other organs and systems.  Due to the scope of this 
study and based on previous unpublished data, the focus of analysis of developmental defects 
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caused by knockdown of Snx30 was limited to the heart.  However, upon evaluation of the 
effect of knockdown of Snx30, it is clear that Snx30 is not only implicated in cardiogenesis but 
also in many other developmental processes.  Aside from cardiac defects, other visible 
malformations were observed in Snx30 knockdown embryos: they are shorter in length, and 
they have malformations of the eyes and digestive system.  CNS defects may also be present 
but this was not evaluated.  The fact that Snx30 seems to be implicated in multiple 
developmental pathways hints towards a characteristic of many sorting nexins: their 
promiscuous nature.  This is not surprising if you take into account the presence of the BAR 
domain.  This dimerization domain offers many potential SNX-BAR combinations.  Indeed, at 
least in vitro, Snx30 can homodimerize as well as form a dimer with Snx4.  How this affects 
various signaling pathways and developmental processes has yet to be discovered but does 
increase the complexity of this group of proteins.  Do the combinations of Snx30-Snx30 and 
Snx30-Snx4 have different functions or are they redundant?  Cells would benefit from both 
options.  In one case, the diversity of interactions offered by various SNX-BARs would provide 
the cell with an efficient way to regulate multiple pathways.  On the other hand, redundancy is 
a good way to prevent catastrophic outcomes in case a single protein is mutated or misfolded.  
Of course, not all BAR domains dimerize together.  For example, in retromer, Snx1 will dimerize 
with Snx5 or Snx6 but not with Snx2 [114].  Likewise, Snx5 will dimerize with Snx1 or Snx2 but 
not with Snx6 [114].  However in yeast only two proteins forming the Snx dimer exist (Vps5p 
and Vps17p).  The specialized roles of multicellular organisms like vertebrates require higher 
specialization, which may have resulted in the expansion of the Snx family.  Future studies will 
be needed to answer these questions.  
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SNX30 and Wnt/β-catenin signaling 
 
Recently, Taelman et al. (2010) found that Wnt/β-catenin signaling is dependent upon 
intracellular trafficking of LRP6 signalosomes to MVBs [103].  The fact that altering Snx30 
expression in HEK293T cells significantly alters the output of Wnt/β-catenin signaling supports 
the idea that intracellular trafficking is an essential part of this signaling pathway.  To 
substantiate the strength of this experience, an evaluation of the expression of each receptor 
would be needed.  However, the finding that this effect is only detectable for a certain set of 
Wnt receptors is indicative of increased specificity.  Indeed, Snx30 has differing effects on 
Wnt/β-catenin signaling depending on the receptor present.  While RABs and the ESCRT are 
well-known to be essential for vesicle movement and MVB formation, their requirement during 
Wnt signaling is fundamental.  In other words, any change in expression of these crucial genes 
affects every trafficking events to MVBs, at all stages of development, in every cells.  On the 
other hand, Snx30 is expressed in a specific set of cells and plays a role on the trafficking of a 
specific set of Wnt receptors.  Therefore, altering its expression does not cause generalized 
Wnt signaling variations nor is it lethal during development.  For example, knockdown of Snx30 
did not affect Wnt/β-catenin signaling via the Fz4 receptor, neither did it affect its localization.  
This characteristic is interesting pharmacologically because of its specific mode of action.  
Endogenous variability in Snx30 expression across time and space may be a way of fine-tuning 
Wnt/β-catenin signaling.   
How does Snx30 accomplish its negative effect on Wnt/β-catenin signaling?  One possibility 
is that it mediates the recycling of LRP6 signalosomes back to membranes facing the 
cytoplasm, thereby releasing GSK3 from intralumenal vesicles (Figure 19).  Data on trafficking 
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to and from the internal membranes of MVBs is scarce.  In mammalian cells that have impaired 
LBPA functions, CI-M6PR accumulates in the internal membranes of late endosomes [83].  
Therefore, proteins may at least to some extent cycle between the outer and inner membranes 
of MVBs.  Although essential to MVB formation, the ESCRT machinery can be considered as 
a generic mediator of this process that does not show any cargo specificity.  Therefore, 
additional factors likely come into play when a protein complex like the LRP6 signalosome gets 
sorted to MVBs.  The extent of this work did not address whether or not Snx30 plays this role 
but this possibility would be interesting to examine.  
 
 
 
Figure 19. First model for a mechanism of Wnt/β-catenin signaling inhibition by SNX30. 
In order to reduce the levels of cytoplasmic β-catenin, LRP signalosomes could be 
released from MVBs through sorting by SNX30 (homo- or heterodimer of SNX-BAR, 
SNX30 or SNX4). 
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Another possibility is that Snx30 sorts receptors found in MVBs to the lysosome (Figure 
20).  This would ultimately limit the amount of receptors available for activation at the cell 
membrane and reduce Wnt signaling via those receptors.  Both models suggest a trafficking 
decision taken at MVBs, based mainly on immunohistochemistry data.  Co-localization studies 
of Snx30 and the various candidate cargos may help in clarifying the mechanism of Snx30 
function. 
 There is often a gap of unanswered questions between biomolecular and physiological 
research.  As such integrating biomolecular data into a holistic model requires both in vivo and 
in vitro experiments.  Here, we found that Snx30’s expression profile corresponds to periods of 
rapidly changing Wnt/β-catenin signaling activity, namely the period at which the Xnr3 and 
Siamois target genes are downregulated in X. laevis.  This and other results suggest that Snx30 
is a developmentally regulated gene that allows cardiac specification of mesoderm cells.  It 
does so carrying out intracellular trafficking events that lead to the inhibition of Wnt/β-catenin 
signaling (phosphorylation of β-catenin by GSK3).  The Fz8 receptor is expressed in the 
Spemann organizer and early dorsal mesoderm [363].  As this was one of the receptors that 
responded the most to knockdown of Snx30, it would make sense physiologically and 
biomolecularly that Snx30 downregulates Wnt/β-catenin signaling by mediating trafficking of 
Fz8 receptor complexes.  By doing so, activation of Wnt/β-catenin signaling via Fz8 would be 
inhibited without necessarily causing its degradation, which may be energetically expensive for 
the cell.  Instead, Snx30 could release Fz8-containing LRP signalosomes from MVBs, returning 
Fz8 to the plasma membrane and at the same time allowing GSK3 to phosphorylate β-catenin.  
Again further study will be needed to address this question. 
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Figure 20. Second model for a mechanism of Wnt/β-catenin signaling inhibition by 
SNX30. SNX30 could inhibit Wnt/β-catenin signaling by sorting receptors towards the 
degradative pathway. 
 
Although our current data clearly suggests a role for Snx30 in regulating Wnt/β-catenin 
signaling, many new and remaining questions will have to be addressed before we can include 
Snx30 as a bona fide regulator of Wnt signaling.  What is the nature of Snx30’s cargo and does 
it bind directly to it?  Does Snx30 mediate the sequestration of the LRP6 complex to late 
endosomes as previously described or does it rather help release LRP signalosome from the 
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MVB [103].  Are in vivo TopFlash reporters similar to results from cell culture?  Is Snx30 
associated with proteins involved with trafficking LRP6 to multivesicular bodies?  Are any other 
signaling pathways regulated by Snx30? 
The fundamental importance of Wnt signaling during vertebrate embryogenesis and its link 
with many diseases makes any new finding on the regulation of Wnt signaling very exciting.  
However, it must be taken into account that other signaling pathways may be controlled by 
Snx30 through the formation of various BAR dimers (SNX30-Snx30 and SNX30-SNX4).  As 
the precise role of Snx30 becomes better understood, therapeutic applications may begin to 
appear. 
 
 
The dual functions of SNX11 
 
As previously mentioned, Snx11 appears to have at least two functions.  The first function 
seems to involve actin-dependent processes that involve either the production or indirect 
modification of extracellular proteins.  Although this remains to be proven, many lines of 
evidence suggest such a function.  First, expression of Snx11 in cartilage and its requirement 
for somitogenesis suggest an underlying function in either sending or receiving signals from 
the extracellular matrix.  Second, actin remodelling is not uncommon during processes that 
engage the extra-cellular matrix and Snx11 clearly seems to have a positive effect on actin 
polymerization.  It would be interesting to evaluate the link between Snx11 and actin, and to 
evaluate if it localizes preferentially to the cell membrane. 
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The second function that was discovered is the Snx11-dependent inhibition of DOR 
recycling, in which recycling was actin-independent and seems to occur from late endosomes, 
which is relatively far from interactions with the extra-cellular matrix.  However, further work into 
this process would be required to determine whether this inhibition is dependent upon actin 
polymerization and what is the trafficking outcome of the receptor after the involvement of 
SNX11.  A possible outcomes include trafficking towards the degradative pathway and this 
could involve actin polymerization.  In addition, due to the availability of the DOR recycling 
assay, this experiment was used to evaluate the role of SNX11 in receptor recycling.  However, 
it would be interesting and more relevant to evaluate the effect of Snx11 on the trafficking of 
other receptors, especially those involved in the main signaling pathways of somitogenesis 
(e.g. Notch receptor).  Unfortunately, a mechanistic model for such functions is still lacking due 
to insufficient data.  In addition, it would be interesting to determine whether overexpression of 
SNX11 inhibits DOR recycling and whether it can counter the effect of shRNA-mediated 
knockdown.  This would substantially increase the strength of the conclusions found in this 
paper. 
Both studies have evaluated the role of these proteins in vivo and in vitro.  Taken together, 
the work presented here will provide valuable background information for future studies of 
Snx11 and Snx30. 
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